<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Ischaemic preconditioning for the reduction of renal ischaemia reperfusion injury - Menting, TP - 2017 | Cochrane Library</title> <meta content="Ischaemic preconditioning for the reduction of renal ischaemia reperfusion injury - Menting, TP - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010777.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Ischaemic preconditioning for the reduction of renal ischaemia reperfusion injury - Menting, TP - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010777.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010777.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Ischaemic preconditioning for the reduction of renal ischaemia reperfusion injury" name="citation_title"/> <meta content="Theo P Menting" name="citation_author"/> <meta content="Radboud University Nijmegen Medical Centre" name="citation_author_institution"/> <meta content="theo.menting@radboudumc.nl" name="citation_author_email"/> <meta content="Kimberley E Wever" name="citation_author"/> <meta content="Radboud University Nijmegen Medical Centre" name="citation_author_institution"/> <meta content="Denise MD Ozdemir‐van Brunschot" name="citation_author"/> <meta content="Radboud University Nijmegen Medical Centre" name="citation_author_institution"/> <meta content="Daan JA Van der Vliet" name="citation_author"/> <meta content="Radboud University Nijmegen Medical Centre" name="citation_author_institution"/> <meta content="Maroeska M Rovers" name="citation_author"/> <meta content="Radboud University Nijmegen Medical Centre" name="citation_author_institution"/> <meta content="Michiel C Warle" name="citation_author"/> <meta content="Radboud University Nijmegen Medical Centre" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD010777.pub2" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/03/04" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010777.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010777.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010777.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Creatinine [blood]; Ischemic Preconditioning [adverse effects, *methods, mortality]; Kidney [*blood supply]; Kidney Diseases [blood, mortality, *prevention &amp; control]; Randomized Controlled Trials as Topic; Reperfusion Injury [blood, mortality, *prevention &amp; control]; Time Factors" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010777.pub2&amp;doi=10.1002/14651858.CD010777.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010777.pub2&amp;doi=10.1002/14651858.CD010777.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010777.pub2&amp;doi=10.1002/14651858.CD010777.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010777.pub2&amp;doi=10.1002/14651858.CD010777.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010777.pub2&amp;doi=10.1002/14651858.CD010777.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010777.pub2&amp;doi=10.1002/14651858.CD010777.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010777.pub2&amp;doi=10.1002/14651858.CD010777.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010777.pub2&amp;doi=10.1002/14651858.CD010777.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010777.pub2&amp;doi=10.1002/14651858.CD010777.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010777.pub2&amp;doi=10.1002/14651858.CD010777.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010777.pub2&amp;doi=10.1002/14651858.CD010777.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010777.pub2&amp;doi=10.1002/14651858.CD010777.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010777.pub2&amp;doi=10.1002/14651858.CD010777.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010777.pub2&amp;doi=10.1002/14651858.CD010777.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010777.pub2&amp;doi=10.1002/14651858.CD010777.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010777.pub2&amp;doi=10.1002/14651858.CD010777.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010777.pub2&amp;doi=10.1002/14651858.CD010777.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010777.pub2&amp;doi=10.1002/14651858.CD010777.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010777.pub2&amp;doi=10.1002/14651858.CD010777.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010777.pub2&amp;doi=10.1002/14651858.CD010777.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010777.pub2&amp;doi=10.1002/14651858.CD010777.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010777.pub2&amp;doi=10.1002/14651858.CD010777.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010777.pub2&amp;doi=10.1002/14651858.CD010777.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="77cjsSG8";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010777\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010777\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010777\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010777\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","ms","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010777.pub2",title:"Ischaemic preconditioning for the reduction of renal ischaemia reperfusion injury",firstPublishedDate:"Mar 4, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Kidney and Transplant Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=77cjsSG8&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010777.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010777.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010777.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010777.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010777.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010777.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010777.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010777.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010777.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010777.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2148 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010777.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/full#CD010777-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/full#CD010777-sec-0094"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/full#CD010777-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/full#CD010777-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/full#CD010777-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/full#CD010777-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/full#CD010777-sec-0052"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/full#CD010777-sec-0088"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/appendices#CD010777-sec-0099"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/table_n/CD010777StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/table_n/CD010777StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Ischaemic preconditioning for the reduction of renal ischaemia reperfusion injury</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/information#CD010777-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Theo P Menting</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/information#CD010777-cr-0003">Kimberley E Wever</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/information#CD010777-cr-0004">Denise MD Ozdemir‐van Brunschot</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/information#CD010777-cr-0005">Daan JA Van der Vliet</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/information#CD010777-cr-0006">Maroeska M Rovers</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010777.pub2/information#CD010777-cr-0007">Michiel C Warle</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/information/en#CD010777-sec-0103">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 04 March 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010777.pub2">https://doi.org/10.1002/14651858.CD010777.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010777-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010777-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010777-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010777-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010777-abs-0009">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010777-abs-0001" lang="en"> <section id="CD010777-sec-0001"> <h3 class="title" id="CD010777-sec-0001">Background</h3> <p>Ischaemia reperfusion injury can lead to kidney dysfunction or failure. Ischaemic preconditioning is a short period of deprivation of blood supply to particular organs or tissue, followed by a period of reperfusion. It has the potential to protect kidneys from ischaemia reperfusion injury. </p> </section> <section id="CD010777-sec-0002"> <h3 class="title" id="CD010777-sec-0002">Objectives</h3> <p>This review aimed to look at the benefits and harms of local and remote ischaemic preconditioning to reduce ischaemia and reperfusion injury among people with renal ischaemia reperfusion injury. </p> </section> <section id="CD010777-sec-0003"> <h3 class="title" id="CD010777-sec-0003">Search methods</h3> <p>We searched Cochrane Kidney and Transplant's Specialised Register to 5 August 2016 through contact with the Information Specialist using search terms relevant to this review. </p> </section> <section id="CD010777-sec-0004"> <h3 class="title" id="CD010777-sec-0004">Selection criteria</h3> <p>We included all randomised controlled trials measuring kidney function and the role of ischaemic preconditioning in patients undergoing a surgical intervention that induces kidney injury. Kidney transplantation studies were excluded. </p> </section> <section id="CD010777-sec-0005"> <h3 class="title" id="CD010777-sec-0005">Data collection and analysis</h3> <p>Studies were assessed for eligibility and quality; data were extracted by two independent authors. We collected basic study characteristics: type of surgery, remote ischaemic preconditioning protocol, type of anaesthesia. We collected primary outcome measurements: serum creatinine and adverse effects to remote ischaemic preconditioning and secondary outcome measurements: acute kidney injury, need for dialysis, neutrophil gelatinase‐associated lipocalin, hospital stay and mortality. Summary estimates of effect were obtained using a random‐effects model, and results were expressed as risk ratios (RR) and their 95% confidence intervals (CI) for dichotomous outcomes, and mean difference (MD) and 95% CI for continuous outcomes. </p> </section> <section id="CD010777-sec-0006"> <h3 class="title" id="CD010777-sec-0006">Main results</h3> <p>We included 28 studies which randomised a total of 6851 patients. Risk of bias assessment indicated unclear to low risk of bias for most studies. For consistency regarding the direction of effects, continuous outcomes with negative values, and dichotomous outcomes with values less than one favour remote ischaemic preconditioning. Based on high quality evidence, remote ischaemic preconditioning made little or no difference to the reduction of serum creatinine levels at postoperative days one (14 studies, 1022 participants: MD ‐0.02 mg/dL, 95% CI ‐0.05 to 0.02; I<sup>2</sup> = 21%), two (9 studies, 770 participants: MD ‐0.04 mg/dL, 95% CI ‐0.09 to 0.02; I<sup>2</sup> = 31%), and three (6 studies, 417 participants: MD ‐0.05 mg/dL, 95% CI ‐0.19 to 0.10; I<sup>2</sup> = 68%) compared to control. </p> <p>Serious adverse events occurred in four patients receiving remote ischaemic preconditioning by iliac clamping. It is uncertain whether remote ischaemic preconditioning by cuff inflation leads to increased adverse effects compared to control because the certainty of the evidence is low (15 studies, 3993 participants: RR 3.47, 95% CI 0.55 to 21.76; I<sup>2</sup> = 0%); only two of 15 studies reported any adverse effects (6/1999 in the remote ischaemic preconditioning group and 1/1994 in the control group), the remaining 13 studies stated no adverse effects were observed in either group. </p> <p>Compared to control, remote ischaemic preconditioning made little or no difference to the need for dialysis (13 studies, 2417 participants: RR 0.85, 95% CI 0.37 to 1.94; I<sup>2</sup> = 60%; moderate quality evidence), length of hospital stay (8 studies, 920 participants: MD 0.17 days, 95% CI ‐0.46 to 0.80; I<sup>2</sup> = 49%, high quality evidence), or all‐cause mortality (24 studies, 4931 participants: RR 0.86, 95% CI 0.54 to 1.37; I<sup>2</sup> = 0%, high quality evidence). </p> <p>Remote ischaemic preconditioning may have slightly improved the incidence of acute kidney injury using either the AKIN (8 studies, 2364 participants: RR 0.76, 95% CI 0.57 to 1.00; I<sup>2</sup> = 61%, high quality evidence) or RIFLE criteria (3 studies, 1586 participants: RR 0.91, 95% CI 0.75 to 1.12; I<sup>2</sup> = 0%, moderate quality evidence). </p> </section> <section id="CD010777-sec-0007"> <h3 class="title" id="CD010777-sec-0007">Authors' conclusions</h3> <p>Remote ischaemic preconditioning by cuff inflation appears to be a safe method, and probably leads to little or no difference in serum creatinine, adverse effects, need for dialysis, length of hospital stay, death and in the incidence of acute kidney injury. Overall we had moderate‐high certainty evidence however the available data does not confirm the efficacy of remote ischaemic preconditioning in reducing renal ischaemia reperfusion injury in patients undergoing major cardiac and vascular surgery in which renal ischaemia reperfusion injury may occur. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010777-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010777-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010777-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010777-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ms#CD010777-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD010777-abs-0004">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010777-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010777-abs-0003" lang="en"> <h3>Short periods of limb blood flow obstruction to reduce kidney injury</h3> <p><b>What is the issue?</b> </p> <p>The kidney is highly sensitive to shortage in blood flow and thus oxygen supply. This may cause irreversible kidney injury leading to haemodialysis or death. Kidney injury does not only relate to the temporary lack of oxygen supply, but is also due to the re‐saturation of blood flow. At this stage, toxic products are released and initiate a reaction of the body causing further cellular damage within the kidney, the so called ‘ischaemia‐reperfusion injury’. A lack of oxygen supply to the kidney injury may have many different causes, for example blood pressure changes that may occur during major surgery. </p> <p><b>What did we do?</b> </p> <p>Our hypothesis is that short harmless periods (5 minutes) of blood flow obstruction to an organ can reduce injury in this particular organ (local ischaemic preconditioning), but can also reduce injury in other organs at a distance (remote ischaemic preconditioning). A blood flow obstruction can easily and safely be achieved in a limb by inflating blood pressure cuff around the upper arm or leg. The mechanism of this remote ischaemic preconditioning is not precisely known, it is assumed that a protective signal from the remote organ to the kidney is transferred through the blood stream or nervous system. </p> <p>In this analysis our primary goal is to investigate whether remote ischaemic preconditioning is safe and effective in reducing kidney injury in patients undergoing a (surgical) procedure in which kidney injury may occur. Kidney injury after kidney transplantation may have a different underlying pathophysiology and therefore these studies are not taken into account. The impact of remote ischaemic preconditioning on the need for dialysis, hospital stay and mortality will be assessed. </p> <p><b>What did we find?</b> </p> <p>We performed a search off all available literature on 8 August 2016 to find all randomised controlled studies. 28 studies including 6851 patients were included in this analysis. Five studies included children undergoing cardiac surgery. Adult studies included patients undergoing major vascular surgery (three studies), cardiac surgery (nine studies), coronary bypass surgery (10 studies) and partial kidney resection (one study). The overall quality of the studies was acceptable. </p> <p>Twenty studies were funded without economical interest. One study was funded from a source with commercial interest. The other seven studies did not report funding. </p> <p>Remote ischaemic preconditioning performed with a blood pressure cuff appears to be safe as only two of 15 studies reported adverse effects (6/1999 in the remote ischaemic preconditioning group and 1/1994 in the control group). However remote ischaemic preconditioning by vascular clamping may cause vascular complications. Kidney injury in patients undergoing (surgical) procedures in which kidney injury may occur, was not reduced by remote Ischaemic preconditioning measured at day one, two or three after surgery. The need for dialysis, hospital stay and death were not reduced by remote ischaemic preconditioning. </p> <p><b>Conclusion</b> </p> <p>Although remote ischaemic preconditioning by cuff inflation is safe, available data do not confirm the efficacy of remote ischaemic preconditioning in reducing kidney injury. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010777-sec-0094" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010777-sec-0094"></div> <h3 class="title" id="CD010777-sec-0095">Implications for practice</h3> <section id="CD010777-sec-0095"> <p>Remote ischaemic preconditioning by cuff inflation appears to be a safe method, and probably leads to little or no difference in serum creatinine, adverse effects, need for dialysis, length of hospital stay, death and in the incidence of acute kidney injury. Overall we have moderate‐high certainty evidence however the available data did not confirm the efficacy of remote ischaemic preconditioning in reducing renal ischaemia reperfusion injury in patients undergoing major cardiac and vascular surgery in which renal ischaemia reperfusion injury may occur. </p> </section> <h3 class="title" id="CD010777-sec-0096">Implications for research</h3> <section id="CD010777-sec-0096"> <p>Future RCTs should focus on patients undergoing a procedure that is associated with significant kidney ischaemia reperfusion injury, such as open abdominal aortic or kidney transplant surgery. Furthermore, fundamental research is required to be able to predict the protective effect of remote ischaemic preconditioning and to increase the efficacy of the preconditioning protocol in humans. </p> <p>Future studies should be adequately powered and designed with undisputed endpoints such as need for dialysis, mortality and/or quality of life, rather than short‐term kidney function. Markers of (subtle) ischaemic kidney injury are useful for research purposes, but should be secondary to long‐term clinically pertinent outcome measures. </p> <p>Studies need to report methods of allocation, blinding and outcome data in detail and should publish a predefined study protocol. Doing so will increase study quality and make the conclusions more applicable to clinical practice. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010777-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010777-sec-0022"></div> <div class="table" id="CD010777-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings table</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Ischaemic preconditioning for the reduction of renal ischaemia reperfusion injury</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patients or population:</b> patients undergoing a surgical intervention that induces kidney injury<br/> <b>Setting:</b> perioperative hospital setting<br/> <b>Intervention:</b> ischaemic preconditioning<br/> <b>Control:</b> no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Absolute effect<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of patients<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with RIPC</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serum creatinine: day 1</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean serum creatinine on day 1 was 0 mg/dL</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD was <b>0.02 mg/dL lower</b> (0.05 mg/dL lower to 0.02 mg/dL higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1022 (14)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Funnel plot assessment suggests publication bias. Analysis without small studies showed no significant differences. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serum creatinine: day 2</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean serum creatinine on day 2 was 0 mg/dL</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD was <b>0.04 mg/dL lower</b> (0.09 mg/dL lower to 0.02 mg/dL higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>770 (9)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Funnel plot assessment suggests publication bias, however due to a limited amount of studies these results should be interpreted with care. Analysis without small studies showed no significant difference </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serum creatinine: day 3</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean serum creatinine day 3 was 0 mg/dL</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD was <b>0.05 mg/dL lower</b> (0.19 mg/dL lower to 0.1 mg/dL higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>417 (6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insufficient data to assess publication bias.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Adverse events related to RIPC</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 3.47<br/> (0.55 to 21.76) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>3993 (15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Adverse effects due to remote ischaemic preconditioning only occurred in traumatic clamping of arteries. There were no reports of adverse events when applying remote ischaemic preconditioning by cuff </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2 per 1,000<br/> (0 to 11) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Need for dialysis</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.85<br/> (0.37 to 1.94) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2417 (13)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊖<br/> <b>Moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>The low incidence of dialysis results in a moderate Grade of evidence</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>38 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>32 per 1,000<br/> (14 to 74) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Acute kidney injury defined by AKIN</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.76<br/> (0.57 to 1.00) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2364 (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>This outcome regards the overall AKIN score, when subdivided in grade 1, 2 and 3 there is no evidence of effect </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>369 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>281 per 1,000<br/> (211 to 369) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Mortality</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.86<br/> (0.54 to 1.37) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>4931 (24)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>17 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>15 per 1,000<br/> (9 to 23) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>The risk in the intervention group</b> (and the 95% confidence interval) is based on the risk in the control group and the <b>relative effect</b> of the intervention<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High quality</b>: Further research is very unlikely to change our confidence in the estimate of effect. </p> <p><b>Moderate quality</b>: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. </p> <p><b>Low quality</b>: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> <p><b>Very low quality</b>: We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>RIPC ‐ remote ischaemic preconditioning</p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010777-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010777-sec-0023"></div> <section id="CD010777-sec-0024"> <h3 class="title" id="CD010777-sec-0024">Description of the condition</h3> <p>Ischaemia reperfusion injury is defined as damage to an organ that occurs after a critical period of ischaemia, followed by restoration of blood supply. This can happen spontaneously, such as in stroke or myocardial infarction, or during transplantation and other types of surgery. Cells become deprived of oxygen in the ischaemic phase, and as a result, metabolism switches from aerobic to anaerobic glycolysis, leading to cell swelling, acidosis, ATP depletion, intracellular sodium (Na<sup>+</sup>) and calcium ion (Ca<sup>2+</sup>) overload and inhibition of the mitochondrial respiration chain. This leads to cell death in minutes to hours, depending on the cell type. Restoration of blood flow after ischaemia is therefore essential for cell survival. However, reperfusion of ischaemic tissue invokes paradoxical effects that are detrimental, rather than beneficial, to cells. This particularly holds true for sudden restoration of oxygen (which leads to oxidative stress), pH (which can induce cell death), and evoked inflammatory response. Inflammatory response induces adhesion of cytokine‐releasing leukocytes, which attracts neutrophils, macrophages, lymphocytes and dendritic cells to the site. This may cause further release of reactive oxygen species and microvascular dysfunction (<a href="./references#CD010777-bbs2-0058" title="BonventreJV . Mediators of ischemic renal injury. Annual Review of Medicine1988;39:531‐44. [MEDLINE: 3285790] ">Bonventre 1988</a>; <a href="./references#CD010777-bbs2-0072" title="PiperHM , García‐DoradoD , OvizeM . A fresh look at reperfusion injury. Cardiovascular Research1998;38(2):291‐300. [MEDLINE: 9709390] ">Piper 1998</a>; <a href="./references#CD010777-bbs2-0088" title="YellonDM , HausenloyDJ . Myocardial reperfusion injury. New England Journal of Medicine2007;357(11):1121‐35. [MEDLINE: 17855673] ">Yellon 2007</a>). </p> <p>Ischaemia reperfusion injury can lead to organ dysfunction or failure and is a significant clinical problem in transplantation, shock and major surgery. The high metabolism and vascular anatomy of the kidney is particularly sensitive to ischaemia reperfusion injury. The critical ischaemic period is organ‐dependent: 15 to 20 minutes of ischaemia has been shown to cause irreversible damage to the kidney (<a href="./references#CD010777-bbs2-0068" title="JaeschkeH . Reperfusion injury after warm ischemia or cold storage of the liver: role of apoptotic cell death. Transplantation Proceedings2002;34(7):2656‐8. [MEDLINE: 12431564] ">Jaeschke 2002</a>; <a href="./references#CD010777-bbs2-0076" title="SafianRD , TextorSC . Renal‐artery stenosis. New England Journal of Medicine2001;344(6):431–42. [MEDLINE: 11172181] ">Safian 2001</a>; <a href="./references#CD010777-bbs2-0078" title="SchrierRW , WangW . Acute renal failure and sepsis. New England Journal of Medicine2004;351(2):159–69. [MEDLINE: 15247356] ">Schrier 2004</a>). </p> </section> <section id="CD010777-sec-0025"> <h3 class="title" id="CD010777-sec-0025">Description of the intervention</h3> <p>Ischaemic preconditioning is a short and harmless period of deprivation of blood supply to particular organs or tissue, followed by a period of reperfusion (<a href="./references#CD010777-bbs2-0059" title="ChenX , LiuX , WanX , WuY , ChenY , CaoC . Ischemic preconditioning attenuates renal ischemia‐reperfusion injury by inhibiting activation of IKKbeta and inflammatory response. American Journal of Nephrology2009;30(3):287–94. [MEDLINE: 19546526] ">Chen 2009</a>; <a href="./references#CD010777-bbs2-0065" title="HausenloyDJ , YellonDM . Preconditioning and postconditioning: underlying mechanisms and clinical application. Atherosclerosis2009;204(2):334–41. [MEDLINE: 19081095] ">Hausenloy 2009</a>; <a href="./references#CD010777-bbs2-0089" title="YinDP , SankaryHN , ChongAS , MaLL , ShenJ , FosterP , et al. Protective effect of ischemic preconditioning on liver preservation‐reperfusion injury in rats. Transplantation1998;66(2):152–7. [MEDLINE: 9701256] ">Yin 1998</a>). Preconditioning stimulus is applied before onset of ischaemia reperfusion injury to a target organ. In 1986 it was shown that ischaemic preconditioning on the heart can reduce ischaemia reperfusion injury, (local ischaemic preconditioning) (<a href="./references#CD010777-bbs2-0071" title="MurryCE , JenningsRB , ReimerKA . Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation1986;74(5):1124–36. [MEDLINE: 3769170] ">Murry 1986</a>), and has since been reproduced in many other target organs. Later on, studies have shown that ischaemic preconditioning of remote organs and tissues at a distance can protect the target organ from ischaemia reperfusion injury as well (remote ischaemic preconditioning, <a href="./references#CD010777-bbs2-0073" title="PrzyklenkK , BauerB , OvizeM , KlonerRA , WhittakerP . Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation1993;87(3):893–9. [MEDLINE: 7680290] ">Przyklenk 1993</a>). Use of the limbs as remote tissue offers many advantages, since skeletal muscle is less susceptible to ischaemia reperfusion injury compared to visceral tissues. </p> <p>A typical schedule of five minute periods of ischaemic preconditioning, separated by five minutes of reperfusion, applied directly before the ischaemia reperfusion injury period of the target organ, is used in most clinical studies. Numerous variations to this schedule have been studied in animals and the efficacy of the ischaemic preconditioning has been shown to vary, depending on the animal sex, animal species, preconditioned tissue volume, length of ischaemic preconditioning, reperfusion and time between ischaemic preconditioning and ischaemia reperfusion injury. The optimal schedule is still unclear and is probably different for different target organs and species (<a href="./references#CD010777-bbs2-0057" title="AlrejaG , BuganoD , LotfiA . Effect of remote ischemic preconditioning on myocardial and renal injury: meta‐analysis of randomized controlled trials. Journal of Invasive Cardiology2012;24(2):42‐8. [MEDLINE: 22294530] ">Alreja 2012</a>; <a href="./references#CD010777-bbs2-0060" title="CochraneJ , WilliamsBT , BanerjeeA , HarkenAH , BurkeTJ , CairnsCB , et al. Ischemic preconditioning attenuates functional, metabolic, and morphologic injury from ischemic acute renal failure in the rat. Renal Failure1999;21(2):135–45. [MEDLINE: 10088174] ">Cochrane 1999</a>; <a href="./references#CD010777-bbs2-0086" title="WeverKE , MentingTP , RoversM , van derVlietJA , RongenGA , MasereeuwR , et al. Ischemic preconditioning in the animal kidney, a systematic review and meta‐analysis. PLoS ONE [Electronic Resource]2012;7(2):e32296. [MEDLINE: 22389693] ">Wever 2012</a>). </p> </section> <section id="CD010777-sec-0026"> <h3 class="title" id="CD010777-sec-0026">How the intervention might work</h3> <p>Several endogenous molecules have been implicated in local and remote ischaemic preconditioning signalling, most of which are known to have cytoprotective effects. Downstream, the ultimate protective step in ischaemic preconditioning signalling appears to be inhibition of mitochondrial permeability transition pore opening, which prevents cell death. Remote and local ischaemic preconditioning appear to be similar in terms of invoking mitochondrial permeability transition pore inhibition, and many signalling molecules seem to be similar to those implicated in local ischaemic preconditioning signalling. The theoretical difference is that remote ischaemic preconditioning requires transduction of the protective signal from the remote organ or tissue to the target organ. </p> <p>The protective effects of ischaemic preconditioning are found both directly after application of the stimulus (early window of protection), and in the days or weeks following (second window of protection). In animal models, both windows of protection have been shown to reduce renal ischaemia reperfusion injury (<a href="./references#CD010777-bbs2-0086" title="WeverKE , MentingTP , RoversM , van derVlietJA , RongenGA , MasereeuwR , et al. Ischemic preconditioning in the animal kidney, a systematic review and meta‐analysis. PLoS ONE [Electronic Resource]2012;7(2):e32296. [MEDLINE: 22389693] ">Wever 2012</a>). Although there are similarities in the mechanisms underlying early and second windows of protection, the second window of protection has been found to require de novo protein synthesis of distal mediators such as iNOS and COX‐2. However, remote ischaemic preconditioning signalling has been most extensively studied in the early window of protection, where three major pathways have been indicated in this process (<a href="#CD010777-fig-0001">Figure 1</a>): the humoral route, the neurogenic pathway and alteration of immune cells. Signalling via the humoral route (upper route, <a href="#CD010777-fig-0001">Figure 1</a>) requires release of signalling molecules such as adenosine or endorphins from the remote organ into the bloodstream, which are then carried to the target organ to exert their protective effects via their respective receptors. </p> <div class="figure" id="CD010777-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Remote ischaemic preconditioning signalling pathways" data-id="CD010777-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Remote ischaemic preconditioning signalling pathways</p> </div> </div> </div> <p>The nervous system also appears to play a role in some models of remote ischaemic preconditioning: denervation or ganglion blockade inhibit the protective effect of remote ischaemic preconditioning (middle route, <a href="#CD010777-fig-0001">Figure 1</a>). Activation of the neurogenic pathway by peptides released from the remote organ may cause systemic factor release (combined humoral‐neurogenic route), lead to local factor release or activation of central reflexes. Both the humoral and the neurogenic pathways are thought to induce various kinase cascades and eventually prevent opening of the mitochondrial permeability transition pore in the target organ cells, thereby reducing cell death. Thirdly, remote ischaemic preconditioning has been shown to modulate gene and receptor expression on immune cells, which therefore pose a third signalling pathway that presumably reduces damage by altering the inflammatory response (lower route, <a href="#CD010777-fig-0001">Figure 1</a>) (<a href="./references#CD010777-bbs2-0082" title="TapuriaN , KumarY , HabibMM , Abu AmaraM , SeifalianAM , DavidsonBR . Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury‐‐a review. Journal of Surgical Research2008;150(2):304‐30. [MEDLINE: 19040966] ">Tapuria 2008</a>). </p> </section> <section id="CD010777-sec-0027"> <h3 class="title" id="CD010777-sec-0027">Why it is important to do this review</h3> <p>Despite that the efficacy of ischaemic preconditioning has been acknowledged since described by <a href="./references#CD010777-bbs2-0071" title="MurryCE , JenningsRB , ReimerKA . Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation1986;74(5):1124–36. [MEDLINE: 3769170] ">Murry 1986</a>, the technique was introduced into clinical studies only relatively recently; however, results to date have not been consistently positive (<a href="./references#CD010777-bbs2-0001" title="AliZA , CallaghanCJ , LimE , AliAA , NouraeiSA , AktharAM , et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation2007;116(11 Suppl):I98‐105. [MEDLINE: 17846333] ">Ali 2007</a>; <a href="./references#CD010777-bbs2-0003" title="ChoiYS , ShimJK , KimJC , KangKS , SeoYH , AhnKR , et al. Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2011;142(1):148‐54. [MEDLINE: 21272897] ">Choi 2011</a>; <a href="./references#CD010777-bbs2-0085" title="WalshSR , TangTY , KullarP , JenkinsDP , DutkaDP , GauntME . Ischaemic preconditioning during cardiac surgery: systematic review and meta‐analysis of perioperative outcomes in randomised clinical trials. European Journal of Cardio‐Thoracic Surgery2008;34(5):985–94. [MEDLINE: 18783958] ">Walsh 2008</a>; <a href="./references#CD010777-bbs2-0026" title="WalshSR , SadatU , BoyleJR , TangTY , LapsleyM , NordenAG , et al. Remote ischemic preconditioning for renal protection during elective open infrarenal abdominal aortic aneurysm repair: randomized controlled trial. Vascular &amp; Endovascular Surgery2010;44(5):334‐40. [MEDLINE: 20484066] ">Walsh 2010</a>; <a href="./references#CD010777-bbs2-0029" title="ZimmermanRF , EzeanunaPU , KaneJC , ClelandCD , KempananjappaTJ , LucasFL , et al. Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney International2011;80(8):861‐7. [MEDLINE: 21677633] ">Zimmerman 2011</a>). Although experimental data show promise, the mechanism underlying ischaemic preconditioning signalling remains unclear and the optimal preconditioning protocol remains unknown (<a href="./references#CD010777-bbs2-0086" title="WeverKE , MentingTP , RoversM , van derVlietJA , RongenGA , MasereeuwR , et al. Ischemic preconditioning in the animal kidney, a systematic review and meta‐analysis. PLoS ONE [Electronic Resource]2012;7(2):e32296. [MEDLINE: 22389693] ">Wever 2012</a>). </p> <p>The kidney is very sensitive to ischaemia reperfusion injury, and therefore, is an organ system that can benefit from ischaemic preconditioning. Furthermore, kidney function and damage are very well documented and can be tested using robust endpoints. The kidney is therefore an ideal target organ to investigate the protective effects of ischaemic preconditioning on renal ischaemia reperfusion injury. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010777-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010777-sec-0028"></div> <p>This review aimed to look at the benefits and harms of local and remote ischaemic preconditioning to reduce ischaemia and reperfusion injury among people with renal ischaemia reperfusion injury. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010777-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010777-sec-0029"></div> <section id="CD010777-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010777-sec-0031"> <h4 class="title">Types of studies</h4> <p>All randomised controlled trials (RCTs) looking at the role of ischaemic preconditioning versus no ischaemic preconditioning among patients undergoing interventions that result in ischaemic kidney damage were eligible for inclusion. There was no restriction on publication status, language, or sample size. Quasi‐RCTs (RCTs in which allocation to treatment was obtained by alternation, use of alternate medical records, date of birth or other predictable methods) were excluded. </p> </section> <section id="CD010777-sec-0032"> <h4 class="title">Types of participants</h4> <p>We included all patients who underwent any intervention for any indication that resulted in ischaemic kidney damage (e.g. extracorporeal membrane oxygenation, open aneurysm repair, coronary artery bypass grafting, aortic surgery and any other type kidney surgery). Liver, lung and peripheral bypass surgeries in which kidney injury was highly unlikely were excluded. Studies investigating ischaemic preconditioning in kidney transplantation or patients at risk for contrast‐induced nephropathy, including endovascular aneurysm repair, were excluded. </p> </section> <section id="CD010777-sec-0033"> <h4 class="title">Types of interventions</h4> <p>The ischaemic preconditioning protocol could include remote and/or local ischaemic preconditioning stimulus applied before the intervention and the remote stimulus could be applied to any organ. Preconditioning stimuli could be continuous (one continuous ischaemic pulse followed by reperfusion) or fractioned (two or more cycles of brief ischaemia and reperfusion). The ischaemic preconditioning stimulus could be applied directly before index ischaemia or some time, even days, before. The control condition of no ischaemic preconditioning could be no intervention or mock ischaemic preconditioning, that is, application of a tourniquet, blood pressure cuff or other means of occlusion without actually interrupting blood flow. </p> </section> <section id="CD010777-sec-0034"> <h4 class="title">Types of outcome measures</h4> <section id="CD010777-sec-0035"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD010777-list-0001"> <li> <p>Serum creatinine on days one, two or three postoperative</p> </li> <li> <p>Complications and adverse effects related to ischaemic preconditioning</p> </li> </ul> </p> </section> <section id="CD010777-sec-0036"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD010777-list-0002"> <li> <p>Need for dialysis following kidney‐related ischaemia</p> </li> <li> <p>Acute kidney injury (AKI) as defined by KDIGO, AKIN and RIFLE criteria (<a href="./references#CD010777-bbs2-0069" title="Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International ‐ Supplement2012;2(1):1‐138. [DOI: 10.1038/kisup.2012.1] ">KDIGO 2012</a>; <a href="./references#CD010777-bbs2-0070" title="MehtaRL , KellumJA , ShahSV , MolitorisBA , RoncoC , WarnockDG , et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Critical Care (London, England)2007;11(2):R31. [MEDLINE: 17331245] ">Mehta 2007</a>; <a href="./references#CD010777-bbs2-0075" title="RicciZ , CruzD , RoncoC . The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney International2008;73(5):538‐46. [MEDLINE: 18160961] ">Ricci 2008</a>) </p> </li> <li> <p>Blood urea nitrogen (BUN)</p> </li> <li> <p>Serum/urine neutrophil gelatinase‐associated lipocalin (NGAL)</p> </li> <li> <p>Serum/urine kidney injury molecule‐1 (KIM‐1)</p> </li> <li> <p>Mortality</p> </li> <li> <p>Quality of life</p> </li> <li> <p>Length of hospital stay</p> </li> </ul> </p> </section> </section> </section> <section id="CD010777-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010777-sec-0038"> <h4 class="title">Electronic searches</h4> <p>We searched the <a href="http://kidneyandtransplant.cochrane.org/cochrane-kidney-and-transplant-specialised-register" target="_blank">Cochrane Kidney and Transplant Specialised Register</a> up to 8 August 2016 through contact with the Information Specialist using search terms relevant to this review. The Specialised Register contains studies identified from the following sources. </p> <p> <ol id="CD010777-list-0003"> <li> <p>Monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL)</p> </li> <li> <p>Weekly searches of MEDLINE OVID SP</p> </li> <li> <p>Handsearching of kidney‐related journals and the proceedings of major kidney conferences</p> </li> <li> <p>Searching of the current year of EMBASE OVID SP</p> </li> <li> <p>Weekly current awareness alerts for selected kidney journals</p> </li> <li> <p>Searches of the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov</p> </li> </ol> </p> <p>Studies contained in the Specialised Register are identified through search strategies for CENTRAL, MEDLINE, and EMBASE based on the scope of Cochrane Kidney and Transplant. Details of these strategies, as well as a list of handsearched journals, conference proceedings and current awareness alerts, are available in the Specialised Register section of information about <a href="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/RENAL/frame.html" target="_blank">Cochrane Kidney and Transplant</a>. </p> <p>See <a href="./appendices#CD010777-sec-0100">Appendix 1</a> for search terms used in strategies for this review. </p> </section> <section id="CD010777-sec-0039"> <h4 class="title">Searching other resources</h4> <p> <ol id="CD010777-list-0004"> <li> <p>Reference lists of review articles, relevant studies, and clinical practice guidelines.</p> </li> <li> <p>Letters seeking information about unpublished or incomplete studies to investigators known to be involved in previous studies. </p> </li> </ol> </p> </section> </section> <section id="CD010777-sec-0040"> <h3 class="title" id="CD010777-sec-0040">Data collection and analysis</h3> <section id="CD010777-sec-0041"> <h4 class="title">Selection of studies</h4> <p>The search strategy described was used to obtain titles and abstracts of studies that may be relevant to the review. Titles and abstracts were screened independently by two authors, who discarded studies that were not applicable; however studies and reviews thought to include relevant data or information on studies were retained initially. Two authors independently assessed retrieved abstracts and if required assessed the full text of these studies to determine which satisfied the inclusion criteria. </p> </section> <section id="CD010777-sec-0042"> <h4 class="title">Data extraction and management</h4> <p>Data extraction was carried out independently by two authors using standard data extraction forms. Studies reported in non‐English language journals were to be translated before assessment. Where more than one publication of one study existed, reports were grouped together and the publication with the most complete data was used in the analyses. Where relevant outcomes were only published in earlier versions these data were used. Any discrepancy between published versions was to be highlighted. </p> </section> <section id="CD010777-sec-0043"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The following items were independently assessed by two authors using the risk of bias assessment tool (<a href="./references#CD010777-bbs2-0067" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) (see <a href="./appendices#CD010777-sec-0101">Appendix 2</a>). </p> <p> <ul id="CD010777-list-0005"> <li> <p>Was there adequate sequence generation (selection bias)?</p> </li> <li> <p>Was allocation adequately concealed (selection bias)?</p> </li> <li> <p>Was knowledge of the allocated interventions adequately prevented during the study?</p> <ul id="CD010777-list-0006"> <li> <p>Participants and personnel (performance bias)</p> </li> <li> <p>Outcome assessors (detection bias)</p> </li> </ul> </li> <li> <p>Were incomplete outcome data adequately addressed (attrition bias)?</p> </li> <li> <p>Are reports of the study free of suggestion of selective outcome reporting (reporting bias)? </p> </li> <li> <p>Was the study apparently free of other problems that could put it at a risk of bias?</p> </li> </ul> </p> </section> <section id="CD010777-sec-0044"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous outcomes (e.g. need for dialysis and death) results were expressed as risk ratio (RR) with 95% confidence intervals (CI). Where continuous scales of measurement had been used to assess the effects of treatment (e.g. serum creatinine), the mean difference (MD) was used, or the standardised mean difference (SMD) if different scales were used. </p> </section> <section id="CD010777-sec-0045"> <h4 class="title">Dealing with missing data</h4> <p>Any further information required from the original author was requested by written correspondence (e.g. e‐mailing or writing to corresponding authors) and any relevant information obtained in this manner was included in the review. Evaluation of important numerical data such as screened, randomised patients as well as intention‐to‐treat, as‐treated and per‐protocol population was carefully performed. Attrition rates, for example dropouts, losses to follow‐up and withdrawals were investigated. Issues of missing data and imputation methods (for example, last‐observation‐carried‐forward) were critically appraised (<a href="./references#CD010777-bbs2-0067" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD010777-sec-0046"> <h4 class="title">Assessment of heterogeneity</h4> <p>Heterogeneity was analysed using a Chi<sup>2</sup> test on N‐1 degrees of freedom, with an alpha of 0.05 used for statistical significance and with the I<sup>2</sup> test (<a href="./references#CD010777-bbs2-0066" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. [MEDLINE: 12958120] ">Higgins 2003</a>). I<sup>2</sup> values of 25%, 50% and 75% correspond to low, medium and high levels of heterogeneity. </p> </section> <section id="CD010777-sec-0047"> <h4 class="title">Assessment of reporting biases</h4> <p>If possible, funnel plots were to be used to assess for the potential existence of small study bias (<a href="./references#CD010777-bbs2-0067" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD010777-sec-0048"> <h4 class="title">Data synthesis</h4> <p>Data were pooled using the random‐effects model but the fixed‐effect model was also to be used to ensure robustness of the model chosen and susceptibility to outliers. </p> </section> <section id="CD010777-sec-0049"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Subgroup analysis was used to explore possible sources of heterogeneity (e.g. preconditioning site, number of ischaemic preconditioning stimuli, early versus late windows of protection). Heterogeneity among participants related to age and gender. Heterogeneity in treatments related to the type of intervention such as major aorta surgery or coronary artery bypass surgery. Adverse effects were to be tabulated and assessed using descriptive techniques. Where possible, the risk difference with 95% CI was to be calculated for each adverse effect, either compared with no treatment or another agent. </p> </section> <section id="CD010777-sec-0050"> <h4 class="title">Sensitivity analysis</h4> <p>We performed sensitivity analyses to explore the influence of the following factors on effect size. </p> <p> <ul id="CD010777-list-0007"> <li> <p>Repeating the analysis excluding unpublished studies</p> </li> <li> <p>Repeating the analysis taking account of risk of bias, as specified</p> </li> <li> <p>Repeating the analysis excluding any very long or large studies to establish how much they dominate the results </p> </li> <li> <p>Repeating the analysis excluding studies using the following filters: diagnostic criteria, language of publication, source of funding (industry versus other), and country. </p> </li> </ul> </p> <section id="CD010777-sec-0051"> <h5 class="title">Summary of findings tables</h5> <p>We presented the main results of the review in 'Summary of findings' tables. These tables present key information concerning the quality of the evidence, the magnitude of the effects of the interventions examined, and the sum of the available data for the main outcomes (<a href="./references#CD010777-bbs2-0079" title="SchünemannHJ , OxmanAD , HigginsJP , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011a</a>). The 'Summary of findings' tables also include an overall grading of the evidence related to each of the main outcomes using the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) approach (<a href="./references#CD010777-bbs2-0064" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck‐YtterY , Alonso‐CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924‐6. [MEDLINE: 18436948] ">GRADE 2008</a>). The GRADE approach defines the quality of a body of evidence as the extent to which one can be confident that an estimate of effect or association is close to the true quantity of specific interest. The quality of a body of evidence involves consideration of within‐trial risk of bias (methodological quality), directness of evidence, heterogeneity, precision of effect estimates and risk of publication bias (<a href="./references#CD010777-bbs2-0080" title="SchünemannHJ , OxmanAD , HigginsJP , DeeksJJ , GlasziouP , GuyattGH . Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011b</a>). We presented the following outcomes in the 'Summary of findings' tables. </p> <p> <ul id="CD010777-list-0008"> <li> <p>Serum creatinine on days one, two and three</p> </li> <li> <p>Adverse events of remote ischaemic preconditioning</p> </li> <li> <p>Need for dialysis</p> </li> <li> <p>AKI defined by the AKIN score</p> </li> <li> <p>Mortality</p> </li> </ul> </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010777-sec-0052" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010777-sec-0052"></div> <section id="CD010777-sec-0053"> <h3 class="title">Description of studies</h3> <p>A detailed description of all studies can be found in <a href="./references#CD010777-sec-0106" title="">Characteristics of included studies</a> and <a href="./references#CD010777-sec-0107" title="">Characteristics of excluded studies</a>. </p> <section id="CD010777-sec-0054"> <h4 class="title">Results of the search</h4> <p>The search identified 1381 unique records (<a href="./appendices#CD010777-sec-0100">Appendix 1</a>). Two independent review authors screened each reference for inclusion on the basis of title and abstract, and subsequently assessed full‐text copies of all publications eligible for inclusion. For five studies presented only as abstract, full text publications were obtained by contacting authors by e‐mail. We identified 55 studies (70 records). Of these, 28 studies (38 records) were included and 27 excluded (32 records) (<a href="#CD010777-fig-0002">Figure 2</a>). </p> <div class="figure" id="CD010777-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="The flow diagram of references" data-id="CD010777-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>The flow diagram of references</p> </div> </div> </div> </section> <section id="CD010777-sec-0055"> <h4 class="title">Included studies</h4> <p>We included 28 studies (<a href="./references#CD010777-bbs2-0001" title="AliZA , CallaghanCJ , LimE , AliAA , NouraeiSA , AktharAM , et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation2007;116(11 Suppl):I98‐105. [MEDLINE: 17846333] ">Ali 2007</a>; <a href="./references#CD010777-bbs2-0002" title="CandilioL , MalikA , AritiC , BarnardM , DiSalvoC , LawrenceD , et al. Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial. Heart2015;101(3):185‐92. [MEDLINE: 25252696] ">Candilio 2015</a>; <a href="./references#CD010777-bbs2-0003" title="ChoiYS , ShimJK , KimJC , KangKS , SeoYH , AhnKR , et al. Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2011;142(1):148‐54. [MEDLINE: 21272897] ">Choi 2011</a>; <a href="./references#CD010777-bbs2-0004" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(5):976‐84. [MEDLINE: 18842422] ">Czibik‐stable 2008</a>; <a href="./references#CD010777-bbs2-0005" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(1):976‐84. [MEDLINE: 18842422] ">Czibik‐unstable 2008</a>; <a href="./references#CD010777-bbs2-0006" title="HausenloyDJ , CandilioL , EvansR , AritiC , JenkinsDP , KolvekarS , et al. Remote ischemic preconditioning and outcomes of cardiac surgery. New England Journal of Medicine2015;373(15):1408‐17. [MEDLINE: 26436207] HausenloyDJ , CandilioL , LaingC , KunstG , PepperJ , KolvekarS , et al. Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi‐centre randomized double‐blinded controlled clinical trial. Clinical Research in Cardiology2012;101(5):339‐48. [MEDLINE: 22186969] ">ERICCA Study 2012</a>; <a href="./references#CD010777-bbs2-0007" title="HongDM , JeonY , LeeCS , KimHJ , LeeJM , BahkJH , et al. Effects of remote ischemic preconditioning with postconditioning in patients undergoing off‐pump coronary artery bypass surgery ‐ randomized controlled trial. Circulation Journal2012;76(4):884‐90. [MEDLINE: 22301846] ">Hong 2012</a>; <a href="./references#CD010777-bbs2-0008" title="HongDM , LeeEH , KimHJ , MinJJ , ChinJH , ChoiDK , et al. Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial. European Heart Journal2014;35(3):176‐83. [MEDLINE: 24014392] ">Hong 2014</a>; <a href="./references#CD010777-bbs2-0009" title="HuangJ , ChenY , DongB , KongW , ZhangJ , XueW , et al. Effect of remote ischaemic preconditioning on renal protection in patients undergoing laparoscopic partial nephrectomy: a 'blinded' randomised controlled trial. BJU International2013;112(1):74‐80. [MEDLINE: 23452148] ">Huang 2013</a>; <a href="./references#CD010777-bbs2-0010" title="KimJC , ShimJK , LeeS , YooYC , YangSY , KwakYL . Effect of combined remote ischemic preconditioning and postconditioning on pulmonary function in valvular heart surgery. Chest2012;142(2):467‐75. [MEDLINE: 22281799] ">Kim 2012a</a>; <a href="./references#CD010777-bbs2-0011" title="LeeJH , ParkYH , ByonHJ , KimHS , KimCS , KimJT . Effect of remote ischaemic preconditioning on ischaemic‐reperfusion injury in pulmonary hypertensive infants receiving ventricular septal defect repair. British Journal of Anaesthesia2012;108(2):223‐8. [MEDLINE: 22157844] ">Lee 2012</a>; <a href="./references#CD010777-bbs2-0012" title="LiC , LiYS , XuM , WenSH , YaoX , WuY , et al. Limb remote ischemic preconditioning for intestinal and pulmonary protection during elective open infrarenal abdominal aortic aneurysm repair: a randomized controlled trial. Anesthesiology2013;118(4):842‐52. [MEDLINE: 23353795] ">Li 2013</a>; <a href="./references#CD010777-bbs2-0013" title="LomivorotovVV , ShmyrevVA , NepomnyaschihVA , PonomarevDN , KnyazkovaLG , LomivorotovVN , et al. Remote ischaemic preconditioning does not protect the heart in patients undergoing coronary artery bypass grafting. Interactive Cardiovascular &amp; Thoracic Surgery2012;15(1):18‐22. [MEDLINE: 22493101] ">Lomivorotov 2012</a>; <a href="./references#CD010777-bbs2-0014" title="LucchinettiE , BestmannL , FengJ , FreidankH , ClanachanAS , FineganBA , et al. Remote ischemic preconditioning applied during isoflurane inhalation provides no benefit to the myocardium of patients undergoing on‐pump coronary artery bypass graft surgery: lack of synergy or evidence of antagonism in cardioprotection?. Anesthesiology2012;116(2):296‐310. [MEDLINE: 22222469] ">Luchinetti 2012</a>; <a href="./references#CD010777-bbs2-0015" title="McCrindleBW , ClariziaN , KhaikinS , ColesJ , HoltbyH , SchwartzS , et al. Remote ischemic preconditioning in children undergoing surgery with cardiopulmonary bypass: a single centre double‐blinded randomized trial [abstract no: 11013]. Circulation2011;124(21 Suppl 1). [EMBASE: 70618970] McCrindleBW , ClariziaNA , KhaikinS , HoltbyHS , ManlhiotC , SchwartzSM , et al. Remote ischemic preconditioning in children undergoing cardiac surgery with cardiopulmonary bypass: a single‐center double‐blinded randomized trial. Journal of the American Heart Association2014;3(4):e000964. [MEDLINE: 25074698] ">McCrindle 2014</a>; <a href="./references#CD010777-bbs2-0016" title="PavioneMA , CarmonaF , deCastroM , CarlottiAP . Late remote ischemic preconditioning in children undergoing cardiopulmonary bypass: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2012;144(1):178‐83. [MEDLINE: 22244567] ">Pavione 2012</a>; <a href="./references#CD010777-bbs2-0017" title="PedersenKR , RavnHB , PovlsenJV , SchmidtMR , ErlandsenEJ , HjortdalVE . Failure of remote ischemic preconditioning to reduce the risk of postoperative acute kidney injury in children undergoing operation for complex congenital heart disease: a randomized single‐center study. Journal of Thoracic &amp; Cardiovascular Surgery2012;143(3):576‐83. [MEDLINE: 21955475] ">Pedersen 2012</a>; <a href="./references#CD010777-bbs2-0018" title="PepeS , LiawNY , HepponstallM , SheeranFL , YongMS , d'UdekemY , et al. Effect of remote ischemic preconditioning on phosphorylated protein signaling in children undergoing tetralogy of fallot repair: a randomized controlled trial. Journal of the American Heart Association2013;2(3):e000095. [MEDLINE: 23666460] ">Pepe 2013</a>; <a href="./references#CD010777-bbs2-0019" title="PinaudF , CorbeauJJ , BaufretonC , BinuaniJP , DeBruxJL , FouquetO , et al. Remote ischemic preconditioning in aortic valve surgery: results of a randomized controlled study. Journal of Cardiology2016;67(1):36‐41. [MEDLINE: 26271449] ">Pinaud 2016</a>; <a href="./references#CD010777-bbs2-0020" title="RahmanIA , MascaroJG , SteedsRP , FrenneauxMP , NightingaleP , GoslingP , et al. Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment?. Circulation2010;122(11 Suppl):S53‐9. [MEDLINE: 20837926] ">Rahman 2010</a>; <a href="./references#CD010777-bbs2-0021" title="MeybohmP , BeinB , BrosteanuO , CremerJ , GruenewaldM , StoppeC , et al. A multicenter trial of remote ischemic preconditioning for heart surgery. New England Journal of Medicine2015;373(15):1397‐407. [MEDLINE: 26436208] MeybohmP , ZacharowskiK , CremerJ , RoesnerJ , KletzinF , SchaelteG , et al. Remote ischaemic preconditioning for heart surgery. The study design for a multi‐center randomized double‐blinded controlled clinical trial‐‐the RIPHeart‐Study. European Heart Journal2012;33(12):1423‐6. [MEDLINE: 22880214] ">RIPHeart Study 2012</a>; <a href="./references#CD010777-bbs2-0022" title="SlagsvoldKH , RognmoO , HoydalM , WisloffU , WahbaA . Remote ischemic preconditioning preserves mitochondrial function and influences myocardial microRNA expression in atrial myocardium during coronary bypass surgery. Circulation Research2014;114(5):851‐9. [MEDLINE: 24371264] ">Slagsvold 2014</a>; <a href="./references#CD010777-bbs2-0023" title="ThielmannM , KottenbergE , BoenglerK , RaffelsieperC , NeuhaeuserM , PetersJ , et al. Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest. Basic Research in Cardiology2010;105(5):657‐64. [MEDLINE: 20495811] ThielmannM , KottenbergE , BoenglerK , RaffelsieperC , WendtD , NeuhauserM , et al. Remote ischemic preconditioning reduces myocardial and renal injury in elective coronary artery bypass surgery with crystalloid cardioplegic arrest: a randomized controlled trial [abstract no: D101]. Innovations: Technology &amp; Techniques in Cardiothoracic &amp; Vascular Surgery2010;5(3):239. [EMBASE: 70471618] ">Thielmann 2010</a>; <a href="./references#CD010777-bbs2-0024" title="KottenbergE , MusiolikJ , ThielmannM , JakobH , PetersJ , HeuschG . Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting. Journal of Thoracic &amp; Cardiovascular Surgery2014;147(1):376‐82. [MEDLINE: 23465551] KottenbergE , ThielmannM , BergmannL , HeineT , JakobH , HeuschG , et al. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol ‐ a clinical trial. Acta Anaesthesiologica Scandinavica2012;56(1):30‐8. [MEDLINE: 22103808] KottenbergE , ThielmannM , KleinbongardP , FreyUH , HeineT , JakobH , et al. Myocardial protection by remote ischaemic pre‐conditioning is abolished in sulphonylurea‐treated diabetics undergoing coronary revascularisation. Acta Anaesthesiologica Scandinavica2014;58(4):453‐62. [MEDLINE: 24548338] ThielmannM , KottenbergE , KleinbongardP , WendtD , GedikN , PasaS , et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single‐centre randomised, double‐blind, controlled trial.[Erratum appears in Lancet. 2013 Sep 14;382(9896):940]. Lancet2013;382(9892):597‐604. [MEDLINE: 23953384] ThielmannM , KottenbergE , MusiolikJ , WendtD , GedikN , SchluterM , et al. Prognostic benefit from remote ischemic preconditioning in 300 patients undergoing coronary artery bypass surgery: a randomized controlled trial [abstract no: 14034]. Circulation2012;126(21 Suppl 1). [EMBASE: 70958738] ">Thielmann 2013</a>; <a href="./references#CD010777-bbs2-0025" title="VenugopalV , HausenloyDJ , LudmanA , DiSalvoC , KolvekarS , YapJ , et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold‐blood cardioplegia: a randomised controlled trial. Heart2009;95(19):1567‐71. [MEDLINE: 19508973] VenugopalV , HausenloyDJ , LudmanA , LaingCM , YellonDM . Does remote ischemic preconditioning prevent acute kidney injury in patients undergoing elective cardiac surgery? [abstract no: P05]. British Transplantation Society (BTS).12th Annual Congress; 2009 Apr 21‐24; Liverpool, UK. 2009. VenugopalV , LaingCM , LudmanA , YellonDM , HausenloyD . Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials. American Journal of Kidney Diseases2010;56(6):1043‐9. [MEDLINE: 20974511] ">Venugopal 2009</a>; <a href="./references#CD010777-bbs2-0026" title="WalshSR , SadatU , BoyleJR , TangTY , LapsleyM , NordenAG , et al. Remote ischemic preconditioning for renal protection during elective open infrarenal abdominal aortic aneurysm repair: randomized controlled trial. Vascular &amp; Endovascular Surgery2010;44(5):334‐40. [MEDLINE: 20484066] ">Walsh 2010</a>; <a href="./references#CD010777-bbs2-0027" title="YoungPJ , DalleyP , GardenA , HorrocksC , LaFlammeA , MahonB , et al. A pilot study investigating the effects of remote ischemic preconditioning in high‐risk cardiac surgery using a randomised controlled double‐blind protocol. Basic Research in Cardiology2012;107(3):256. [MEDLINE: 22406977] ">Young 2012</a>; <a href="./references#CD010777-bbs2-0028" title="ZarbockA , SchmidtC , vanAkenH , WempeC , MartensS , ZahnPK , et al. Effect of remote ischemic preconditioning on kidney injury among high‐risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA2015;313(21):2133‐41. [MEDLINE: 26024502] ">Zarbock 2015</a>; <a href="./references#CD010777-bbs2-0029" title="ZimmermanRF , EzeanunaPU , KaneJC , ClelandCD , KempananjappaTJ , LucasFL , et al. Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney International2011;80(8):861‐7. [MEDLINE: 21677633] ">Zimmerman 2011</a>) reporting data from a total of 6851 patients undergoing a surgical procedure associated with renal ischaemia and reperfusion (I/R). <a href="./references#CD010777-bbs2-0004" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(5):976‐84. [MEDLINE: 18842422] ">Czibik‐stable 2008</a> and <a href="./references#CD010777-bbs2-0005" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(1):976‐84. [MEDLINE: 18842422] ">Czibik‐unstable 2008</a> are the same study, however we have analysed this as two separate studies because the outcomes for two different patient populations (stable and unstable angina) were reported separately. </p> <p>Patients were randomised to undergo remote ischaemic preconditioning (remote ischaemic preconditioning; n = 3441) or a control intervention consisting of sham remote ischaemic preconditioning or no treatment (n = 3441). All 28 studies reported at least one kidney outcome measure. See <a href="./references#CD010777-sec-0106" title="">Characteristics of included studies</a> for details on sample size, procedure, patient characteristics, inclusion and exclusion criteria, intervention and reported outcomes. </p> <section id="CD010777-sec-0056"> <h5 class="title">Participants</h5> <p>Five studies included only children, all aged &lt; 17 years old, scheduled for heart surgery (<a href="./references#CD010777-bbs2-0011" title="LeeJH , ParkYH , ByonHJ , KimHS , KimCS , KimJT . Effect of remote ischaemic preconditioning on ischaemic‐reperfusion injury in pulmonary hypertensive infants receiving ventricular septal defect repair. British Journal of Anaesthesia2012;108(2):223‐8. [MEDLINE: 22157844] ">Lee 2012</a>; <a href="./references#CD010777-bbs2-0015" title="McCrindleBW , ClariziaN , KhaikinS , ColesJ , HoltbyH , SchwartzS , et al. Remote ischemic preconditioning in children undergoing surgery with cardiopulmonary bypass: a single centre double‐blinded randomized trial [abstract no: 11013]. Circulation2011;124(21 Suppl 1). [EMBASE: 70618970] McCrindleBW , ClariziaNA , KhaikinS , HoltbyHS , ManlhiotC , SchwartzSM , et al. Remote ischemic preconditioning in children undergoing cardiac surgery with cardiopulmonary bypass: a single‐center double‐blinded randomized trial. Journal of the American Heart Association2014;3(4):e000964. [MEDLINE: 25074698] ">McCrindle 2014</a>; <a href="./references#CD010777-bbs2-0016" title="PavioneMA , CarmonaF , deCastroM , CarlottiAP . Late remote ischemic preconditioning in children undergoing cardiopulmonary bypass: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2012;144(1):178‐83. [MEDLINE: 22244567] ">Pavione 2012</a>; <a href="./references#CD010777-bbs2-0017" title="PedersenKR , RavnHB , PovlsenJV , SchmidtMR , ErlandsenEJ , HjortdalVE . Failure of remote ischemic preconditioning to reduce the risk of postoperative acute kidney injury in children undergoing operation for complex congenital heart disease: a randomized single‐center study. Journal of Thoracic &amp; Cardiovascular Surgery2012;143(3):576‐83. [MEDLINE: 21955475] ">Pedersen 2012</a>; <a href="./references#CD010777-bbs2-0018" title="PepeS , LiawNY , HepponstallM , SheeranFL , YongMS , d'UdekemY , et al. Effect of remote ischemic preconditioning on phosphorylated protein signaling in children undergoing tetralogy of fallot repair: a randomized controlled trial. Journal of the American Heart Association2013;2(3):e000095. [MEDLINE: 23666460] ">Pepe 2013</a>). Other studies included adult cardiovascular patients scheduled for a coronary artery bypass graft (11 studies), cardiac surgery (nine studies) or aortic aneurysm repair (three studies). One study included kidney cancer patients undergoing partial nephrectomy (<a href="./references#CD010777-bbs2-0009" title="HuangJ , ChenY , DongB , KongW , ZhangJ , XueW , et al. Effect of remote ischaemic preconditioning on renal protection in patients undergoing laparoscopic partial nephrectomy: a 'blinded' randomised controlled trial. BJU International2013;112(1):74‐80. [MEDLINE: 23452148] ">Huang 2013</a>). </p> </section> <section id="CD010777-sec-0057"> <h5 class="title">Methods of remote ischaemic preconditioning induction: site, timing and protocols</h5> <p>The intervention of interest in all studies was remote ischaemic preconditioning, which was compared to a control intervention. All studies applied preconditioning only, except for <a href="./references#CD010777-bbs2-0007" title="HongDM , JeonY , LeeCS , KimHJ , LeeJM , BahkJH , et al. Effects of remote ischemic preconditioning with postconditioning in patients undergoing off‐pump coronary artery bypass surgery ‐ randomized controlled trial. Circulation Journal2012;76(4):884‐90. [MEDLINE: 22301846] ">Hong 2012</a>, <a href="./references#CD010777-bbs2-0008" title="HongDM , LeeEH , KimHJ , MinJJ , ChinJH , ChoiDK , et al. Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial. European Heart Journal2014;35(3):176‐83. [MEDLINE: 24014392] ">Hong 2014</a> and <a href="./references#CD010777-bbs2-0010" title="KimJC , ShimJK , LeeS , YooYC , YangSY , KwakYL . Effect of combined remote ischemic preconditioning and postconditioning on pulmonary function in valvular heart surgery. Chest2012;142(2):467‐75. [MEDLINE: 22281799] ">Kim 2012a</a>, in which the conditioning protocol was applied both before and after surgery, thereby inducing a combination of remote ischaemic preconditioning and remote ischaemic postconditioning. </p> <p>Cuff inflation was the preferred method of remote ischaemic preconditioning induction: 25 studies used a blood pressure cuff to induce ischaemia in an upper arm (15 studies), lower limb (nine studies) or both (<a href="./references#CD010777-bbs2-0002" title="CandilioL , MalikA , AritiC , BarnardM , DiSalvoC , LawrenceD , et al. Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial. Heart2015;101(3):185‐92. [MEDLINE: 25252696] ">Candilio 2015</a>). <a href="./references#CD010777-bbs2-0026" title="WalshSR , SadatU , BoyleJR , TangTY , LapsleyM , NordenAG , et al. Remote ischemic preconditioning for renal protection during elective open infrarenal abdominal aortic aneurysm repair: randomized controlled trial. Vascular &amp; Endovascular Surgery2010;44(5):334‐40. [MEDLINE: 20484066] ">Walsh 2010</a> applied their remote ischaemic preconditioning protocol to each lower limb, one after the other. <a href="./references#CD010777-bbs2-0001" title="AliZA , CallaghanCJ , LimE , AliAA , NouraeiSA , AktharAM , et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation2007;116(11 Suppl):I98‐105. [MEDLINE: 17846333] ">Ali 2007</a> and <a href="./references#CD010777-bbs2-0026" title="WalshSR , SadatU , BoyleJR , TangTY , LapsleyM , NordenAG , et al. Remote ischemic preconditioning for renal protection during elective open infrarenal abdominal aortic aneurysm repair: randomized controlled trial. Vascular &amp; Endovascular Surgery2010;44(5):334‐40. [MEDLINE: 20484066] ">Walsh 2010</a> induced remote ischaemic preconditioning by clamping of the common iliac artery. In one study, (<a href="./references#CD010777-bbs2-0004" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(5):976‐84. [MEDLINE: 18842422] ">Czibik‐stable 2008</a>; <a href="./references#CD010777-bbs2-0005" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(1):976‐84. [MEDLINE: 18842422] ">Czibik‐unstable 2008</a>) the (suprarenal) ascending aorta was clamped, thereby inducing both remote ischaemic preconditioning and local ischaemic preconditioning. </p> <p>The remote ischaemic preconditioning stimulus was applied directly after anaesthetic induction in all studies, except for <a href="./references#CD010777-bbs2-0016" title="PavioneMA , CarmonaF , deCastroM , CarlottiAP . Late remote ischemic preconditioning in children undergoing cardiopulmonary bypass: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2012;144(1):178‐83. [MEDLINE: 22244567] ">Pavione 2012</a>, in which remote ischaemic preconditioning was induced 24 hours before surgery, making this the only study investigating the so‐called second window of protection by ischaemic preconditioning. </p> <p>Seven different remote ischaemic preconditioning protocols were used among the 28 studies. The most frequently used protocol consisted of three cycles of five minutes of occlusion of the remote organ, interspersed with five minutes of reperfusion (3 x 5'/5' I/R), (<a href="./references#CD010777-bbs2-0009" title="HuangJ , ChenY , DongB , KongW , ZhangJ , XueW , et al. Effect of remote ischaemic preconditioning on renal protection in patients undergoing laparoscopic partial nephrectomy: a 'blinded' randomised controlled trial. BJU International2013;112(1):74‐80. [MEDLINE: 23452148] ">Huang 2013</a>; <a href="./references#CD010777-bbs2-0012" title="LiC , LiYS , XuM , WenSH , YaoX , WuY , et al. Limb remote ischemic preconditioning for intestinal and pulmonary protection during elective open infrarenal abdominal aortic aneurysm repair: a randomized controlled trial. Anesthesiology2013;118(4):842‐52. [MEDLINE: 23353795] ">Li 2013</a>; <a href="./references#CD010777-bbs2-0013" title="LomivorotovVV , ShmyrevVA , NepomnyaschihVA , PonomarevDN , KnyazkovaLG , LomivorotovVN , et al. Remote ischaemic preconditioning does not protect the heart in patients undergoing coronary artery bypass grafting. Interactive Cardiovascular &amp; Thoracic Surgery2012;15(1):18‐22. [MEDLINE: 22493101] ">Lomivorotov 2012</a>; <a href="./references#CD010777-bbs2-0019" title="PinaudF , CorbeauJJ , BaufretonC , BinuaniJP , DeBruxJL , FouquetO , et al. Remote ischemic preconditioning in aortic valve surgery: results of a randomized controlled study. Journal of Cardiology2016;67(1):36‐41. [MEDLINE: 26271449] ">Pinaud 2016</a>; <a href="./references#CD010777-bbs2-0020" title="RahmanIA , MascaroJG , SteedsRP , FrenneauxMP , NightingaleP , GoslingP , et al. Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment?. Circulation2010;122(11 Suppl):S53‐9. [MEDLINE: 20837926] ">Rahman 2010</a>; <a href="./references#CD010777-bbs2-0022" title="SlagsvoldKH , RognmoO , HoydalM , WisloffU , WahbaA . Remote ischemic preconditioning preserves mitochondrial function and influences myocardial microRNA expression in atrial myocardium during coronary bypass surgery. Circulation Research2014;114(5):851‐9. [MEDLINE: 24371264] ">Slagsvold 2014</a>; <a href="./references#CD010777-bbs2-0023" title="ThielmannM , KottenbergE , BoenglerK , RaffelsieperC , NeuhaeuserM , PetersJ , et al. Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest. Basic Research in Cardiology2010;105(5):657‐64. [MEDLINE: 20495811] ThielmannM , KottenbergE , BoenglerK , RaffelsieperC , WendtD , NeuhauserM , et al. Remote ischemic preconditioning reduces myocardial and renal injury in elective coronary artery bypass surgery with crystalloid cardioplegic arrest: a randomized controlled trial [abstract no: D101]. Innovations: Technology &amp; Techniques in Cardiothoracic &amp; Vascular Surgery2010;5(3):239. [EMBASE: 70471618] ">Thielmann 2010</a>; <a href="./references#CD010777-bbs2-0024" title="KottenbergE , MusiolikJ , ThielmannM , JakobH , PetersJ , HeuschG . Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting. Journal of Thoracic &amp; Cardiovascular Surgery2014;147(1):376‐82. [MEDLINE: 23465551] KottenbergE , ThielmannM , BergmannL , HeineT , JakobH , HeuschG , et al. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol ‐ a clinical trial. Acta Anaesthesiologica Scandinavica2012;56(1):30‐8. [MEDLINE: 22103808] KottenbergE , ThielmannM , KleinbongardP , FreyUH , HeineT , JakobH , et al. Myocardial protection by remote ischaemic pre‐conditioning is abolished in sulphonylurea‐treated diabetics undergoing coronary revascularisation. Acta Anaesthesiologica Scandinavica2014;58(4):453‐62. [MEDLINE: 24548338] ThielmannM , KottenbergE , KleinbongardP , WendtD , GedikN , PasaS , et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single‐centre randomised, double‐blind, controlled trial.[Erratum appears in Lancet. 2013 Sep 14;382(9896):940]. Lancet2013;382(9892):597‐604. [MEDLINE: 23953384] ThielmannM , KottenbergE , MusiolikJ , WendtD , GedikN , SchluterM , et al. Prognostic benefit from remote ischemic preconditioning in 300 patients undergoing coronary artery bypass surgery: a randomized controlled trial [abstract no: 14034]. Circulation2012;126(21 Suppl 1). [EMBASE: 70958738] ">Thielmann 2013</a>; <a href="./references#CD010777-bbs2-0025" title="VenugopalV , HausenloyDJ , LudmanA , DiSalvoC , KolvekarS , YapJ , et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold‐blood cardioplegia: a randomised controlled trial. Heart2009;95(19):1567‐71. [MEDLINE: 19508973] VenugopalV , HausenloyDJ , LudmanA , LaingCM , YellonDM . Does remote ischemic preconditioning prevent acute kidney injury in patients undergoing elective cardiac surgery? [abstract no: P05]. British Transplantation Society (BTS).12th Annual Congress; 2009 Apr 21‐24; Liverpool, UK. 2009. VenugopalV , LaingCM , LudmanA , YellonDM , HausenloyD . Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials. American Journal of Kidney Diseases2010;56(6):1043‐9. [MEDLINE: 20974511] ">Venugopal 2009</a>; <a href="./references#CD010777-bbs2-0028" title="ZarbockA , SchmidtC , vanAkenH , WempeC , MartensS , ZahnPK , et al. Effect of remote ischemic preconditioning on kidney injury among high‐risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA2015;313(21):2133‐41. [MEDLINE: 26024502] ">Zarbock 2015</a>; <a href="./references#CD010777-bbs2-0029" title="ZimmermanRF , EzeanunaPU , KaneJC , ClelandCD , KempananjappaTJ , LucasFL , et al. Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney International2011;80(8):861‐7. [MEDLINE: 21677633] ">Zimmerman 2011</a>). Other protocols were 4 x 5'/5' I/R (<a href="./references#CD010777-bbs2-0006" title="HausenloyDJ , CandilioL , EvansR , AritiC , JenkinsDP , KolvekarS , et al. Remote ischemic preconditioning and outcomes of cardiac surgery. New England Journal of Medicine2015;373(15):1408‐17. [MEDLINE: 26436207] HausenloyDJ , CandilioL , LaingC , KunstG , PepperJ , KolvekarS , et al. Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi‐centre randomized double‐blinded controlled clinical trial. Clinical Research in Cardiology2012;101(5):339‐48. [MEDLINE: 22186969] ">ERICCA Study 2012</a>; <a href="./references#CD010777-bbs2-0007" title="HongDM , JeonY , LeeCS , KimHJ , LeeJM , BahkJH , et al. Effects of remote ischemic preconditioning with postconditioning in patients undergoing off‐pump coronary artery bypass surgery ‐ randomized controlled trial. Circulation Journal2012;76(4):884‐90. [MEDLINE: 22301846] ">Hong 2012</a>; <a href="./references#CD010777-bbs2-0008" title="HongDM , LeeEH , KimHJ , MinJJ , ChinJH , ChoiDK , et al. Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial. European Heart Journal2014;35(3):176‐83. [MEDLINE: 24014392] ">Hong 2014</a>; <a href="./references#CD010777-bbs2-0011" title="LeeJH , ParkYH , ByonHJ , KimHS , KimCS , KimJT . Effect of remote ischaemic preconditioning on ischaemic‐reperfusion injury in pulmonary hypertensive infants receiving ventricular septal defect repair. British Journal of Anaesthesia2012;108(2):223‐8. [MEDLINE: 22157844] ">Lee 2012</a>; <a href="./references#CD010777-bbs2-0014" title="LucchinettiE , BestmannL , FengJ , FreidankH , ClanachanAS , FineganBA , et al. Remote ischemic preconditioning applied during isoflurane inhalation provides no benefit to the myocardium of patients undergoing on‐pump coronary artery bypass graft surgery: lack of synergy or evidence of antagonism in cardioprotection?. Anesthesiology2012;116(2):296‐310. [MEDLINE: 22222469] ">Luchinetti 2012</a>; <a href="./references#CD010777-bbs2-0015" title="McCrindleBW , ClariziaN , KhaikinS , ColesJ , HoltbyH , SchwartzS , et al. Remote ischemic preconditioning in children undergoing surgery with cardiopulmonary bypass: a single centre double‐blinded randomized trial [abstract no: 11013]. Circulation2011;124(21 Suppl 1). [EMBASE: 70618970] McCrindleBW , ClariziaNA , KhaikinS , HoltbyHS , ManlhiotC , SchwartzSM , et al. Remote ischemic preconditioning in children undergoing cardiac surgery with cardiopulmonary bypass: a single‐center double‐blinded randomized trial. Journal of the American Heart Association2014;3(4):e000964. [MEDLINE: 25074698] ">McCrindle 2014</a>; <a href="./references#CD010777-bbs2-0016" title="PavioneMA , CarmonaF , deCastroM , CarlottiAP . Late remote ischemic preconditioning in children undergoing cardiopulmonary bypass: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2012;144(1):178‐83. [MEDLINE: 22244567] ">Pavione 2012</a>; <a href="./references#CD010777-bbs2-0017" title="PedersenKR , RavnHB , PovlsenJV , SchmidtMR , ErlandsenEJ , HjortdalVE . Failure of remote ischemic preconditioning to reduce the risk of postoperative acute kidney injury in children undergoing operation for complex congenital heart disease: a randomized single‐center study. Journal of Thoracic &amp; Cardiovascular Surgery2012;143(3):576‐83. [MEDLINE: 21955475] ">Pedersen 2012</a>; <a href="./references#CD010777-bbs2-0018" title="PepeS , LiawNY , HepponstallM , SheeranFL , YongMS , d'UdekemY , et al. Effect of remote ischemic preconditioning on phosphorylated protein signaling in children undergoing tetralogy of fallot repair: a randomized controlled trial. Journal of the American Heart Association2013;2(3):e000095. [MEDLINE: 23666460] ">Pepe 2013</a>; <a href="./references#CD010777-bbs2-0021" title="MeybohmP , BeinB , BrosteanuO , CremerJ , GruenewaldM , StoppeC , et al. A multicenter trial of remote ischemic preconditioning for heart surgery. New England Journal of Medicine2015;373(15):1397‐407. [MEDLINE: 26436208] MeybohmP , ZacharowskiK , CremerJ , RoesnerJ , KletzinF , SchaelteG , et al. Remote ischaemic preconditioning for heart surgery. The study design for a multi‐center randomized double‐blinded controlled clinical trial‐‐the RIPHeart‐Study. European Heart Journal2012;33(12):1423‐6. [MEDLINE: 22880214] ">RIPHeart Study 2012</a>; <a href="./references#CD010777-bbs2-0027" title="YoungPJ , DalleyP , GardenA , HorrocksC , LaFlammeA , MahonB , et al. A pilot study investigating the effects of remote ischemic preconditioning in high‐risk cardiac surgery using a randomised controlled double‐blind protocol. Basic Research in Cardiology2012;107(3):256. [MEDLINE: 22406977] ">Young 2012</a>), 3 x 10'/10' I/R (<a href="./references#CD010777-bbs2-0003" title="ChoiYS , ShimJK , KimJC , KangKS , SeoYH , AhnKR , et al. Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2011;142(1):148‐54. [MEDLINE: 21272897] ">Choi 2011</a>; <a href="./references#CD010777-bbs2-0010" title="KimJC , ShimJK , LeeS , YooYC , YangSY , KwakYL . Effect of combined remote ischemic preconditioning and postconditioning on pulmonary function in valvular heart surgery. Chest2012;142(2):467‐75. [MEDLINE: 22281799] ">Kim 2012a</a>), 2 x 10'/10' I/R (<a href="./references#CD010777-bbs2-0001" title="AliZA , CallaghanCJ , LimE , AliAA , NouraeiSA , AktharAM , et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation2007;116(11 Suppl):I98‐105. [MEDLINE: 17846333] ">Ali 2007</a>), 2x 5 min (<a href="./references#CD010777-bbs2-0002" title="CandilioL , MalikA , AritiC , BarnardM , DiSalvoC , LawrenceD , et al. Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial. Heart2015;101(3):185‐92. [MEDLINE: 25252696] ">Candilio 2015</a>), 2 x 2'/3' I/R (<a href="./references#CD010777-bbs2-0004" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(5):976‐84. [MEDLINE: 18842422] ">Czibik‐stable 2008</a>; <a href="./references#CD010777-bbs2-0005" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(1):976‐84. [MEDLINE: 18842422] ">Czibik‐unstable 2008</a>) and cross‐clamping the right common iliac artery 10 min, thereafter clamping the left common iliac artery (<a href="./references#CD010777-bbs2-0026" title="WalshSR , SadatU , BoyleJR , TangTY , LapsleyM , NordenAG , et al. Remote ischemic preconditioning for renal protection during elective open infrarenal abdominal aortic aneurysm repair: randomized controlled trial. Vascular &amp; Endovascular Surgery2010;44(5):334‐40. [MEDLINE: 20484066] ">Walsh 2010</a>). </p> </section> <section id="CD010777-sec-0058"> <h5 class="title">Outcome measures</h5> <p>The included studies reported a variety of outcome measures. Kidney impairment (e.g. postoperative creatinine, NGAL, AKIN score and RIFLE score) was the primary outcome in seven studies (25%) (<a href="./references#CD010777-bbs2-0003" title="ChoiYS , ShimJK , KimJC , KangKS , SeoYH , AhnKR , et al. Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2011;142(1):148‐54. [MEDLINE: 21272897] ">Choi 2011</a>; <a href="./references#CD010777-bbs2-0009" title="HuangJ , ChenY , DongB , KongW , ZhangJ , XueW , et al. Effect of remote ischaemic preconditioning on renal protection in patients undergoing laparoscopic partial nephrectomy: a 'blinded' randomised controlled trial. BJU International2013;112(1):74‐80. [MEDLINE: 23452148] ">Huang 2013</a>; <a href="./references#CD010777-bbs2-0017" title="PedersenKR , RavnHB , PovlsenJV , SchmidtMR , ErlandsenEJ , HjortdalVE . Failure of remote ischemic preconditioning to reduce the risk of postoperative acute kidney injury in children undergoing operation for complex congenital heart disease: a randomized single‐center study. Journal of Thoracic &amp; Cardiovascular Surgery2012;143(3):576‐83. [MEDLINE: 21955475] ">Pedersen 2012</a>; <a href="./references#CD010777-bbs2-0026" title="WalshSR , SadatU , BoyleJR , TangTY , LapsleyM , NordenAG , et al. Remote ischemic preconditioning for renal protection during elective open infrarenal abdominal aortic aneurysm repair: randomized controlled trial. Vascular &amp; Endovascular Surgery2010;44(5):334‐40. [MEDLINE: 20484066] ">Walsh 2010</a>; <a href="./references#CD010777-bbs2-0027" title="YoungPJ , DalleyP , GardenA , HorrocksC , LaFlammeA , MahonB , et al. A pilot study investigating the effects of remote ischemic preconditioning in high‐risk cardiac surgery using a randomised controlled double‐blind protocol. Basic Research in Cardiology2012;107(3):256. [MEDLINE: 22406977] ">Young 2012</a>; <a href="./references#CD010777-bbs2-0028" title="ZarbockA , SchmidtC , vanAkenH , WempeC , MartensS , ZahnPK , et al. Effect of remote ischemic preconditioning on kidney injury among high‐risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA2015;313(21):2133‐41. [MEDLINE: 26024502] ">Zarbock 2015</a>; <a href="./references#CD010777-bbs2-0029" title="ZimmermanRF , EzeanunaPU , KaneJC , ClelandCD , KempananjappaTJ , LucasFL , et al. Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney International2011;80(8):861‐7. [MEDLINE: 21677633] ">Zimmerman 2011</a>). <a href="./references#CD010777-bbs2-0021" title="MeybohmP , BeinB , BrosteanuO , CremerJ , GruenewaldM , StoppeC , et al. A multicenter trial of remote ischemic preconditioning for heart surgery. New England Journal of Medicine2015;373(15):1397‐407. [MEDLINE: 26436208] MeybohmP , ZacharowskiK , CremerJ , RoesnerJ , KletzinF , SchaelteG , et al. Remote ischaemic preconditioning for heart surgery. The study design for a multi‐center randomized double‐blinded controlled clinical trial‐‐the RIPHeart‐Study. European Heart Journal2012;33(12):1423‐6. [MEDLINE: 22880214] ">RIPHeart Study 2012</a> reported a composite primary end point of death, myocardial infarction, stroke and AKI. Cardiac outcome measures were the primary endpoint in 10 studies (<a href="./references#CD010777-bbs2-0001" title="AliZA , CallaghanCJ , LimE , AliAA , NouraeiSA , AktharAM , et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation2007;116(11 Suppl):I98‐105. [MEDLINE: 17846333] ">Ali 2007</a>; <a href="./references#CD010777-bbs2-0002" title="CandilioL , MalikA , AritiC , BarnardM , DiSalvoC , LawrenceD , et al. Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial. Heart2015;101(3):185‐92. [MEDLINE: 25252696] ">Candilio 2015</a>; <a href="./references#CD010777-bbs2-0006" title="HausenloyDJ , CandilioL , EvansR , AritiC , JenkinsDP , KolvekarS , et al. Remote ischemic preconditioning and outcomes of cardiac surgery. New England Journal of Medicine2015;373(15):1408‐17. [MEDLINE: 26436207] HausenloyDJ , CandilioL , LaingC , KunstG , PepperJ , KolvekarS , et al. Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi‐centre randomized double‐blinded controlled clinical trial. Clinical Research in Cardiology2012;101(5):339‐48. [MEDLINE: 22186969] ">ERICCA Study 2012</a>; <a href="./references#CD010777-bbs2-0007" title="HongDM , JeonY , LeeCS , KimHJ , LeeJM , BahkJH , et al. Effects of remote ischemic preconditioning with postconditioning in patients undergoing off‐pump coronary artery bypass surgery ‐ randomized controlled trial. Circulation Journal2012;76(4):884‐90. [MEDLINE: 22301846] ">Hong 2012</a>; <a href="./references#CD010777-bbs2-0008" title="HongDM , LeeEH , KimHJ , MinJJ , ChinJH , ChoiDK , et al. Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial. European Heart Journal2014;35(3):176‐83. [MEDLINE: 24014392] ">Hong 2014</a>; <a href="./references#CD010777-bbs2-0011" title="LeeJH , ParkYH , ByonHJ , KimHS , KimCS , KimJT . Effect of remote ischaemic preconditioning on ischaemic‐reperfusion injury in pulmonary hypertensive infants receiving ventricular septal defect repair. British Journal of Anaesthesia2012;108(2):223‐8. [MEDLINE: 22157844] ">Lee 2012</a>; <a href="./references#CD010777-bbs2-0019" title="PinaudF , CorbeauJJ , BaufretonC , BinuaniJP , DeBruxJL , FouquetO , et al. Remote ischemic preconditioning in aortic valve surgery: results of a randomized controlled study. Journal of Cardiology2016;67(1):36‐41. [MEDLINE: 26271449] ">Pinaud 2016</a>; <a href="./references#CD010777-bbs2-0020" title="RahmanIA , MascaroJG , SteedsRP , FrenneauxMP , NightingaleP , GoslingP , et al. Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment?. Circulation2010;122(11 Suppl):S53‐9. [MEDLINE: 20837926] ">Rahman 2010</a>; <a href="./references#CD010777-bbs2-0023" title="ThielmannM , KottenbergE , BoenglerK , RaffelsieperC , NeuhaeuserM , PetersJ , et al. Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest. Basic Research in Cardiology2010;105(5):657‐64. [MEDLINE: 20495811] ThielmannM , KottenbergE , BoenglerK , RaffelsieperC , WendtD , NeuhauserM , et al. Remote ischemic preconditioning reduces myocardial and renal injury in elective coronary artery bypass surgery with crystalloid cardioplegic arrest: a randomized controlled trial [abstract no: D101]. Innovations: Technology &amp; Techniques in Cardiothoracic &amp; Vascular Surgery2010;5(3):239. [EMBASE: 70471618] ">Thielmann 2010</a>; <a href="./references#CD010777-bbs2-0024" title="KottenbergE , MusiolikJ , ThielmannM , JakobH , PetersJ , HeuschG . Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting. Journal of Thoracic &amp; Cardiovascular Surgery2014;147(1):376‐82. [MEDLINE: 23465551] KottenbergE , ThielmannM , BergmannL , HeineT , JakobH , HeuschG , et al. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol ‐ a clinical trial. Acta Anaesthesiologica Scandinavica2012;56(1):30‐8. [MEDLINE: 22103808] KottenbergE , ThielmannM , KleinbongardP , FreyUH , HeineT , JakobH , et al. Myocardial protection by remote ischaemic pre‐conditioning is abolished in sulphonylurea‐treated diabetics undergoing coronary revascularisation. Acta Anaesthesiologica Scandinavica2014;58(4):453‐62. [MEDLINE: 24548338] ThielmannM , KottenbergE , KleinbongardP , WendtD , GedikN , PasaS , et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single‐centre randomised, double‐blind, controlled trial.[Erratum appears in Lancet. 2013 Sep 14;382(9896):940]. Lancet2013;382(9892):597‐604. [MEDLINE: 23953384] ThielmannM , KottenbergE , MusiolikJ , WendtD , GedikN , SchluterM , et al. Prognostic benefit from remote ischemic preconditioning in 300 patients undergoing coronary artery bypass surgery: a randomized controlled trial [abstract no: 14034]. Circulation2012;126(21 Suppl 1). [EMBASE: 70958738] ">Thielmann 2013</a>), and pulmonary outcome measures were the primary endpoint in three studies (<a href="./references#CD010777-bbs2-0010" title="KimJC , ShimJK , LeeS , YooYC , YangSY , KwakYL . Effect of combined remote ischemic preconditioning and postconditioning on pulmonary function in valvular heart surgery. Chest2012;142(2):467‐75. [MEDLINE: 22281799] ">Kim 2012a</a>; <a href="./references#CD010777-bbs2-0012" title="LiC , LiYS , XuM , WenSH , YaoX , WuY , et al. Limb remote ischemic preconditioning for intestinal and pulmonary protection during elective open infrarenal abdominal aortic aneurysm repair: a randomized controlled trial. Anesthesiology2013;118(4):842‐52. [MEDLINE: 23353795] ">Li 2013</a>; <a href="./references#CD010777-bbs2-0014" title="LucchinettiE , BestmannL , FengJ , FreidankH , ClanachanAS , FineganBA , et al. Remote ischemic preconditioning applied during isoflurane inhalation provides no benefit to the myocardium of patients undergoing on‐pump coronary artery bypass graft surgery: lack of synergy or evidence of antagonism in cardioprotection?. Anesthesiology2012;116(2):296‐310. [MEDLINE: 22222469] ">Luchinetti 2012</a>). <a href="./references#CD010777-bbs2-0015" title="McCrindleBW , ClariziaN , KhaikinS , ColesJ , HoltbyH , SchwartzS , et al. Remote ischemic preconditioning in children undergoing surgery with cardiopulmonary bypass: a single centre double‐blinded randomized trial [abstract no: 11013]. Circulation2011;124(21 Suppl 1). [EMBASE: 70618970] McCrindleBW , ClariziaNA , KhaikinS , HoltbyHS , ManlhiotC , SchwartzSM , et al. Remote ischemic preconditioning in children undergoing cardiac surgery with cardiopulmonary bypass: a single‐center double‐blinded randomized trial. Journal of the American Heart Association2014;3(4):e000964. [MEDLINE: 25074698] ">McCrindle 2014</a> reported hospital stay, <a href="./references#CD010777-bbs2-0016" title="PavioneMA , CarmonaF , deCastroM , CarlottiAP . Late remote ischemic preconditioning in children undergoing cardiopulmonary bypass: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2012;144(1):178‐83. [MEDLINE: 22244567] ">Pavione 2012</a> reported IL4, and <a href="./references#CD010777-bbs2-0022" title="SlagsvoldKH , RognmoO , HoydalM , WisloffU , WahbaA . Remote ischemic preconditioning preserves mitochondrial function and influences myocardial microRNA expression in atrial myocardium during coronary bypass surgery. Circulation Research2014;114(5):851‐9. [MEDLINE: 24371264] ">Slagsvold 2014</a> reported myocardial microRNA expression as primary outcome measures. In the remaining four studies there were no specified primary or secondary outcome measures (<a href="./references#CD010777-bbs2-0004" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(5):976‐84. [MEDLINE: 18842422] ">Czibik‐stable 2008</a>; <a href="./references#CD010777-bbs2-0005" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(1):976‐84. [MEDLINE: 18842422] ">Czibik‐unstable 2008</a>; <a href="./references#CD010777-bbs2-0025" title="VenugopalV , HausenloyDJ , LudmanA , DiSalvoC , KolvekarS , YapJ , et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold‐blood cardioplegia: a randomised controlled trial. Heart2009;95(19):1567‐71. [MEDLINE: 19508973] VenugopalV , HausenloyDJ , LudmanA , LaingCM , YellonDM . Does remote ischemic preconditioning prevent acute kidney injury in patients undergoing elective cardiac surgery? [abstract no: P05]. British Transplantation Society (BTS).12th Annual Congress; 2009 Apr 21‐24; Liverpool, UK. 2009. VenugopalV , LaingCM , LudmanA , YellonDM , HausenloyD . Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials. American Journal of Kidney Diseases2010;56(6):1043‐9. [MEDLINE: 20974511] ">Venugopal 2009</a>; <a href="./references#CD010777-bbs2-0013" title="LomivorotovVV , ShmyrevVA , NepomnyaschihVA , PonomarevDN , KnyazkovaLG , LomivorotovVN , et al. Remote ischaemic preconditioning does not protect the heart in patients undergoing coronary artery bypass grafting. Interactive Cardiovascular &amp; Thoracic Surgery2012;15(1):18‐22. [MEDLINE: 22493101] ">Lomivorotov 2012</a>; <a href="./references#CD010777-bbs2-0018" title="PepeS , LiawNY , HepponstallM , SheeranFL , YongMS , d'UdekemY , et al. Effect of remote ischemic preconditioning on phosphorylated protein signaling in children undergoing tetralogy of fallot repair: a randomized controlled trial. Journal of the American Heart Association2013;2(3):e000095. [MEDLINE: 23666460] ">Pepe 2013</a>). Mortality was reported in 24 studies, duration of hospital stay in 8 studies, and incidence of adverse effects of remote ischaemic preconditioning in 13 studies. Other reported outcome measures were myocardial injury, pulmonary injury, stroke, ICU stay, inotropic support, and a wide variety of non‐kidney molecular markers (e.g. IL‐8, CK‐MB and NF‐kB). </p> <p>Kidney outcome measures differed substantially among studies. Serum creatinine was published in 15 studies at 13 different time points postoperatively. Serum NGAL was reported in two studies (<a href="./references#CD010777-bbs2-0003" title="ChoiYS , ShimJK , KimJC , KangKS , SeoYH , AhnKR , et al. Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2011;142(1):148‐54. [MEDLINE: 21272897] ">Choi 2011</a>; <a href="./references#CD010777-bbs2-0017" title="PedersenKR , RavnHB , PovlsenJV , SchmidtMR , ErlandsenEJ , HjortdalVE . Failure of remote ischemic preconditioning to reduce the risk of postoperative acute kidney injury in children undergoing operation for complex congenital heart disease: a randomized single‐center study. Journal of Thoracic &amp; Cardiovascular Surgery2012;143(3):576‐83. [MEDLINE: 21955475] ">Pedersen 2012</a>) at day one, two and three after surgery. Incidence of AKI was reported in 10 studies, of which <a href="./references#CD010777-bbs2-0017" title="PedersenKR , RavnHB , PovlsenJV , SchmidtMR , ErlandsenEJ , HjortdalVE . Failure of remote ischemic preconditioning to reduce the risk of postoperative acute kidney injury in children undergoing operation for complex congenital heart disease: a randomized single‐center study. Journal of Thoracic &amp; Cardiovascular Surgery2012;143(3):576‐83. [MEDLINE: 21955475] ">Pedersen 2012</a>, <a href="./references#CD010777-bbs2-0021" title="MeybohmP , BeinB , BrosteanuO , CremerJ , GruenewaldM , StoppeC , et al. A multicenter trial of remote ischemic preconditioning for heart surgery. New England Journal of Medicine2015;373(15):1397‐407. [MEDLINE: 26436208] MeybohmP , ZacharowskiK , CremerJ , RoesnerJ , KletzinF , SchaelteG , et al. Remote ischaemic preconditioning for heart surgery. The study design for a multi‐center randomized double‐blinded controlled clinical trial‐‐the RIPHeart‐Study. European Heart Journal2012;33(12):1423‐6. [MEDLINE: 22880214] ">RIPHeart Study 2012</a> and <a href="./references#CD010777-bbs2-0027" title="YoungPJ , DalleyP , GardenA , HorrocksC , LaFlammeA , MahonB , et al. A pilot study investigating the effects of remote ischemic preconditioning in high‐risk cardiac surgery using a randomised controlled double‐blind protocol. Basic Research in Cardiology2012;107(3):256. [MEDLINE: 22406977] ">Young 2012</a> assessed AKI incidence according to the RIFLE criteria, and <a href="./references#CD010777-bbs2-0002" title="CandilioL , MalikA , AritiC , BarnardM , DiSalvoC , LawrenceD , et al. Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial. Heart2015;101(3):185‐92. [MEDLINE: 25252696] ">Candilio 2015</a>, <a href="./references#CD010777-bbs2-0003" title="ChoiYS , ShimJK , KimJC , KangKS , SeoYH , AhnKR , et al. Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2011;142(1):148‐54. [MEDLINE: 21272897] ">Choi 2011</a>, <a href="./references#CD010777-bbs2-0006" title="HausenloyDJ , CandilioL , EvansR , AritiC , JenkinsDP , KolvekarS , et al. Remote ischemic preconditioning and outcomes of cardiac surgery. New England Journal of Medicine2015;373(15):1408‐17. [MEDLINE: 26436207] HausenloyDJ , CandilioL , LaingC , KunstG , PepperJ , KolvekarS , et al. Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi‐centre randomized double‐blinded controlled clinical trial. Clinical Research in Cardiology2012;101(5):339‐48. [MEDLINE: 22186969] ">ERICCA Study 2012</a>, <a href="./references#CD010777-bbs2-0019" title="PinaudF , CorbeauJJ , BaufretonC , BinuaniJP , DeBruxJL , FouquetO , et al. Remote ischemic preconditioning in aortic valve surgery: results of a randomized controlled study. Journal of Cardiology2016;67(1):36‐41. [MEDLINE: 26271449] ">Pinaud 2016</a>, <a href="./references#CD010777-bbs2-0025" title="VenugopalV , HausenloyDJ , LudmanA , DiSalvoC , KolvekarS , YapJ , et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold‐blood cardioplegia: a randomised controlled trial. Heart2009;95(19):1567‐71. [MEDLINE: 19508973] VenugopalV , HausenloyDJ , LudmanA , LaingCM , YellonDM . Does remote ischemic preconditioning prevent acute kidney injury in patients undergoing elective cardiac surgery? [abstract no: P05]. British Transplantation Society (BTS).12th Annual Congress; 2009 Apr 21‐24; Liverpool, UK. 2009. VenugopalV , LaingCM , LudmanA , YellonDM , HausenloyD . Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials. American Journal of Kidney Diseases2010;56(6):1043‐9. [MEDLINE: 20974511] ">Venugopal 2009</a>, <a href="./references#CD010777-bbs2-0028" title="ZarbockA , SchmidtC , vanAkenH , WempeC , MartensS , ZahnPK , et al. Effect of remote ischemic preconditioning on kidney injury among high‐risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA2015;313(21):2133‐41. [MEDLINE: 26024502] ">Zarbock 2015</a>, and <a href="./references#CD010777-bbs2-0029" title="ZimmermanRF , EzeanunaPU , KaneJC , ClelandCD , KempananjappaTJ , LucasFL , et al. Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney International2011;80(8):861‐7. [MEDLINE: 21677633] ">Zimmerman 2011</a> used the AKIN criteria. </p> </section> </section> <section id="CD010777-sec-0059"> <h4 class="title">Excluded studies</h4> <p>Studies on surgical procedures unlikely to cause kidney ischaemia reperfusion injury (<a href="./references#CD010777-bbs2-0034" title="FudickarA , KunathS , VosD , SiggelkowM , CavusE , SteinfathM , et al. Effect of ischemic and pharmacological preconditioning of lower limb muscle tissue on tissue oxygenation measured by near‐infrared spectroscopy‐‐a pilot study. BMC Anesthesiology2014;14:54. [MEDLINE: 25132803] ">Fudickar 2014</a>; <a href="./references#CD010777-bbs2-0037" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(1):159‐67. [MEDLINE: 24203849] ">Hougaard 2014</a>; <a href="./references#CD010777-bbs2-0041" title="LiC , XuM , WuY , LiYS , HuangWQ , LiuKX . Limb remote ischemic preconditioning attenuates lung injury after pulmonary resection under propofol‐remifentanil anesthesia: a randomized controlled study. Anesthesiology2014;121(2):249‐59. [MEDLINE: 24743579] ">Li 2014f</a>; <a href="./references#CD010777-bbs2-0043" title="McDonaldMA , BragaJR , LiJ , ManlhiotC , RossHJ , RedingtonAN . A randomized pilot trial of remote ischemic preconditioning in heart failure with reduced ejection fraction. PLoS ONE [Electronic Resource]2014;9(9):e105361. [MEDLINE: 25181050] ">McDonald 2014</a>; <a href="./references#CD010777-bbs2-0044" title="MemtsoudisSG , StundnerO , YooD , Gonzalez Della ValleA , BoettnerF , BombardieriAM , et al. Does limb preconditioning reduce pain after total knee arthroplasty? A randomized, double‐blind study. Clinical Orthopaedics &amp; Related Research2014;472(5):1467‐74. [MEDLINE: 23761178] ">Memtsoudis 2014</a>; <a href="./references#CD010777-bbs2-0045" title="ParkJ , AnnSH , ChungHC , LeeJS , KimSJ , GargS , et al. Remote ischemic preconditioning in hemodialysis: a pilot study.[Erratum appears in Heart Vessels. 2014 Mar;29(2):286]. Heart &amp; Vessels2014;29(1):58‐64. [MEDLINE: 23532306] ">Park 2014a</a>; <a href="./references#CD010777-bbs2-0048" title="RodriguezA , TauraP , Garcia DomingoMI , HerreroE , CampsJ , ForcadaP , et al. Hepatic cytoprotective effect of ischemic and anesthetic preconditioning before liver resection when using intermittent vascular inflow occlusion: a randomized clinical trial. Surgery2015;157(2):249‐59. [MEDLINE: 25616941] ">Rodriguez 2015</a>; <a href="./references#CD010777-bbs2-0050" title="StaziA , ScaloneG , LauritoM , MiloM , PelargonioG , NarducciML , et al. Effect of remote ischemic preconditioning on platelet activation and reactivity induced by ablation for atrial fibrillation. Circulation2014;129(1):11‐7. [MEDLINE: 24277055] ">Stazi 2014</a>), studies without remote ischaemic preconditioning applied (<a href="./references#CD010777-bbs2-0038" title="GarciaC , JulierK , BestmannL , ZollingerA , vonSegesserLK , PaschT , et al. Preconditioning with sevoflurane decreases PECAM‐1 expression and improves one‐year cardiovascular outcome in coronary artery bypass graft surgery. British Journal of Anaesthesia2005;94(2):159‐65. [MEDLINE: 15556966] JulierK , daSilvaR , GarciaC , BestmannL , FrascaroloP , ZollingerA , et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double‐blinded, placebo‐controlled, multicenter study. Anesthesiology2003;98(6):1315‐27. [MEDLINE: 12766638] ">Julier 2003</a>; <a href="./references#CD010777-bbs2-0046" title="RablH , KhoschsorurG , ColomboT , PetritschP , RauchenwaldM , KoltringerP , et al. A multivitamin infusion prevents lipid peroxidation and improves transplantation performance. Kidney International1993;43(4):912‐7. [MEDLINE: 8479129] ">Rabl 1993</a>; <a href="./references#CD010777-bbs2-0051" title="VesninaZ , Arsen'evaI , Emel'ianovaTV , KozlovBN , LishmanovI . Radionuclide renal scintigraphy in assessment of nephroprotective effect of hypoxic preconditioning for myocardial revascularization under artificial circulation. Angiologiia i Sosudistaia Khirurgiia [Angiology &amp; Vascular Surgery]2011;17(4):41‐6. [MEDLINE: 22616228] ">Vesnina 2011</a>; <a href="./references#CD010777-bbs2-0053" title="WangQ , LuoW , ZhouQ . Intervention of NGAL and HO‐1 in valve replacement surgery‐induced acute kidney injury. Zhong Nan da Xue Xue Bao. Yi Xue Ban [Journal of Central South University. Medical Sciences]2014;39(10):1001‐7. [MEDLINE: 25355252] ">Wang 2014d</a>; <a href="./references#CD010777-bbs2-0055" title="ZiegelerS . Preconditioning with sevoflurane reduces biochemical markers for myocardial and renal dysfunction after aortocoronary procedures [Prakonditionierung mit Sevofluran verringert biochemische Marker fur myokardiale und renale Dysfunktionen nach aortokoronaren Eingriffen]. Anaesthesist2004;53(9):880‐1. [MEDLINE: 15197465] ">Ziegeler 2004</a>), studies relating to transplantation (<a href="./references#CD010777-bbs2-0031" title="ChenY , ZhengH , WangX , ZhouZ , LuoA , TianY . Remote ischemic preconditioning fails to improve early renal function of patients undergoing living‐donor renal transplantation: a randomized controlled trial. Transplantation2013;95(2):e4‐6. [MEDLINE: 23325011] ">Chen 2013</a>), and studies investigating iodine contrast (<a href="./references#CD010777-bbs2-0032" title="CrimiG , FerliniM , GalloF , SormaniMP , RaineriC , BramucciE , et al. Remote ischemic postconditioning as a strategy to reduce acute kidney injury during primary PCI: a post‐hoc analysis of a randomized trial. International Journal of Cardiology2014;177(2):500‐2. [MEDLINE: 25183541] CrimiG , PicaS , RaineriC , BramucciE , DeFerrariGM , KlersyC , et al. Remote ischemic post‐conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial. JACC: Cardiovascular Interventions2013;6(10):1055‐63. [MEDLINE: 24156966] ">Crimi 2013</a>; <a href="./references#CD010777-bbs2-0033" title="HooleSP , HeckPM , SharplesL , KhanSN , DuehmkeR , DensemCG , et al. Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial. Circulation2009;119(6):820‐7. [MEDLINE: 19188504] ">CRISP Stent Study 2009</a>; <a href="./references#CD010777-bbs2-0039" title="LaviS , D'AlfonsoS , DiamantourosP , CamugliaA , GargP , TeefyP , et al. Remote ischemic postconditioning during percutaneous coronary interventions: remote ischemic postconditioning‐percutaneous coronary intervention randomized trial. Circulation: Cardiovascular Interventions2014;7(2):225‐32. [MEDLINE: 24692535] ">Lavi 2014</a>; <a href="./references#CD010777-bbs2-0042" title="ManchurovV , RyazankinaN , KhmaraT , SkrypnikD , ReztsovR , VasilievaE , et al. Remote ischemic preconditioning and endothelial function in patients with acute myocardial infarction and primary PCI. American Journal of Medicine2014;127(7):670‐3. [MEDLINE: 24565591] ">Manchurov 2014</a>; <a href="./references#CD010777-bbs2-0047" title="ErF , NiaAM , DoppH , HellmichM , DahlemKM , CaglayanE , et al. Ischemic preconditioning for prevention of contrast medium‐induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial). Circulation2012;126(3):296‐303. [MEDLINE: 22735306] ">RenPro Trial 2012</a>; <a href="./references#CD010777-bbs2-0049" title="SlothAD , SchmidtMR , MunkK , KharbandaRK , RedingtonAN , SchmidtM , et al. Improved long‐term clinical outcomes in patients with ST‐elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention. European Heart Journal2014;35(3):168‐75. [MEDLINE: 24031025] ">Sloth 2014</a>; <a href="./references#CD010777-bbs2-0052" title="WalshS . Remote ischemic preconditioning reduces renal injury during endovascular aneurysm repair: randomized controlled trial [abstract]. Vascular2009;17:S71‐2. [EMBASE: 70091542] WalshSR , BoyleJR , TangTY , SadatU , CooperDG , LapsleyM , et al. Remote ischemic preconditioning for renal and cardiac protection during endovascular aneurysm repair: a randomized controlled trial. Journal of Endovascular Therapy2009;16(6):680‐9. [MEDLINE: 19995115] ">Walsh 2009a</a>; <a href="./references#CD010777-bbs2-0054" title="XuX , ZhouY , LuoS , ZhangW , ZhaoY , YuM , et al. Effect of remote ischemic preconditioning in the elderly patients with coronary artery disease with diabetes mellitus undergoing elective drug‐eluting stent implantation. Angiology2014;65(8):660‐6. [MEDLINE: 24163121] ">Xu 2014</a>; <a href="./references#CD010777-bbs2-0056" title="ZografosTA , KatritsisGD , TsiafoutisI , BourboulisN , KatsivasA , KatritsisDG . Effect of one‐cycle remote ischemic preconditioning to reduce myocardial injury during percutaneous coronary intervention. American Journal of Cardiology2014;113(12):2013‐7. [MEDLINE: 24793669] ">Zografos 2014</a>) were excluded. Studies in patients undergoing kidney transplantation or intravenous contrast administration were excluded because of the differences in pathophysiology of the inflicted kidney injury. </p> <p>Studies with a different primary outcome measure than kidney injury and with an intervention causing kidney injury were included if they published kidney outcome measures. However, not all studies reported kidney outcome measures, we emailed the authors of those studies for kidney data and if no reply was received, we attempted to contact them again after three weeks. Studies without published kidney outcome measures were excluded after this second email attempt (<a href="./references#CD010777-bbs2-0030" title="BautinAE , GalagudzaMM , DatsenkoSV , TashkhanovDM , MarichevAO , BakanovAI , et al. Effects of remote ischemic preconditioning on perioperative period in elective aortic valve replacement. Anesteziologiia i Reanimatologiia2014, (3):11‐7. [MEDLINE: 25306677] ">Bautin 2014</a>; <a href="./references#CD010777-bbs2-0035" title="HausenloyDJ , MwamurePK , VenugopalV , HarrisJ , BarnardM , GrundyE , et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet2007;370(9587):575‐9. [MEDLINE: 17707752] VenugopalV , HausenloyDJ , LudmanA , LiangC , YellonDM . Remote ischaemic preconditioning reduces renal injury in patients undergoing coronary artery bypass graft surgery [abstract no: 3647]. European Heart Journal2009;30(Suppl 1):597. [EMBASE: 70355433] VenugopalV , LaingCM , LudmanA , YellonDM , HausenloyD . Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials. American Journal of Kidney Diseases2010;56(6):1043‐9. [MEDLINE: 20974511] ">Hausenloy 2007</a>; <a href="./references#CD010777-bbs2-0036" title="HolmbergFE , OttasKA , AndreasenC , PerkoMJ , MollerCH , EngstromT , et al. Conditioning techniques and ischemic reperfusion injury in relation to on‐pump cardiac surgery. Scandinavian Cardiovascular Journal2014;48(4):241‐8. [MEDLINE: 24852515] ">Holmberg 2014</a>; <a href="./references#CD010777-bbs2-0040" title="LiG , ChenS , LuE . Protective effects of ischemic preconditioning on myocardium during patients undergoing heart valve replacement surgery. Bulletin of Hunan Medical University1999;24(5):478‐80. [MEDLINE: 12080691] ">Li 1999a</a>). </p> </section> </section> <section id="CD010777-sec-0060"> <h3 class="title">Risk of bias in included studies</h3> <p>Risk of bias assessment was performed by two independent review authors and summarised in <a href="#CD010777-fig-0003">Figure 3</a> and <a href="#CD010777-fig-0004">Figure 4</a>. </p> <div class="figure" id="CD010777-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010777-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD010777-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010777-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD010777-sec-0061"> <h4 class="title">Allocation</h4> <p>Most included studies reported adequate methods of random sequence generation for patient allocation, which was assessed at low risk of selection bias. A computer generated random number sequence was used in 22 studies; <a href="./references#CD010777-bbs2-0029" title="ZimmermanRF , EzeanunaPU , KaneJC , ClelandCD , KempananjappaTJ , LucasFL , et al. Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney International2011;80(8):861‐7. [MEDLINE: 21677633] ">Zimmerman 2011</a> used manually shuffled blocks which we also reported as low risk of bias. In one study (<a href="./references#CD010777-bbs2-0004" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(5):976‐84. [MEDLINE: 18842422] ">Czibik‐stable 2008</a>; <a href="./references#CD010777-bbs2-0005" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(1):976‐84. [MEDLINE: 18842422] ">Czibik‐unstable 2008</a>) randomisation was not reported, leading to a high risk of selection bias. <a href="./references#CD010777-bbs2-0011" title="LeeJH , ParkYH , ByonHJ , KimHS , KimCS , KimJT . Effect of remote ischaemic preconditioning on ischaemic‐reperfusion injury in pulmonary hypertensive infants receiving ventricular septal defect repair. British Journal of Anaesthesia2012;108(2):223‐8. [MEDLINE: 22157844] ">Lee 2012</a>, <a href="./references#CD010777-bbs2-0013" title="LomivorotovVV , ShmyrevVA , NepomnyaschihVA , PonomarevDN , KnyazkovaLG , LomivorotovVN , et al. Remote ischaemic preconditioning does not protect the heart in patients undergoing coronary artery bypass grafting. Interactive Cardiovascular &amp; Thoracic Surgery2012;15(1):18‐22. [MEDLINE: 22493101] ">Lomivorotov 2012</a>, <a href="./references#CD010777-bbs2-0018" title="PepeS , LiawNY , HepponstallM , SheeranFL , YongMS , d'UdekemY , et al. Effect of remote ischemic preconditioning on phosphorylated protein signaling in children undergoing tetralogy of fallot repair: a randomized controlled trial. Journal of the American Heart Association2013;2(3):e000095. [MEDLINE: 23666460] ">Pepe 2013</a> and <a href="./references#CD010777-bbs2-0023" title="ThielmannM , KottenbergE , BoenglerK , RaffelsieperC , NeuhaeuserM , PetersJ , et al. Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest. Basic Research in Cardiology2010;105(5):657‐64. [MEDLINE: 20495811] ThielmannM , KottenbergE , BoenglerK , RaffelsieperC , WendtD , NeuhauserM , et al. Remote ischemic preconditioning reduces myocardial and renal injury in elective coronary artery bypass surgery with crystalloid cardioplegic arrest: a randomized controlled trial [abstract no: D101]. Innovations: Technology &amp; Techniques in Cardiothoracic &amp; Vascular Surgery2010;5(3):239. [EMBASE: 70471618] ">Thielmann 2010</a> reported randomisation, but did not report the method used, and were therefore assessed to be at unclear risk of selection bias. </p> <p>There were 16 studies reporting blinding of allocation using numbered, sealed, opaque envelopes, which was assessed to introduce a low risk of selection bias. The remaining 12 studies did not mention whether the patient allocation was blinded. For these studies (<a href="./references#CD010777-bbs2-0003" title="ChoiYS , ShimJK , KimJC , KangKS , SeoYH , AhnKR , et al. Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2011;142(1):148‐54. [MEDLINE: 21272897] ">Choi 2011</a>; <a href="./references#CD010777-bbs2-0004" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(5):976‐84. [MEDLINE: 18842422] ">Czibik‐stable 2008</a>; <a href="./references#CD010777-bbs2-0005" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(1):976‐84. [MEDLINE: 18842422] ">Czibik‐unstable 2008</a>; <a href="./references#CD010777-bbs2-0006" title="HausenloyDJ , CandilioL , EvansR , AritiC , JenkinsDP , KolvekarS , et al. Remote ischemic preconditioning and outcomes of cardiac surgery. New England Journal of Medicine2015;373(15):1408‐17. [MEDLINE: 26436207] HausenloyDJ , CandilioL , LaingC , KunstG , PepperJ , KolvekarS , et al. Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi‐centre randomized double‐blinded controlled clinical trial. Clinical Research in Cardiology2012;101(5):339‐48. [MEDLINE: 22186969] ">ERICCA Study 2012</a>; <a href="./references#CD010777-bbs2-0009" title="HuangJ , ChenY , DongB , KongW , ZhangJ , XueW , et al. Effect of remote ischaemic preconditioning on renal protection in patients undergoing laparoscopic partial nephrectomy: a 'blinded' randomised controlled trial. BJU International2013;112(1):74‐80. [MEDLINE: 23452148] ">Huang 2013</a>; <a href="./references#CD010777-bbs2-0011" title="LeeJH , ParkYH , ByonHJ , KimHS , KimCS , KimJT . Effect of remote ischaemic preconditioning on ischaemic‐reperfusion injury in pulmonary hypertensive infants receiving ventricular septal defect repair. British Journal of Anaesthesia2012;108(2):223‐8. [MEDLINE: 22157844] ">Lee 2012</a>; <a href="./references#CD010777-bbs2-0013" title="LomivorotovVV , ShmyrevVA , NepomnyaschihVA , PonomarevDN , KnyazkovaLG , LomivorotovVN , et al. Remote ischaemic preconditioning does not protect the heart in patients undergoing coronary artery bypass grafting. Interactive Cardiovascular &amp; Thoracic Surgery2012;15(1):18‐22. [MEDLINE: 22493101] ">Lomivorotov 2012</a>; <a href="./references#CD010777-bbs2-0016" title="PavioneMA , CarmonaF , deCastroM , CarlottiAP . Late remote ischemic preconditioning in children undergoing cardiopulmonary bypass: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2012;144(1):178‐83. [MEDLINE: 22244567] ">Pavione 2012</a>; <a href="./references#CD010777-bbs2-0018" title="PepeS , LiawNY , HepponstallM , SheeranFL , YongMS , d'UdekemY , et al. Effect of remote ischemic preconditioning on phosphorylated protein signaling in children undergoing tetralogy of fallot repair: a randomized controlled trial. Journal of the American Heart Association2013;2(3):e000095. [MEDLINE: 23666460] ">Pepe 2013</a>; <a href="./references#CD010777-bbs2-0019" title="PinaudF , CorbeauJJ , BaufretonC , BinuaniJP , DeBruxJL , FouquetO , et al. Remote ischemic preconditioning in aortic valve surgery: results of a randomized controlled study. Journal of Cardiology2016;67(1):36‐41. [MEDLINE: 26271449] ">Pinaud 2016</a>; <a href="./references#CD010777-bbs2-0023" title="ThielmannM , KottenbergE , BoenglerK , RaffelsieperC , NeuhaeuserM , PetersJ , et al. Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest. Basic Research in Cardiology2010;105(5):657‐64. [MEDLINE: 20495811] ThielmannM , KottenbergE , BoenglerK , RaffelsieperC , WendtD , NeuhauserM , et al. Remote ischemic preconditioning reduces myocardial and renal injury in elective coronary artery bypass surgery with crystalloid cardioplegic arrest: a randomized controlled trial [abstract no: D101]. Innovations: Technology &amp; Techniques in Cardiothoracic &amp; Vascular Surgery2010;5(3):239. [EMBASE: 70471618] ">Thielmann 2010</a>; <a href="./references#CD010777-bbs2-0025" title="VenugopalV , HausenloyDJ , LudmanA , DiSalvoC , KolvekarS , YapJ , et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold‐blood cardioplegia: a randomised controlled trial. Heart2009;95(19):1567‐71. [MEDLINE: 19508973] VenugopalV , HausenloyDJ , LudmanA , LaingCM , YellonDM . Does remote ischemic preconditioning prevent acute kidney injury in patients undergoing elective cardiac surgery? [abstract no: P05]. British Transplantation Society (BTS).12th Annual Congress; 2009 Apr 21‐24; Liverpool, UK. 2009. VenugopalV , LaingCM , LudmanA , YellonDM , HausenloyD . Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials. American Journal of Kidney Diseases2010;56(6):1043‐9. [MEDLINE: 20974511] ">Venugopal 2009</a>), the risk of selection bias was assessed as unclear. </p> </section> <section id="CD010777-sec-0062"> <h4 class="title">Blinding</h4> <p>Many studies did not adequately report measures to reduce performance and detection bias. Only 16 studies reported adequate blinding of investigators and involved personnel, such as by hiding the blood pressure cuff and using an independent investigator to perform the remote ischaemic preconditioning protocol. The risk of performance bias in these studies was therefore assessed to be low. <a href="./references#CD010777-bbs2-0019" title="PinaudF , CorbeauJJ , BaufretonC , BinuaniJP , DeBruxJL , FouquetO , et al. Remote ischemic preconditioning in aortic valve surgery: results of a randomized controlled study. Journal of Cardiology2016;67(1):36‐41. [MEDLINE: 26271449] ">Pinaud 2016</a> reported their study as single blinded and therefore was assessed as high risk of bias. The remaining 11 studies had unclear risk of bias as blinding was not described. Patients were anaesthetised during remote ischaemic preconditioning in all studies except for <a href="./references#CD010777-bbs2-0016" title="PavioneMA , CarmonaF , deCastroM , CarlottiAP . Late remote ischemic preconditioning in children undergoing cardiopulmonary bypass: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2012;144(1):178‐83. [MEDLINE: 22244567] ">Pavione 2012</a>; however, anaesthesia does not ensure that patients are fully blinded for the allocated intervention. All studies therefore were assessed at unclear risk of bias. </p> <p>Ten studies (<a href="./references#CD010777-bbs2-0002" title="CandilioL , MalikA , AritiC , BarnardM , DiSalvoC , LawrenceD , et al. Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial. Heart2015;101(3):185‐92. [MEDLINE: 25252696] ">Candilio 2015</a>; <a href="./references#CD010777-bbs2-0006" title="HausenloyDJ , CandilioL , EvansR , AritiC , JenkinsDP , KolvekarS , et al. Remote ischemic preconditioning and outcomes of cardiac surgery. New England Journal of Medicine2015;373(15):1408‐17. [MEDLINE: 26436207] HausenloyDJ , CandilioL , LaingC , KunstG , PepperJ , KolvekarS , et al. Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi‐centre randomized double‐blinded controlled clinical trial. Clinical Research in Cardiology2012;101(5):339‐48. [MEDLINE: 22186969] ">ERICCA Study 2012</a>; <a href="./references#CD010777-bbs2-0014" title="LucchinettiE , BestmannL , FengJ , FreidankH , ClanachanAS , FineganBA , et al. Remote ischemic preconditioning applied during isoflurane inhalation provides no benefit to the myocardium of patients undergoing on‐pump coronary artery bypass graft surgery: lack of synergy or evidence of antagonism in cardioprotection?. Anesthesiology2012;116(2):296‐310. [MEDLINE: 22222469] ">Luchinetti 2012</a>; <a href="./references#CD010777-bbs2-0015" title="McCrindleBW , ClariziaN , KhaikinS , ColesJ , HoltbyH , SchwartzS , et al. Remote ischemic preconditioning in children undergoing surgery with cardiopulmonary bypass: a single centre double‐blinded randomized trial [abstract no: 11013]. Circulation2011;124(21 Suppl 1). [EMBASE: 70618970] McCrindleBW , ClariziaNA , KhaikinS , HoltbyHS , ManlhiotC , SchwartzSM , et al. Remote ischemic preconditioning in children undergoing cardiac surgery with cardiopulmonary bypass: a single‐center double‐blinded randomized trial. Journal of the American Heart Association2014;3(4):e000964. [MEDLINE: 25074698] ">McCrindle 2014</a>; <a href="./references#CD010777-bbs2-0019" title="PinaudF , CorbeauJJ , BaufretonC , BinuaniJP , DeBruxJL , FouquetO , et al. Remote ischemic preconditioning in aortic valve surgery: results of a randomized controlled study. Journal of Cardiology2016;67(1):36‐41. [MEDLINE: 26271449] ">Pinaud 2016</a>; <a href="./references#CD010777-bbs2-0016" title="PavioneMA , CarmonaF , deCastroM , CarlottiAP . Late remote ischemic preconditioning in children undergoing cardiopulmonary bypass: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2012;144(1):178‐83. [MEDLINE: 22244567] ">Pavione 2012</a>; <a href="./references#CD010777-bbs2-0020" title="RahmanIA , MascaroJG , SteedsRP , FrenneauxMP , NightingaleP , GoslingP , et al. Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment?. Circulation2010;122(11 Suppl):S53‐9. [MEDLINE: 20837926] ">Rahman 2010</a>; <a href="./references#CD010777-bbs2-0021" title="MeybohmP , BeinB , BrosteanuO , CremerJ , GruenewaldM , StoppeC , et al. A multicenter trial of remote ischemic preconditioning for heart surgery. New England Journal of Medicine2015;373(15):1397‐407. [MEDLINE: 26436208] MeybohmP , ZacharowskiK , CremerJ , RoesnerJ , KletzinF , SchaelteG , et al. Remote ischaemic preconditioning for heart surgery. The study design for a multi‐center randomized double‐blinded controlled clinical trial‐‐the RIPHeart‐Study. European Heart Journal2012;33(12):1423‐6. [MEDLINE: 22880214] ">RIPHeart Study 2012</a>; <a href="./references#CD010777-bbs2-0022" title="SlagsvoldKH , RognmoO , HoydalM , WisloffU , WahbaA . Remote ischemic preconditioning preserves mitochondrial function and influences myocardial microRNA expression in atrial myocardium during coronary bypass surgery. Circulation Research2014;114(5):851‐9. [MEDLINE: 24371264] ">Slagsvold 2014</a>; <a href="./references#CD010777-bbs2-0027" title="YoungPJ , DalleyP , GardenA , HorrocksC , LaFlammeA , MahonB , et al. A pilot study investigating the effects of remote ischemic preconditioning in high‐risk cardiac surgery using a randomised controlled double‐blind protocol. Basic Research in Cardiology2012;107(3):256. [MEDLINE: 22406977] ">Young 2012</a>) reported adequate blinding of outcome assessors and were therefore rated as being at low risk of detection bias. Fifteen studies did not adequately report blinding of outcome assessors and were assessed at unclear risk of detection bias. Three studies did not mention blinding of outcome assessors and were assessed at high risk of bias (<a href="./references#CD010777-bbs2-0004" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(5):976‐84. [MEDLINE: 18842422] ">Czibik‐stable 2008</a>; <a href="./references#CD010777-bbs2-0005" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(1):976‐84. [MEDLINE: 18842422] ">Czibik‐unstable 2008</a>; <a href="./references#CD010777-bbs2-0012" title="LiC , LiYS , XuM , WenSH , YaoX , WuY , et al. Limb remote ischemic preconditioning for intestinal and pulmonary protection during elective open infrarenal abdominal aortic aneurysm repair: a randomized controlled trial. Anesthesiology2013;118(4):842‐52. [MEDLINE: 23353795] ">Li 2013</a>; <a href="./references#CD010777-bbs2-0029" title="ZimmermanRF , EzeanunaPU , KaneJC , ClelandCD , KempananjappaTJ , LucasFL , et al. Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney International2011;80(8):861‐7. [MEDLINE: 21677633] ">Zimmerman 2011</a>). </p> </section> <section id="CD010777-sec-0063"> <h4 class="title">Incomplete outcome data</h4> <p>Risk of attrition bias was unclear in 15 studies (<a href="./references#CD010777-bbs2-0001" title="AliZA , CallaghanCJ , LimE , AliAA , NouraeiSA , AktharAM , et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation2007;116(11 Suppl):I98‐105. [MEDLINE: 17846333] ">Ali 2007</a>; <a href="./references#CD010777-bbs2-0004" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(5):976‐84. [MEDLINE: 18842422] ">Czibik‐stable 2008</a>; <a href="./references#CD010777-bbs2-0005" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(1):976‐84. [MEDLINE: 18842422] ">Czibik‐unstable 2008</a>; <a href="./references#CD010777-bbs2-0007" title="HongDM , JeonY , LeeCS , KimHJ , LeeJM , BahkJH , et al. Effects of remote ischemic preconditioning with postconditioning in patients undergoing off‐pump coronary artery bypass surgery ‐ randomized controlled trial. Circulation Journal2012;76(4):884‐90. [MEDLINE: 22301846] ">Hong 2012</a>; <a href="./references#CD010777-bbs2-0008" title="HongDM , LeeEH , KimHJ , MinJJ , ChinJH , ChoiDK , et al. Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial. European Heart Journal2014;35(3):176‐83. [MEDLINE: 24014392] ">Hong 2014</a>; <a href="./references#CD010777-bbs2-0011" title="LeeJH , ParkYH , ByonHJ , KimHS , KimCS , KimJT . Effect of remote ischaemic preconditioning on ischaemic‐reperfusion injury in pulmonary hypertensive infants receiving ventricular septal defect repair. British Journal of Anaesthesia2012;108(2):223‐8. [MEDLINE: 22157844] ">Lee 2012</a>; <a href="./references#CD010777-bbs2-0013" title="LomivorotovVV , ShmyrevVA , NepomnyaschihVA , PonomarevDN , KnyazkovaLG , LomivorotovVN , et al. Remote ischaemic preconditioning does not protect the heart in patients undergoing coronary artery bypass grafting. Interactive Cardiovascular &amp; Thoracic Surgery2012;15(1):18‐22. [MEDLINE: 22493101] ">Lomivorotov 2012</a>; <a href="./references#CD010777-bbs2-0014" title="LucchinettiE , BestmannL , FengJ , FreidankH , ClanachanAS , FineganBA , et al. Remote ischemic preconditioning applied during isoflurane inhalation provides no benefit to the myocardium of patients undergoing on‐pump coronary artery bypass graft surgery: lack of synergy or evidence of antagonism in cardioprotection?. Anesthesiology2012;116(2):296‐310. [MEDLINE: 22222469] ">Luchinetti 2012</a>; <a href="./references#CD010777-bbs2-0015" title="McCrindleBW , ClariziaN , KhaikinS , ColesJ , HoltbyH , SchwartzS , et al. Remote ischemic preconditioning in children undergoing surgery with cardiopulmonary bypass: a single centre double‐blinded randomized trial [abstract no: 11013]. Circulation2011;124(21 Suppl 1). [EMBASE: 70618970] McCrindleBW , ClariziaNA , KhaikinS , HoltbyHS , ManlhiotC , SchwartzSM , et al. Remote ischemic preconditioning in children undergoing cardiac surgery with cardiopulmonary bypass: a single‐center double‐blinded randomized trial. Journal of the American Heart Association2014;3(4):e000964. [MEDLINE: 25074698] ">McCrindle 2014</a>; <a href="./references#CD010777-bbs2-0016" title="PavioneMA , CarmonaF , deCastroM , CarlottiAP . Late remote ischemic preconditioning in children undergoing cardiopulmonary bypass: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2012;144(1):178‐83. [MEDLINE: 22244567] ">Pavione 2012</a>; <a href="./references#CD010777-bbs2-0018" title="PepeS , LiawNY , HepponstallM , SheeranFL , YongMS , d'UdekemY , et al. Effect of remote ischemic preconditioning on phosphorylated protein signaling in children undergoing tetralogy of fallot repair: a randomized controlled trial. Journal of the American Heart Association2013;2(3):e000095. [MEDLINE: 23666460] ">Pepe 2013</a>; <a href="./references#CD010777-bbs2-0019" title="PinaudF , CorbeauJJ , BaufretonC , BinuaniJP , DeBruxJL , FouquetO , et al. Remote ischemic preconditioning in aortic valve surgery: results of a randomized controlled study. Journal of Cardiology2016;67(1):36‐41. [MEDLINE: 26271449] ">Pinaud 2016</a>; <a href="./references#CD010777-bbs2-0021" title="MeybohmP , BeinB , BrosteanuO , CremerJ , GruenewaldM , StoppeC , et al. A multicenter trial of remote ischemic preconditioning for heart surgery. New England Journal of Medicine2015;373(15):1397‐407. [MEDLINE: 26436208] MeybohmP , ZacharowskiK , CremerJ , RoesnerJ , KletzinF , SchaelteG , et al. Remote ischaemic preconditioning for heart surgery. The study design for a multi‐center randomized double‐blinded controlled clinical trial‐‐the RIPHeart‐Study. European Heart Journal2012;33(12):1423‐6. [MEDLINE: 22880214] ">RIPHeart Study 2012</a>; <a href="./references#CD010777-bbs2-0023" title="ThielmannM , KottenbergE , BoenglerK , RaffelsieperC , NeuhaeuserM , PetersJ , et al. Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest. Basic Research in Cardiology2010;105(5):657‐64. [MEDLINE: 20495811] ThielmannM , KottenbergE , BoenglerK , RaffelsieperC , WendtD , NeuhauserM , et al. Remote ischemic preconditioning reduces myocardial and renal injury in elective coronary artery bypass surgery with crystalloid cardioplegic arrest: a randomized controlled trial [abstract no: D101]. Innovations: Technology &amp; Techniques in Cardiothoracic &amp; Vascular Surgery2010;5(3):239. [EMBASE: 70471618] ">Thielmann 2010</a>; <a href="./references#CD010777-bbs2-0026" title="WalshSR , SadatU , BoyleJR , TangTY , LapsleyM , NordenAG , et al. Remote ischemic preconditioning for renal protection during elective open infrarenal abdominal aortic aneurysm repair: randomized controlled trial. Vascular &amp; Endovascular Surgery2010;44(5):334‐40. [MEDLINE: 20484066] ">Walsh 2010</a>; <a href="./references#CD010777-bbs2-0027" title="YoungPJ , DalleyP , GardenA , HorrocksC , LaFlammeA , MahonB , et al. A pilot study investigating the effects of remote ischemic preconditioning in high‐risk cardiac surgery using a randomised controlled double‐blind protocol. Basic Research in Cardiology2012;107(3):256. [MEDLINE: 22406977] ">Young 2012</a>) and high in two studies (<a href="./references#CD010777-bbs2-0022" title="SlagsvoldKH , RognmoO , HoydalM , WisloffU , WahbaA . Remote ischemic preconditioning preserves mitochondrial function and influences myocardial microRNA expression in atrial myocardium during coronary bypass surgery. Circulation Research2014;114(5):851‐9. [MEDLINE: 24371264] ">Slagsvold 2014</a>; <a href="./references#CD010777-bbs2-0024" title="KottenbergE , MusiolikJ , ThielmannM , JakobH , PetersJ , HeuschG . Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting. Journal of Thoracic &amp; Cardiovascular Surgery2014;147(1):376‐82. [MEDLINE: 23465551] KottenbergE , ThielmannM , BergmannL , HeineT , JakobH , HeuschG , et al. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol ‐ a clinical trial. Acta Anaesthesiologica Scandinavica2012;56(1):30‐8. [MEDLINE: 22103808] KottenbergE , ThielmannM , KleinbongardP , FreyUH , HeineT , JakobH , et al. Myocardial protection by remote ischaemic pre‐conditioning is abolished in sulphonylurea‐treated diabetics undergoing coronary revascularisation. Acta Anaesthesiologica Scandinavica2014;58(4):453‐62. [MEDLINE: 24548338] ThielmannM , KottenbergE , KleinbongardP , WendtD , GedikN , PasaS , et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single‐centre randomised, double‐blind, controlled trial.[Erratum appears in Lancet. 2013 Sep 14;382(9896):940]. Lancet2013;382(9892):597‐604. [MEDLINE: 23953384] ThielmannM , KottenbergE , MusiolikJ , WendtD , GedikN , SchluterM , et al. Prognostic benefit from remote ischemic preconditioning in 300 patients undergoing coronary artery bypass surgery: a randomized controlled trial [abstract no: 14034]. Circulation2012;126(21 Suppl 1). [EMBASE: 70958738] ">Thielmann 2013</a>). Eleven studies (<a href="./references#CD010777-bbs2-0002" title="CandilioL , MalikA , AritiC , BarnardM , DiSalvoC , LawrenceD , et al. Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial. Heart2015;101(3):185‐92. [MEDLINE: 25252696] ">Candilio 2015</a>; <a href="./references#CD010777-bbs2-0003" title="ChoiYS , ShimJK , KimJC , KangKS , SeoYH , AhnKR , et al. Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2011;142(1):148‐54. [MEDLINE: 21272897] ">Choi 2011</a>; <a href="./references#CD010777-bbs2-0006" title="HausenloyDJ , CandilioL , EvansR , AritiC , JenkinsDP , KolvekarS , et al. Remote ischemic preconditioning and outcomes of cardiac surgery. New England Journal of Medicine2015;373(15):1408‐17. [MEDLINE: 26436207] HausenloyDJ , CandilioL , LaingC , KunstG , PepperJ , KolvekarS , et al. Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi‐centre randomized double‐blinded controlled clinical trial. Clinical Research in Cardiology2012;101(5):339‐48. [MEDLINE: 22186969] ">ERICCA Study 2012</a>; <a href="./references#CD010777-bbs2-0009" title="HuangJ , ChenY , DongB , KongW , ZhangJ , XueW , et al. Effect of remote ischaemic preconditioning on renal protection in patients undergoing laparoscopic partial nephrectomy: a 'blinded' randomised controlled trial. BJU International2013;112(1):74‐80. [MEDLINE: 23452148] ">Huang 2013</a>; <a href="./references#CD010777-bbs2-0010" title="KimJC , ShimJK , LeeS , YooYC , YangSY , KwakYL . Effect of combined remote ischemic preconditioning and postconditioning on pulmonary function in valvular heart surgery. Chest2012;142(2):467‐75. [MEDLINE: 22281799] ">Kim 2012a</a>; <a href="./references#CD010777-bbs2-0012" title="LiC , LiYS , XuM , WenSH , YaoX , WuY , et al. Limb remote ischemic preconditioning for intestinal and pulmonary protection during elective open infrarenal abdominal aortic aneurysm repair: a randomized controlled trial. Anesthesiology2013;118(4):842‐52. [MEDLINE: 23353795] ">Li 2013</a>; <a href="./references#CD010777-bbs2-0017" title="PedersenKR , RavnHB , PovlsenJV , SchmidtMR , ErlandsenEJ , HjortdalVE . Failure of remote ischemic preconditioning to reduce the risk of postoperative acute kidney injury in children undergoing operation for complex congenital heart disease: a randomized single‐center study. Journal of Thoracic &amp; Cardiovascular Surgery2012;143(3):576‐83. [MEDLINE: 21955475] ">Pedersen 2012</a>; <a href="./references#CD010777-bbs2-0020" title="RahmanIA , MascaroJG , SteedsRP , FrenneauxMP , NightingaleP , GoslingP , et al. Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment?. Circulation2010;122(11 Suppl):S53‐9. [MEDLINE: 20837926] ">Rahman 2010</a>; <a href="./references#CD010777-bbs2-0025" title="VenugopalV , HausenloyDJ , LudmanA , DiSalvoC , KolvekarS , YapJ , et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold‐blood cardioplegia: a randomised controlled trial. Heart2009;95(19):1567‐71. [MEDLINE: 19508973] VenugopalV , HausenloyDJ , LudmanA , LaingCM , YellonDM . Does remote ischemic preconditioning prevent acute kidney injury in patients undergoing elective cardiac surgery? [abstract no: P05]. British Transplantation Society (BTS).12th Annual Congress; 2009 Apr 21‐24; Liverpool, UK. 2009. VenugopalV , LaingCM , LudmanA , YellonDM , HausenloyD . Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials. American Journal of Kidney Diseases2010;56(6):1043‐9. [MEDLINE: 20974511] ">Venugopal 2009</a>; <a href="./references#CD010777-bbs2-0028" title="ZarbockA , SchmidtC , vanAkenH , WempeC , MartensS , ZahnPK , et al. Effect of remote ischemic preconditioning on kidney injury among high‐risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA2015;313(21):2133‐41. [MEDLINE: 26024502] ">Zarbock 2015</a>; <a href="./references#CD010777-bbs2-0029" title="ZimmermanRF , EzeanunaPU , KaneJC , ClelandCD , KempananjappaTJ , LucasFL , et al. Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney International2011;80(8):861‐7. [MEDLINE: 21677633] ">Zimmerman 2011</a>) reported missing data and prespecified outcome measures, indicating a low risk of attrition bias. </p> </section> <section id="CD010777-sec-0064"> <h4 class="title">Selective reporting</h4> <p>The risk of reporting bias due to selective outcome reporting was assessed to be low in most studies. This was based on the fact that, in most studies, the outcome measures specified in the introduction matched those presented in the results of the article (19 studies). In six studies (<a href="./references#CD010777-bbs2-0019" title="PinaudF , CorbeauJJ , BaufretonC , BinuaniJP , DeBruxJL , FouquetO , et al. Remote ischemic preconditioning in aortic valve surgery: results of a randomized controlled study. Journal of Cardiology2016;67(1):36‐41. [MEDLINE: 26271449] ">Pinaud 2016</a>; <a href="./references#CD010777-bbs2-0021" title="MeybohmP , BeinB , BrosteanuO , CremerJ , GruenewaldM , StoppeC , et al. A multicenter trial of remote ischemic preconditioning for heart surgery. New England Journal of Medicine2015;373(15):1397‐407. [MEDLINE: 26436208] MeybohmP , ZacharowskiK , CremerJ , RoesnerJ , KletzinF , SchaelteG , et al. Remote ischaemic preconditioning for heart surgery. The study design for a multi‐center randomized double‐blinded controlled clinical trial‐‐the RIPHeart‐Study. European Heart Journal2012;33(12):1423‐6. [MEDLINE: 22880214] ">RIPHeart Study 2012</a>; <a href="./references#CD010777-bbs2-0022" title="SlagsvoldKH , RognmoO , HoydalM , WisloffU , WahbaA . Remote ischemic preconditioning preserves mitochondrial function and influences myocardial microRNA expression in atrial myocardium during coronary bypass surgery. Circulation Research2014;114(5):851‐9. [MEDLINE: 24371264] ">Slagsvold 2014</a>; <a href="./references#CD010777-bbs2-0024" title="KottenbergE , MusiolikJ , ThielmannM , JakobH , PetersJ , HeuschG . Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting. Journal of Thoracic &amp; Cardiovascular Surgery2014;147(1):376‐82. [MEDLINE: 23465551] KottenbergE , ThielmannM , BergmannL , HeineT , JakobH , HeuschG , et al. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol ‐ a clinical trial. Acta Anaesthesiologica Scandinavica2012;56(1):30‐8. [MEDLINE: 22103808] KottenbergE , ThielmannM , KleinbongardP , FreyUH , HeineT , JakobH , et al. Myocardial protection by remote ischaemic pre‐conditioning is abolished in sulphonylurea‐treated diabetics undergoing coronary revascularisation. Acta Anaesthesiologica Scandinavica2014;58(4):453‐62. [MEDLINE: 24548338] ThielmannM , KottenbergE , KleinbongardP , WendtD , GedikN , PasaS , et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single‐centre randomised, double‐blind, controlled trial.[Erratum appears in Lancet. 2013 Sep 14;382(9896):940]. Lancet2013;382(9892):597‐604. [MEDLINE: 23953384] ThielmannM , KottenbergE , MusiolikJ , WendtD , GedikN , SchluterM , et al. Prognostic benefit from remote ischemic preconditioning in 300 patients undergoing coronary artery bypass surgery: a randomized controlled trial [abstract no: 14034]. Circulation2012;126(21 Suppl 1). [EMBASE: 70958738] ">Thielmann 2013</a>; <a href="./references#CD010777-bbs2-0025" title="VenugopalV , HausenloyDJ , LudmanA , DiSalvoC , KolvekarS , YapJ , et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold‐blood cardioplegia: a randomised controlled trial. Heart2009;95(19):1567‐71. [MEDLINE: 19508973] VenugopalV , HausenloyDJ , LudmanA , LaingCM , YellonDM . Does remote ischemic preconditioning prevent acute kidney injury in patients undergoing elective cardiac surgery? [abstract no: P05]. British Transplantation Society (BTS).12th Annual Congress; 2009 Apr 21‐24; Liverpool, UK. 2009. VenugopalV , LaingCM , LudmanA , YellonDM , HausenloyD . Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials. American Journal of Kidney Diseases2010;56(6):1043‐9. [MEDLINE: 20974511] ">Venugopal 2009</a>; <a href="./references#CD010777-bbs2-0028" title="ZarbockA , SchmidtC , vanAkenH , WempeC , MartensS , ZahnPK , et al. Effect of remote ischemic preconditioning on kidney injury among high‐risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA2015;313(21):2133‐41. [MEDLINE: 26024502] ">Zarbock 2015</a>) the risk of reporting bias was assessed to be high, due to the incoherency between reported outcome measures in the method section of the articles and the results. </p> <p>Performing funnel plots for the primary outcome measures, there is a high suspicion of underreporting negative small studies as can be seen in the funnel plots of serum creatinine on days one and two (<a href="#CD010777-fig-0005">Figure 5</a>; <a href="#CD010777-fig-0006">Figure 6</a>). </p> <div class="figure" id="CD010777-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Serum creatinine, outcome: 1.6 Creatinine day 1 [mg/dL]." data-id="CD010777-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Serum creatinine, outcome: 1.6 Creatinine day 1 [mg/dL].</p> </div> </div> </div> <div class="figure" id="CD010777-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Serum creatinine, outcome: 1.8 Creatinine day 2 [mg/dL]." data-id="CD010777-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Serum creatinine, outcome: 1.8 Creatinine day 2 [mg/dL].</p> </div> </div> </div> </section> <section id="CD010777-sec-0065"> <h4 class="title">Other potential sources of bias</h4> <p>Five studies were classified as high risk of bias for the following reasons.</p> <p> <ul id="CD010777-list-0009"> <li> <p><a href="./references#CD010777-bbs2-0016" title="PavioneMA , CarmonaF , deCastroM , CarlottiAP . Late remote ischemic preconditioning in children undergoing cardiopulmonary bypass: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2012;144(1):178‐83. [MEDLINE: 22244567] ">Pavione 2012</a> failed to adequately report the patient inclusion and exclusion criteria </p> </li> <li> <p><a href="./references#CD010777-bbs2-0024" title="KottenbergE , MusiolikJ , ThielmannM , JakobH , PetersJ , HeuschG . Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting. Journal of Thoracic &amp; Cardiovascular Surgery2014;147(1):376‐82. [MEDLINE: 23465551] KottenbergE , ThielmannM , BergmannL , HeineT , JakobH , HeuschG , et al. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol ‐ a clinical trial. Acta Anaesthesiologica Scandinavica2012;56(1):30‐8. [MEDLINE: 22103808] KottenbergE , ThielmannM , KleinbongardP , FreyUH , HeineT , JakobH , et al. Myocardial protection by remote ischaemic pre‐conditioning is abolished in sulphonylurea‐treated diabetics undergoing coronary revascularisation. Acta Anaesthesiologica Scandinavica2014;58(4):453‐62. [MEDLINE: 24548338] ThielmannM , KottenbergE , KleinbongardP , WendtD , GedikN , PasaS , et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single‐centre randomised, double‐blind, controlled trial.[Erratum appears in Lancet. 2013 Sep 14;382(9896):940]. Lancet2013;382(9892):597‐604. [MEDLINE: 23953384] ThielmannM , KottenbergE , MusiolikJ , WendtD , GedikN , SchluterM , et al. Prognostic benefit from remote ischemic preconditioning in 300 patients undergoing coronary artery bypass surgery: a randomized controlled trial [abstract no: 14034]. Circulation2012;126(21 Suppl 1). [EMBASE: 70958738] ">Thielmann 2013</a> and <a href="./references#CD010777-bbs2-0025" title="VenugopalV , HausenloyDJ , LudmanA , DiSalvoC , KolvekarS , YapJ , et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold‐blood cardioplegia: a randomised controlled trial. Heart2009;95(19):1567‐71. [MEDLINE: 19508973] VenugopalV , HausenloyDJ , LudmanA , LaingCM , YellonDM . Does remote ischemic preconditioning prevent acute kidney injury in patients undergoing elective cardiac surgery? [abstract no: P05]. British Transplantation Society (BTS).12th Annual Congress; 2009 Apr 21‐24; Liverpool, UK. 2009. VenugopalV , LaingCM , LudmanA , YellonDM , HausenloyD . Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials. American Journal of Kidney Diseases2010;56(6):1043‐9. [MEDLINE: 20974511] ">Venugopal 2009</a> studies reported changes in the anaesthesia protocol during the study </p> </li> <li> <p><a href="./references#CD010777-bbs2-0021" title="MeybohmP , BeinB , BrosteanuO , CremerJ , GruenewaldM , StoppeC , et al. A multicenter trial of remote ischemic preconditioning for heart surgery. New England Journal of Medicine2015;373(15):1397‐407. [MEDLINE: 26436208] MeybohmP , ZacharowskiK , CremerJ , RoesnerJ , KletzinF , SchaelteG , et al. Remote ischaemic preconditioning for heart surgery. The study design for a multi‐center randomized double‐blinded controlled clinical trial‐‐the RIPHeart‐Study. European Heart Journal2012;33(12):1423‐6. [MEDLINE: 22880214] ">RIPHeart Study 2012</a> recalculated the sample size during the inclusion period and reduced the total number of patients to include </p> </li> <li> <p>The authors of <a href="./references#CD010777-bbs2-0015" title="McCrindleBW , ClariziaN , KhaikinS , ColesJ , HoltbyH , SchwartzS , et al. Remote ischemic preconditioning in children undergoing surgery with cardiopulmonary bypass: a single centre double‐blinded randomized trial [abstract no: 11013]. Circulation2011;124(21 Suppl 1). [EMBASE: 70618970] McCrindleBW , ClariziaNA , KhaikinS , HoltbyHS , ManlhiotC , SchwartzSM , et al. Remote ischemic preconditioning in children undergoing cardiac surgery with cardiopulmonary bypass: a single‐center double‐blinded randomized trial. Journal of the American Heart Association2014;3(4):e000964. [MEDLINE: 25074698] ">McCrindle 2014</a> were shareholders in a company producing a remote ischaemic preconditioning device. </p> </li> </ul> </p> <p><a href="./references#CD010777-bbs2-0004" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(5):976‐84. [MEDLINE: 18842422] ">Czibik‐stable 2008</a>, <a href="./references#CD010777-bbs2-0005" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(1):976‐84. [MEDLINE: 18842422] ">Czibik‐unstable 2008</a>, <a href="./references#CD010777-bbs2-0012" title="LiC , LiYS , XuM , WenSH , YaoX , WuY , et al. Limb remote ischemic preconditioning for intestinal and pulmonary protection during elective open infrarenal abdominal aortic aneurysm repair: a randomized controlled trial. Anesthesiology2013;118(4):842‐52. [MEDLINE: 23353795] ">Li 2013</a>, <a href="./references#CD010777-bbs2-0014" title="LucchinettiE , BestmannL , FengJ , FreidankH , ClanachanAS , FineganBA , et al. Remote ischemic preconditioning applied during isoflurane inhalation provides no benefit to the myocardium of patients undergoing on‐pump coronary artery bypass graft surgery: lack of synergy or evidence of antagonism in cardioprotection?. Anesthesiology2012;116(2):296‐310. [MEDLINE: 22222469] ">Luchinetti 2012</a>, <a href="./references#CD010777-bbs2-0023" title="ThielmannM , KottenbergE , BoenglerK , RaffelsieperC , NeuhaeuserM , PetersJ , et al. Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest. Basic Research in Cardiology2010;105(5):657‐64. [MEDLINE: 20495811] ThielmannM , KottenbergE , BoenglerK , RaffelsieperC , WendtD , NeuhauserM , et al. Remote ischemic preconditioning reduces myocardial and renal injury in elective coronary artery bypass surgery with crystalloid cardioplegic arrest: a randomized controlled trial [abstract no: D101]. Innovations: Technology &amp; Techniques in Cardiothoracic &amp; Vascular Surgery2010;5(3):239. [EMBASE: 70471618] ">Thielmann 2010</a>, <a href="./references#CD010777-bbs2-0026" title="WalshSR , SadatU , BoyleJR , TangTY , LapsleyM , NordenAG , et al. Remote ischemic preconditioning for renal protection during elective open infrarenal abdominal aortic aneurysm repair: randomized controlled trial. Vascular &amp; Endovascular Surgery2010;44(5):334‐40. [MEDLINE: 20484066] ">Walsh 2010</a>, and <a href="./references#CD010777-bbs2-0029" title="ZimmermanRF , EzeanunaPU , KaneJC , ClelandCD , KempananjappaTJ , LucasFL , et al. Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney International2011;80(8):861‐7. [MEDLINE: 21677633] ">Zimmerman 2011</a> did not report their funding source and were classified as unclear risk of bias. All remaining 21 studies adequately reported their funding sources and there were no other concerns. </p> </section> </section> <section id="CD010777-sec-0066"> <h3 class="title" id="CD010777-sec-0066">Effects of interventions</h3> <p>See: <a href="./full#CD010777-tbl-0001"><b>Summary of findings for the main comparison</b> Summary of findings table</a> </p> <p><b>For consistency regarding the direction of effects, continuous outcomes with negative values, and dichotomous outcomes with values less than one favour remote ischaemic preconditioning.</b> </p> <section id="CD010777-sec-0067"> <h4 class="title">Primary outcome measures</h4> <section id="CD010777-sec-0068"> <h5 class="title">Serum creatinine</h5> <p>Serum creatinine levels were reported in 15 studies (<a href="./references#CD010777-bbs2-0001" title="AliZA , CallaghanCJ , LimE , AliAA , NouraeiSA , AktharAM , et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation2007;116(11 Suppl):I98‐105. [MEDLINE: 17846333] ">Ali 2007</a>; <a href="./references#CD010777-bbs2-0003" title="ChoiYS , ShimJK , KimJC , KangKS , SeoYH , AhnKR , et al. Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2011;142(1):148‐54. [MEDLINE: 21272897] ">Choi 2011</a>; <a href="./references#CD010777-bbs2-0004" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(5):976‐84. [MEDLINE: 18842422] ">Czibik‐stable 2008</a>; <a href="./references#CD010777-bbs2-0005" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(1):976‐84. [MEDLINE: 18842422] ">Czibik‐unstable 2008</a>; <a href="./references#CD010777-bbs2-0009" title="HuangJ , ChenY , DongB , KongW , ZhangJ , XueW , et al. Effect of remote ischaemic preconditioning on renal protection in patients undergoing laparoscopic partial nephrectomy: a 'blinded' randomised controlled trial. BJU International2013;112(1):74‐80. [MEDLINE: 23452148] ">Huang 2013</a>; <a href="./references#CD010777-bbs2-0010" title="KimJC , ShimJK , LeeS , YooYC , YangSY , KwakYL . Effect of combined remote ischemic preconditioning and postconditioning on pulmonary function in valvular heart surgery. Chest2012;142(2):467‐75. [MEDLINE: 22281799] ">Kim 2012a</a>; <a href="./references#CD010777-bbs2-0011" title="LeeJH , ParkYH , ByonHJ , KimHS , KimCS , KimJT . Effect of remote ischaemic preconditioning on ischaemic‐reperfusion injury in pulmonary hypertensive infants receiving ventricular septal defect repair. British Journal of Anaesthesia2012;108(2):223‐8. [MEDLINE: 22157844] ">Lee 2012</a>; <a href="./references#CD010777-bbs2-0014" title="LucchinettiE , BestmannL , FengJ , FreidankH , ClanachanAS , FineganBA , et al. Remote ischemic preconditioning applied during isoflurane inhalation provides no benefit to the myocardium of patients undergoing on‐pump coronary artery bypass graft surgery: lack of synergy or evidence of antagonism in cardioprotection?. Anesthesiology2012;116(2):296‐310. [MEDLINE: 22222469] ">Luchinetti 2012</a>; <a href="./references#CD010777-bbs2-0015" title="McCrindleBW , ClariziaN , KhaikinS , ColesJ , HoltbyH , SchwartzS , et al. Remote ischemic preconditioning in children undergoing surgery with cardiopulmonary bypass: a single centre double‐blinded randomized trial [abstract no: 11013]. Circulation2011;124(21 Suppl 1). [EMBASE: 70618970] McCrindleBW , ClariziaNA , KhaikinS , HoltbyHS , ManlhiotC , SchwartzSM , et al. Remote ischemic preconditioning in children undergoing cardiac surgery with cardiopulmonary bypass: a single‐center double‐blinded randomized trial. Journal of the American Heart Association2014;3(4):e000964. [MEDLINE: 25074698] ">McCrindle 2014</a>; <a href="./references#CD010777-bbs2-0016" title="PavioneMA , CarmonaF , deCastroM , CarlottiAP . Late remote ischemic preconditioning in children undergoing cardiopulmonary bypass: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2012;144(1):178‐83. [MEDLINE: 22244567] ">Pavione 2012</a>; <a href="./references#CD010777-bbs2-0017" title="PedersenKR , RavnHB , PovlsenJV , SchmidtMR , ErlandsenEJ , HjortdalVE . Failure of remote ischemic preconditioning to reduce the risk of postoperative acute kidney injury in children undergoing operation for complex congenital heart disease: a randomized single‐center study. Journal of Thoracic &amp; Cardiovascular Surgery2012;143(3):576‐83. [MEDLINE: 21955475] ">Pedersen 2012</a>; <a href="./references#CD010777-bbs2-0018" title="PepeS , LiawNY , HepponstallM , SheeranFL , YongMS , d'UdekemY , et al. Effect of remote ischemic preconditioning on phosphorylated protein signaling in children undergoing tetralogy of fallot repair: a randomized controlled trial. Journal of the American Heart Association2013;2(3):e000095. [MEDLINE: 23666460] ">Pepe 2013</a>; <a href="./references#CD010777-bbs2-0022" title="SlagsvoldKH , RognmoO , HoydalM , WisloffU , WahbaA . Remote ischemic preconditioning preserves mitochondrial function and influences myocardial microRNA expression in atrial myocardium during coronary bypass surgery. Circulation Research2014;114(5):851‐9. [MEDLINE: 24371264] ">Slagsvold 2014</a>; <a href="./references#CD010777-bbs2-0023" title="ThielmannM , KottenbergE , BoenglerK , RaffelsieperC , NeuhaeuserM , PetersJ , et al. Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest. Basic Research in Cardiology2010;105(5):657‐64. [MEDLINE: 20495811] ThielmannM , KottenbergE , BoenglerK , RaffelsieperC , WendtD , NeuhauserM , et al. Remote ischemic preconditioning reduces myocardial and renal injury in elective coronary artery bypass surgery with crystalloid cardioplegic arrest: a randomized controlled trial [abstract no: D101]. Innovations: Technology &amp; Techniques in Cardiothoracic &amp; Vascular Surgery2010;5(3):239. [EMBASE: 70471618] ">Thielmann 2010</a>; <a href="./references#CD010777-bbs2-0025" title="VenugopalV , HausenloyDJ , LudmanA , DiSalvoC , KolvekarS , YapJ , et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold‐blood cardioplegia: a randomised controlled trial. Heart2009;95(19):1567‐71. [MEDLINE: 19508973] VenugopalV , HausenloyDJ , LudmanA , LaingCM , YellonDM . Does remote ischemic preconditioning prevent acute kidney injury in patients undergoing elective cardiac surgery? [abstract no: P05]. British Transplantation Society (BTS).12th Annual Congress; 2009 Apr 21‐24; Liverpool, UK. 2009. VenugopalV , LaingCM , LudmanA , YellonDM , HausenloyD . Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials. American Journal of Kidney Diseases2010;56(6):1043‐9. [MEDLINE: 20974511] ">Venugopal 2009</a>; <a href="./references#CD010777-bbs2-0026" title="WalshSR , SadatU , BoyleJR , TangTY , LapsleyM , NordenAG , et al. Remote ischemic preconditioning for renal protection during elective open infrarenal abdominal aortic aneurysm repair: randomized controlled trial. Vascular &amp; Endovascular Surgery2010;44(5):334‐40. [MEDLINE: 20484066] ">Walsh 2010</a>), measured at 13 different time points postoperatively. In total, serum creatinine was measured in 707 patients undergoing remote ischaemic preconditioning and in 704 patients undergoing a control intervention. <b>Based on high quality evidence</b> remote ischaemic preconditioning <b>had little of no effect on reducing</b> serum creatinine on postoperative days one (<a href="./references#CD010777-fig-0012" title="">Analysis 1.6</a> (14 studies, 1022 participants): MD ‐0.02 mg/dL, 95% CI ‐0.05 to 0.02; I<sup>2</sup> = 21%), two (<a href="./references#CD010777-fig-0014" title="">Analysis 1.8</a> (9 studies, 770 participants): MD ‐0.04 mg/dL, 95% CI ‐0.09 to 0.02; I<sup>2</sup> = 31%), and three (<a href="./references#CD010777-fig-0016" title="">Analysis 1.10</a> (6 studies, 770 participants): MD ‐0.05 mg/dL, 95% CI ‐0.19 to 0.10; I<sup>2</sup> = 68%). </p> <p>We found a reduction in peak postoperative creatinine during the first three days in patients undergoing remote ischaemic preconditioning (<a href="./references#CD010777-fig-0022" title="">Analysis 1.16</a> (3 studies, 365 participants): MD ‐0.10 mg/dL, 95% CI ‐0.20 to ‐0.01; I<sup>2</sup> = 0%). </p> </section> <section id="CD010777-sec-0069"> <h5 class="title">Complications and adverse effects related to ischaemic preconditioning</h5> <p>Data on adverse effects of the preconditioning stimulus were reported in 15 studies (<a href="./references#CD010777-bbs2-0001" title="AliZA , CallaghanCJ , LimE , AliAA , NouraeiSA , AktharAM , et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation2007;116(11 Suppl):I98‐105. [MEDLINE: 17846333] ">Ali 2007</a>; <a href="./references#CD010777-bbs2-0002" title="CandilioL , MalikA , AritiC , BarnardM , DiSalvoC , LawrenceD , et al. Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial. Heart2015;101(3):185‐92. [MEDLINE: 25252696] ">Candilio 2015</a>; <a href="./references#CD010777-bbs2-0003" title="ChoiYS , ShimJK , KimJC , KangKS , SeoYH , AhnKR , et al. Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2011;142(1):148‐54. [MEDLINE: 21272897] ">Choi 2011</a>; <a href="./references#CD010777-bbs2-0004" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(5):976‐84. [MEDLINE: 18842422] ">Czibik‐stable 2008</a>; <a href="./references#CD010777-bbs2-0005" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(1):976‐84. [MEDLINE: 18842422] ">Czibik‐unstable 2008</a>; <a href="./references#CD010777-bbs2-0006" title="HausenloyDJ , CandilioL , EvansR , AritiC , JenkinsDP , KolvekarS , et al. Remote ischemic preconditioning and outcomes of cardiac surgery. New England Journal of Medicine2015;373(15):1408‐17. [MEDLINE: 26436207] HausenloyDJ , CandilioL , LaingC , KunstG , PepperJ , KolvekarS , et al. Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi‐centre randomized double‐blinded controlled clinical trial. Clinical Research in Cardiology2012;101(5):339‐48. [MEDLINE: 22186969] ">ERICCA Study 2012</a>; <a href="./references#CD010777-bbs2-0007" title="HongDM , JeonY , LeeCS , KimHJ , LeeJM , BahkJH , et al. Effects of remote ischemic preconditioning with postconditioning in patients undergoing off‐pump coronary artery bypass surgery ‐ randomized controlled trial. Circulation Journal2012;76(4):884‐90. [MEDLINE: 22301846] ">Hong 2012</a>; <a href="./references#CD010777-bbs2-0008" title="HongDM , LeeEH , KimHJ , MinJJ , ChinJH , ChoiDK , et al. Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial. European Heart Journal2014;35(3):176‐83. [MEDLINE: 24014392] ">Hong 2014</a>; <a href="./references#CD010777-bbs2-0009" title="HuangJ , ChenY , DongB , KongW , ZhangJ , XueW , et al. Effect of remote ischaemic preconditioning on renal protection in patients undergoing laparoscopic partial nephrectomy: a 'blinded' randomised controlled trial. BJU International2013;112(1):74‐80. [MEDLINE: 23452148] ">Huang 2013</a>; <a href="./references#CD010777-bbs2-0010" title="KimJC , ShimJK , LeeS , YooYC , YangSY , KwakYL . Effect of combined remote ischemic preconditioning and postconditioning on pulmonary function in valvular heart surgery. Chest2012;142(2):467‐75. [MEDLINE: 22281799] ">Kim 2012a</a>; <a href="./references#CD010777-bbs2-0013" title="LomivorotovVV , ShmyrevVA , NepomnyaschihVA , PonomarevDN , KnyazkovaLG , LomivorotovVN , et al. Remote ischaemic preconditioning does not protect the heart in patients undergoing coronary artery bypass grafting. Interactive Cardiovascular &amp; Thoracic Surgery2012;15(1):18‐22. [MEDLINE: 22493101] ">Lomivorotov 2012</a>; <a href="./references#CD010777-bbs2-0016" title="PavioneMA , CarmonaF , deCastroM , CarlottiAP . Late remote ischemic preconditioning in children undergoing cardiopulmonary bypass: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2012;144(1):178‐83. [MEDLINE: 22244567] ">Pavione 2012</a>; <a href="./references#CD010777-bbs2-0018" title="PepeS , LiawNY , HepponstallM , SheeranFL , YongMS , d'UdekemY , et al. Effect of remote ischemic preconditioning on phosphorylated protein signaling in children undergoing tetralogy of fallot repair: a randomized controlled trial. Journal of the American Heart Association2013;2(3):e000095. [MEDLINE: 23666460] ">Pepe 2013</a>; <a href="./references#CD010777-bbs2-0024" title="KottenbergE , MusiolikJ , ThielmannM , JakobH , PetersJ , HeuschG . Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting. Journal of Thoracic &amp; Cardiovascular Surgery2014;147(1):376‐82. [MEDLINE: 23465551] KottenbergE , ThielmannM , BergmannL , HeineT , JakobH , HeuschG , et al. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol ‐ a clinical trial. Acta Anaesthesiologica Scandinavica2012;56(1):30‐8. [MEDLINE: 22103808] KottenbergE , ThielmannM , KleinbongardP , FreyUH , HeineT , JakobH , et al. Myocardial protection by remote ischaemic pre‐conditioning is abolished in sulphonylurea‐treated diabetics undergoing coronary revascularisation. Acta Anaesthesiologica Scandinavica2014;58(4):453‐62. [MEDLINE: 24548338] ThielmannM , KottenbergE , KleinbongardP , WendtD , GedikN , PasaS , et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single‐centre randomised, double‐blind, controlled trial.[Erratum appears in Lancet. 2013 Sep 14;382(9896):940]. Lancet2013;382(9892):597‐604. [MEDLINE: 23953384] ThielmannM , KottenbergE , MusiolikJ , WendtD , GedikN , SchluterM , et al. Prognostic benefit from remote ischemic preconditioning in 300 patients undergoing coronary artery bypass surgery: a randomized controlled trial [abstract no: 14034]. Circulation2012;126(21 Suppl 1). [EMBASE: 70958738] ">Thielmann 2013</a>; <a href="./references#CD010777-bbs2-0026" title="WalshSR , SadatU , BoyleJR , TangTY , LapsleyM , NordenAG , et al. Remote ischemic preconditioning for renal protection during elective open infrarenal abdominal aortic aneurysm repair: randomized controlled trial. Vascular &amp; Endovascular Surgery2010;44(5):334‐40. [MEDLINE: 20484066] ">Walsh 2010</a>), including a total of 1999 patients receiving remote ischaemic preconditioning and 1994 patients undergoing a control intervention. It is uncertain whether remote ischaemic preconditioning by cuff inflation leads to increased adverse effects compared to control because the certainty of the evidence is low (<a href="./references#CD010777-fig-0023" title="">Analysis 2.1</a> (15 studies, 3993 participants): RR 3.47; 95% CI 0.55 to 21.76; I<sup>2</sup> = 0%). It should be noted that only two studies (<a href="./references#CD010777-bbs2-0006" title="HausenloyDJ , CandilioL , EvansR , AritiC , JenkinsDP , KolvekarS , et al. Remote ischemic preconditioning and outcomes of cardiac surgery. New England Journal of Medicine2015;373(15):1408‐17. [MEDLINE: 26436207] HausenloyDJ , CandilioL , LaingC , KunstG , PepperJ , KolvekarS , et al. Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi‐centre randomized double‐blinded controlled clinical trial. Clinical Research in Cardiology2012;101(5):339‐48. [MEDLINE: 22186969] ">ERICCA Study 2012</a>; <a href="./references#CD010777-bbs2-0026" title="WalshSR , SadatU , BoyleJR , TangTY , LapsleyM , NordenAG , et al. Remote ischemic preconditioning for renal protection during elective open infrarenal abdominal aortic aneurysm repair: randomized controlled trial. Vascular &amp; Endovascular Surgery2010;44(5):334‐40. [MEDLINE: 20484066] ">Walsh 2010</a>) reported adverse events in the remote ischaemic preconditioning and control groups (6/1999 in the remote ischaemic preconditioning group and 1/1994 in the control group); 13 studies stated no adverse effects were observed in either group. </p> <p>No serious adverse effects were reported in studies using a blood pressure cuff for remote ischaemic preconditioning induction. <a href="./references#CD010777-bbs2-0006" title="HausenloyDJ , CandilioL , EvansR , AritiC , JenkinsDP , KolvekarS , et al. Remote ischemic preconditioning and outcomes of cardiac surgery. New England Journal of Medicine2015;373(15):1408‐17. [MEDLINE: 26436207] HausenloyDJ , CandilioL , LaingC , KunstG , PepperJ , KolvekarS , et al. Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi‐centre randomized double‐blinded controlled clinical trial. Clinical Research in Cardiology2012;101(5):339‐48. [MEDLINE: 22186969] ">ERICCA Study 2012</a> reported skin petechiae at the time of the intervention (35/801 participants; 4.4%), which is considered to be a minor side effect and is therefore not included in this review. Severe adverse effects occurred only in patients in the experimental arm of the study by <a href="./references#CD010777-bbs2-0026" title="WalshSR , SadatU , BoyleJR , TangTY , LapsleyM , NordenAG , et al. Remote ischemic preconditioning for renal protection during elective open infrarenal abdominal aortic aneurysm repair: randomized controlled trial. Vascular &amp; Endovascular Surgery2010;44(5):334‐40. [MEDLINE: 20484066] ">Walsh 2010</a>, in which four patients receiving remote ischaemic preconditioning developed lower limb ischaemia due to the traumatic effects of vascular clamping of the iliac artery. </p> </section> </section> <section id="CD010777-sec-0070"> <h4 class="title">Secondary outcome measures</h4> <section id="CD010777-sec-0071"> <h5 class="title">Need for dialysis</h5> <p>The need for dialysis was reported in 13 studies (<a href="./references#CD010777-bbs2-0001" title="AliZA , CallaghanCJ , LimE , AliAA , NouraeiSA , AktharAM , et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation2007;116(11 Suppl):I98‐105. [MEDLINE: 17846333] ">Ali 2007</a>; <a href="./references#CD010777-bbs2-0003" title="ChoiYS , ShimJK , KimJC , KangKS , SeoYH , AhnKR , et al. Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2011;142(1):148‐54. [MEDLINE: 21272897] ">Choi 2011</a>; <a href="./references#CD010777-bbs2-0007" title="HongDM , JeonY , LeeCS , KimHJ , LeeJM , BahkJH , et al. Effects of remote ischemic preconditioning with postconditioning in patients undergoing off‐pump coronary artery bypass surgery ‐ randomized controlled trial. Circulation Journal2012;76(4):884‐90. [MEDLINE: 22301846] ">Hong 2012</a>; <a href="./references#CD010777-bbs2-0008" title="HongDM , LeeEH , KimHJ , MinJJ , ChinJH , ChoiDK , et al. Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial. European Heart Journal2014;35(3):176‐83. [MEDLINE: 24014392] ">Hong 2014</a>; <a href="./references#CD010777-bbs2-0012" title="LiC , LiYS , XuM , WenSH , YaoX , WuY , et al. Limb remote ischemic preconditioning for intestinal and pulmonary protection during elective open infrarenal abdominal aortic aneurysm repair: a randomized controlled trial. Anesthesiology2013;118(4):842‐52. [MEDLINE: 23353795] ">Li 2013</a>; <a href="./references#CD010777-bbs2-0013" title="LomivorotovVV , ShmyrevVA , NepomnyaschihVA , PonomarevDN , KnyazkovaLG , LomivorotovVN , et al. Remote ischaemic preconditioning does not protect the heart in patients undergoing coronary artery bypass grafting. Interactive Cardiovascular &amp; Thoracic Surgery2012;15(1):18‐22. [MEDLINE: 22493101] ">Lomivorotov 2012</a>; <a href="./references#CD010777-bbs2-0014" title="LucchinettiE , BestmannL , FengJ , FreidankH , ClanachanAS , FineganBA , et al. Remote ischemic preconditioning applied during isoflurane inhalation provides no benefit to the myocardium of patients undergoing on‐pump coronary artery bypass graft surgery: lack of synergy or evidence of antagonism in cardioprotection?. Anesthesiology2012;116(2):296‐310. [MEDLINE: 22222469] ">Luchinetti 2012</a>; <a href="./references#CD010777-bbs2-0017" title="PedersenKR , RavnHB , PovlsenJV , SchmidtMR , ErlandsenEJ , HjortdalVE . Failure of remote ischemic preconditioning to reduce the risk of postoperative acute kidney injury in children undergoing operation for complex congenital heart disease: a randomized single‐center study. Journal of Thoracic &amp; Cardiovascular Surgery2012;143(3):576‐83. [MEDLINE: 21955475] ">Pedersen 2012</a>; <a href="./references#CD010777-bbs2-0019" title="PinaudF , CorbeauJJ , BaufretonC , BinuaniJP , DeBruxJL , FouquetO , et al. Remote ischemic preconditioning in aortic valve surgery: results of a randomized controlled study. Journal of Cardiology2016;67(1):36‐41. [MEDLINE: 26271449] ">Pinaud 2016</a>; <a href="./references#CD010777-bbs2-0020" title="RahmanIA , MascaroJG , SteedsRP , FrenneauxMP , NightingaleP , GoslingP , et al. Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment?. Circulation2010;122(11 Suppl):S53‐9. [MEDLINE: 20837926] ">Rahman 2010</a>; <a href="./references#CD010777-bbs2-0025" title="VenugopalV , HausenloyDJ , LudmanA , DiSalvoC , KolvekarS , YapJ , et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold‐blood cardioplegia: a randomised controlled trial. Heart2009;95(19):1567‐71. [MEDLINE: 19508973] VenugopalV , HausenloyDJ , LudmanA , LaingCM , YellonDM . Does remote ischemic preconditioning prevent acute kidney injury in patients undergoing elective cardiac surgery? [abstract no: P05]. British Transplantation Society (BTS).12th Annual Congress; 2009 Apr 21‐24; Liverpool, UK. 2009. VenugopalV , LaingCM , LudmanA , YellonDM , HausenloyD . Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials. American Journal of Kidney Diseases2010;56(6):1043‐9. [MEDLINE: 20974511] ">Venugopal 2009</a>; <a href="./references#CD010777-bbs2-0028" title="ZarbockA , SchmidtC , vanAkenH , WempeC , MartensS , ZahnPK , et al. Effect of remote ischemic preconditioning on kidney injury among high‐risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA2015;313(21):2133‐41. [MEDLINE: 26024502] ">Zarbock 2015</a>; <a href="./references#CD010777-bbs2-0029" title="ZimmermanRF , EzeanunaPU , KaneJC , ClelandCD , KempananjappaTJ , LucasFL , et al. Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney International2011;80(8):861‐7. [MEDLINE: 21677633] ">Zimmerman 2011</a>), including 1211 remote ischaemic preconditioning‐treated patients and 1206 patients undergoing a control intervention. Forty‐four patients in the remote ischaemic preconditioning group required dialysis versus 46 patients in the control group. Compared to control, remote ischaemic preconditioning made little or no difference to the need for dialysis (<a href="./references#CD010777-fig-0024" title="">Analysis 3.1</a> (13 studies, 2417 participants): RR 0.85; 95% CI 0.37 to 1.94; I<sup>2</sup> = 60%). </p> </section> <section id="CD010777-sec-0072"> <h5 class="title">Acute kidney injury (KDIGO, AKIN, RIFLE criteria)</h5> <p>There were no studies reporting AKI according to the KDIGO criteria.</p> <p>Eight studies (<a href="./references#CD010777-bbs2-0002" title="CandilioL , MalikA , AritiC , BarnardM , DiSalvoC , LawrenceD , et al. Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial. Heart2015;101(3):185‐92. [MEDLINE: 25252696] ">Candilio 2015</a>; <a href="./references#CD010777-bbs2-0003" title="ChoiYS , ShimJK , KimJC , KangKS , SeoYH , AhnKR , et al. Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2011;142(1):148‐54. [MEDLINE: 21272897] ">Choi 2011</a>; <a href="./references#CD010777-bbs2-0006" title="HausenloyDJ , CandilioL , EvansR , AritiC , JenkinsDP , KolvekarS , et al. Remote ischemic preconditioning and outcomes of cardiac surgery. New England Journal of Medicine2015;373(15):1408‐17. [MEDLINE: 26436207] HausenloyDJ , CandilioL , LaingC , KunstG , PepperJ , KolvekarS , et al. Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi‐centre randomized double‐blinded controlled clinical trial. Clinical Research in Cardiology2012;101(5):339‐48. [MEDLINE: 22186969] ">ERICCA Study 2012</a>; <a href="./references#CD010777-bbs2-0010" title="KimJC , ShimJK , LeeS , YooYC , YangSY , KwakYL . Effect of combined remote ischemic preconditioning and postconditioning on pulmonary function in valvular heart surgery. Chest2012;142(2):467‐75. [MEDLINE: 22281799] ">Kim 2012a</a>; <a href="./references#CD010777-bbs2-0019" title="PinaudF , CorbeauJJ , BaufretonC , BinuaniJP , DeBruxJL , FouquetO , et al. Remote ischemic preconditioning in aortic valve surgery: results of a randomized controlled study. Journal of Cardiology2016;67(1):36‐41. [MEDLINE: 26271449] ">Pinaud 2016</a>; <a href="./references#CD010777-bbs2-0025" title="VenugopalV , HausenloyDJ , LudmanA , DiSalvoC , KolvekarS , YapJ , et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold‐blood cardioplegia: a randomised controlled trial. Heart2009;95(19):1567‐71. [MEDLINE: 19508973] VenugopalV , HausenloyDJ , LudmanA , LaingCM , YellonDM . Does remote ischemic preconditioning prevent acute kidney injury in patients undergoing elective cardiac surgery? [abstract no: P05]. British Transplantation Society (BTS).12th Annual Congress; 2009 Apr 21‐24; Liverpool, UK. 2009. VenugopalV , LaingCM , LudmanA , YellonDM , HausenloyD . Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials. American Journal of Kidney Diseases2010;56(6):1043‐9. [MEDLINE: 20974511] ">Venugopal 2009</a>; <a href="./references#CD010777-bbs2-0028" title="ZarbockA , SchmidtC , vanAkenH , WempeC , MartensS , ZahnPK , et al. Effect of remote ischemic preconditioning on kidney injury among high‐risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA2015;313(21):2133‐41. [MEDLINE: 26024502] ">Zarbock 2015</a>; <a href="./references#CD010777-bbs2-0029" title="ZimmermanRF , EzeanunaPU , KaneJC , ClelandCD , KempananjappaTJ , LucasFL , et al. Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney International2011;80(8):861‐7. [MEDLINE: 21677633] ">Zimmerman 2011</a>) used the AKIN criteria to assess the incidence of AKI, including 1170 remote ischaemic preconditioning‐treated patients and 1194 patients undergoing a control intervention. Remote ischaemic preconditioning may have slightly improved the overall incidence of AKI (<a href="./references#CD010777-fig-0025" title="">Analysis 4.1</a> (8 studies, 2364 participants): RR 0.76, 95% CI 0.57 to 1.00; I<sup>2</sup> = 61%, high quality evidence), or when stratified for AKIN grade 1 (<a href="./references#CD010777-fig-0026" title="">Analysis 4.2</a> (5 studies, 2135 participants): RR 0.72, 95% CI 0.47 to 1.11; I<sup>2</sup> = 67%; high quality evidence), grade 2 (<a href="./references#CD010777-fig-0027" title="">Analysis 4.3</a> (5 studies, 2135 participants): RR 0.71, 95% CI 0.41 to 1.24; I<sup>2</sup> = 26%, high quality evidence), and grade 3 (<a href="./references#CD010777-fig-0028" title="">Analysis 4.4</a> (5 studies, 2135 participants): RR 0.63, 95% CI 0.37 to 1.07; I<sup>2</sup> = 11%, high quality evidence). </p> <p>Three studies (<a href="./references#CD010777-bbs2-0017" title="PedersenKR , RavnHB , PovlsenJV , SchmidtMR , ErlandsenEJ , HjortdalVE . Failure of remote ischemic preconditioning to reduce the risk of postoperative acute kidney injury in children undergoing operation for complex congenital heart disease: a randomized single‐center study. Journal of Thoracic &amp; Cardiovascular Surgery2012;143(3):576‐83. [MEDLINE: 21955475] ">Pedersen 2012</a>; <a href="./references#CD010777-bbs2-0021" title="MeybohmP , BeinB , BrosteanuO , CremerJ , GruenewaldM , StoppeC , et al. A multicenter trial of remote ischemic preconditioning for heart surgery. New England Journal of Medicine2015;373(15):1397‐407. [MEDLINE: 26436208] MeybohmP , ZacharowskiK , CremerJ , RoesnerJ , KletzinF , SchaelteG , et al. Remote ischaemic preconditioning for heart surgery. The study design for a multi‐center randomized double‐blinded controlled clinical trial‐‐the RIPHeart‐Study. European Heart Journal2012;33(12):1423‐6. [MEDLINE: 22880214] ">RIPHeart Study 2012</a>; <a href="./references#CD010777-bbs2-0027" title="YoungPJ , DalleyP , GardenA , HorrocksC , LaFlammeA , MahonB , et al. A pilot study investigating the effects of remote ischemic preconditioning in high‐risk cardiac surgery using a randomised controlled double‐blind protocol. Basic Research in Cardiology2012;107(3):256. [MEDLINE: 22406977] ">Young 2012</a>) reported data on the incidence of AKI according to the RIFLE criteria for 794 remote ischaemic preconditioning‐treated patients and 792 patients undergoing a control intervention. Remote ischaemic preconditioning made little of no difference to the overall incidence of AKI (<a href="./references#CD010777-fig-0029" title="">Analysis 5.1</a> (3 studies, 1586 participants): RR 0.91, 95% CI 0.75 to 1.12; I<sup>2</sup> = 0%, moderate quality evidence) and when stratified for <b>R</b>isk (<a href="./references#CD010777-fig-0030" title="">Analysis 5.2</a> (3 studies, 1586 participants): RR 0.77, 95% CI 0.58 to 1.03; I<sup>2</sup> = 0%, moderate quality evidence), <b>I</b>njury (<a href="./references#CD010777-fig-0031" title="">Analysis 5.3</a> (3 studies, 1586 participants): RR 1.09, 95% CI 0.59 to 2.02, moderate quality evidence), or <b>F</b>ailure (<a href="./references#CD010777-fig-0032" title="">Analysis 5.4</a> (3 studies, 1586 participants): RR 1.09; 95% Cl 0.59 to 2.02; I<sup>2</sup> = 0%, moderate quality evidence). There were no events in either group for the RIFLE criteria of <b>L</b> oss and <b>E</b>nd‐stage kidney failure. </p> </section> <section id="CD010777-sec-0073"> <h5 class="title">Blood urea nitrogen (BUN)</h5> <p>Blood urea nitrogen was not reported as an outcome measure by any of the included studies<b>.</b> </p> </section> <section id="CD010777-sec-0074"> <h5 class="title">Neutrophil gelatinase associated lipocalin (NGAL)</h5> <p>Two studies (<a href="./references#CD010777-bbs2-0003" title="ChoiYS , ShimJK , KimJC , KangKS , SeoYH , AhnKR , et al. Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2011;142(1):148‐54. [MEDLINE: 21272897] ">Choi 2011</a>; <a href="./references#CD010777-bbs2-0017" title="PedersenKR , RavnHB , PovlsenJV , SchmidtMR , ErlandsenEJ , HjortdalVE . Failure of remote ischemic preconditioning to reduce the risk of postoperative acute kidney injury in children undergoing operation for complex congenital heart disease: a randomized single‐center study. Journal of Thoracic &amp; Cardiovascular Surgery2012;143(3):576‐83. [MEDLINE: 21955475] ">Pedersen 2012</a>) reported serum NGAL levels measured post‐operatively on day one for 92 preconditioned and 89 control patients. Our meta‐analysis showed remote ischaemic preconditioning probably made little of no difference in reducing serum NGAL compared to control (<a href="./references#CD010777-fig-0035" title="">Analysis 6.1</a> (2 studies, 181 participants): MD 0.57 ng/mL, 95% CI ‐2.65 to 3.79; I<sup>2</sup> = 0%, moderate quality evidence). </p> <p><a href="./references#CD010777-bbs2-0017" title="PedersenKR , RavnHB , PovlsenJV , SchmidtMR , ErlandsenEJ , HjortdalVE . Failure of remote ischemic preconditioning to reduce the risk of postoperative acute kidney injury in children undergoing operation for complex congenital heart disease: a randomized single‐center study. Journal of Thoracic &amp; Cardiovascular Surgery2012;143(3):576‐83. [MEDLINE: 21955475] ">Pedersen 2012</a> also measured serum NGAL post‐operatively at six and 12 hours, and on days two and three, and reported no difference between the groups for any of these time points. </p> <p><a href="./references#CD010777-bbs2-0028" title="ZarbockA , SchmidtC , vanAkenH , WempeC , MartensS , ZahnPK , et al. Effect of remote ischemic preconditioning on kidney injury among high‐risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA2015;313(21):2133‐41. [MEDLINE: 26024502] ">Zarbock 2015</a>, reported urine NGAL was reduced in patients undergoing remote ischaemic preconditioning, when measured four, 12 and 24 hours after surgery (<a href="./references#CD010777-fig-0038" title="">Analysis 7.1</a>; <a href="./references#CD010777-fig-0039" title="">Analysis 7.2</a>; <a href="./references#CD010777-fig-0040" title="">Analysis 7.3</a>). </p> </section> <section id="CD010777-sec-0075"> <h5 class="title">Kidney injury molecule‐1 (KIM‐1)</h5> <p>KIM‐1 was not reported as an outcome measure by any of the included studies<b>.</b> </p> </section> <section id="CD010777-sec-0076"> <h5 class="title">Mortality</h5> <p>Twenty four studies (<a href="./references#CD010777-bbs2-0001" title="AliZA , CallaghanCJ , LimE , AliAA , NouraeiSA , AktharAM , et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation2007;116(11 Suppl):I98‐105. [MEDLINE: 17846333] ">Ali 2007</a>; <a href="./references#CD010777-bbs2-0002" title="CandilioL , MalikA , AritiC , BarnardM , DiSalvoC , LawrenceD , et al. Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial. Heart2015;101(3):185‐92. [MEDLINE: 25252696] ">Candilio 2015</a>; <a href="./references#CD010777-bbs2-0004" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(5):976‐84. [MEDLINE: 18842422] ">Czibik‐stable 2008</a>; <a href="./references#CD010777-bbs2-0005" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(1):976‐84. [MEDLINE: 18842422] ">Czibik‐unstable 2008</a>; <a href="./references#CD010777-bbs2-0006" title="HausenloyDJ , CandilioL , EvansR , AritiC , JenkinsDP , KolvekarS , et al. Remote ischemic preconditioning and outcomes of cardiac surgery. New England Journal of Medicine2015;373(15):1408‐17. [MEDLINE: 26436207] HausenloyDJ , CandilioL , LaingC , KunstG , PepperJ , KolvekarS , et al. Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi‐centre randomized double‐blinded controlled clinical trial. Clinical Research in Cardiology2012;101(5):339‐48. [MEDLINE: 22186969] ">ERICCA Study 2012</a>; <a href="./references#CD010777-bbs2-0007" title="HongDM , JeonY , LeeCS , KimHJ , LeeJM , BahkJH , et al. Effects of remote ischemic preconditioning with postconditioning in patients undergoing off‐pump coronary artery bypass surgery ‐ randomized controlled trial. Circulation Journal2012;76(4):884‐90. [MEDLINE: 22301846] ">Hong 2012</a>; <a href="./references#CD010777-bbs2-0008" title="HongDM , LeeEH , KimHJ , MinJJ , ChinJH , ChoiDK , et al. Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial. European Heart Journal2014;35(3):176‐83. [MEDLINE: 24014392] ">Hong 2014</a>; <a href="./references#CD010777-bbs2-0010" title="KimJC , ShimJK , LeeS , YooYC , YangSY , KwakYL . Effect of combined remote ischemic preconditioning and postconditioning on pulmonary function in valvular heart surgery. Chest2012;142(2):467‐75. [MEDLINE: 22281799] ">Kim 2012a</a>; <a href="./references#CD010777-bbs2-0012" title="LiC , LiYS , XuM , WenSH , YaoX , WuY , et al. Limb remote ischemic preconditioning for intestinal and pulmonary protection during elective open infrarenal abdominal aortic aneurysm repair: a randomized controlled trial. Anesthesiology2013;118(4):842‐52. [MEDLINE: 23353795] ">Li 2013</a>; <a href="./references#CD010777-bbs2-0013" title="LomivorotovVV , ShmyrevVA , NepomnyaschihVA , PonomarevDN , KnyazkovaLG , LomivorotovVN , et al. Remote ischaemic preconditioning does not protect the heart in patients undergoing coronary artery bypass grafting. Interactive Cardiovascular &amp; Thoracic Surgery2012;15(1):18‐22. [MEDLINE: 22493101] ">Lomivorotov 2012</a>; <a href="./references#CD010777-bbs2-0014" title="LucchinettiE , BestmannL , FengJ , FreidankH , ClanachanAS , FineganBA , et al. Remote ischemic preconditioning applied during isoflurane inhalation provides no benefit to the myocardium of patients undergoing on‐pump coronary artery bypass graft surgery: lack of synergy or evidence of antagonism in cardioprotection?. Anesthesiology2012;116(2):296‐310. [MEDLINE: 22222469] ">Luchinetti 2012</a>; <a href="./references#CD010777-bbs2-0015" title="McCrindleBW , ClariziaN , KhaikinS , ColesJ , HoltbyH , SchwartzS , et al. Remote ischemic preconditioning in children undergoing surgery with cardiopulmonary bypass: a single centre double‐blinded randomized trial [abstract no: 11013]. Circulation2011;124(21 Suppl 1). [EMBASE: 70618970] McCrindleBW , ClariziaNA , KhaikinS , HoltbyHS , ManlhiotC , SchwartzSM , et al. Remote ischemic preconditioning in children undergoing cardiac surgery with cardiopulmonary bypass: a single‐center double‐blinded randomized trial. Journal of the American Heart Association2014;3(4):e000964. [MEDLINE: 25074698] ">McCrindle 2014</a>; <a href="./references#CD010777-bbs2-0016" title="PavioneMA , CarmonaF , deCastroM , CarlottiAP . Late remote ischemic preconditioning in children undergoing cardiopulmonary bypass: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2012;144(1):178‐83. [MEDLINE: 22244567] ">Pavione 2012</a>; <a href="./references#CD010777-bbs2-0017" title="PedersenKR , RavnHB , PovlsenJV , SchmidtMR , ErlandsenEJ , HjortdalVE . Failure of remote ischemic preconditioning to reduce the risk of postoperative acute kidney injury in children undergoing operation for complex congenital heart disease: a randomized single‐center study. Journal of Thoracic &amp; Cardiovascular Surgery2012;143(3):576‐83. [MEDLINE: 21955475] ">Pedersen 2012</a>; <a href="./references#CD010777-bbs2-0018" title="PepeS , LiawNY , HepponstallM , SheeranFL , YongMS , d'UdekemY , et al. Effect of remote ischemic preconditioning on phosphorylated protein signaling in children undergoing tetralogy of fallot repair: a randomized controlled trial. Journal of the American Heart Association2013;2(3):e000095. [MEDLINE: 23666460] ">Pepe 2013</a>; <a href="./references#CD010777-bbs2-0020" title="RahmanIA , MascaroJG , SteedsRP , FrenneauxMP , NightingaleP , GoslingP , et al. Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment?. Circulation2010;122(11 Suppl):S53‐9. [MEDLINE: 20837926] ">Rahman 2010</a>; <a href="./references#CD010777-bbs2-0022" title="SlagsvoldKH , RognmoO , HoydalM , WisloffU , WahbaA . Remote ischemic preconditioning preserves mitochondrial function and influences myocardial microRNA expression in atrial myocardium during coronary bypass surgery. Circulation Research2014;114(5):851‐9. [MEDLINE: 24371264] ">Slagsvold 2014</a>; <a href="./references#CD010777-bbs2-0023" title="ThielmannM , KottenbergE , BoenglerK , RaffelsieperC , NeuhaeuserM , PetersJ , et al. Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest. Basic Research in Cardiology2010;105(5):657‐64. [MEDLINE: 20495811] ThielmannM , KottenbergE , BoenglerK , RaffelsieperC , WendtD , NeuhauserM , et al. Remote ischemic preconditioning reduces myocardial and renal injury in elective coronary artery bypass surgery with crystalloid cardioplegic arrest: a randomized controlled trial [abstract no: D101]. Innovations: Technology &amp; Techniques in Cardiothoracic &amp; Vascular Surgery2010;5(3):239. [EMBASE: 70471618] ">Thielmann 2010</a>; <a href="./references#CD010777-bbs2-0024" title="KottenbergE , MusiolikJ , ThielmannM , JakobH , PetersJ , HeuschG . Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting. Journal of Thoracic &amp; Cardiovascular Surgery2014;147(1):376‐82. [MEDLINE: 23465551] KottenbergE , ThielmannM , BergmannL , HeineT , JakobH , HeuschG , et al. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol ‐ a clinical trial. Acta Anaesthesiologica Scandinavica2012;56(1):30‐8. [MEDLINE: 22103808] KottenbergE , ThielmannM , KleinbongardP , FreyUH , HeineT , JakobH , et al. Myocardial protection by remote ischaemic pre‐conditioning is abolished in sulphonylurea‐treated diabetics undergoing coronary revascularisation. Acta Anaesthesiologica Scandinavica2014;58(4):453‐62. [MEDLINE: 24548338] ThielmannM , KottenbergE , KleinbongardP , WendtD , GedikN , PasaS , et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single‐centre randomised, double‐blind, controlled trial.[Erratum appears in Lancet. 2013 Sep 14;382(9896):940]. Lancet2013;382(9892):597‐604. [MEDLINE: 23953384] ThielmannM , KottenbergE , MusiolikJ , WendtD , GedikN , SchluterM , et al. Prognostic benefit from remote ischemic preconditioning in 300 patients undergoing coronary artery bypass surgery: a randomized controlled trial [abstract no: 14034]. Circulation2012;126(21 Suppl 1). [EMBASE: 70958738] ">Thielmann 2013</a>; <a href="./references#CD010777-bbs2-0025" title="VenugopalV , HausenloyDJ , LudmanA , DiSalvoC , KolvekarS , YapJ , et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold‐blood cardioplegia: a randomised controlled trial. Heart2009;95(19):1567‐71. [MEDLINE: 19508973] VenugopalV , HausenloyDJ , LudmanA , LaingCM , YellonDM . Does remote ischemic preconditioning prevent acute kidney injury in patients undergoing elective cardiac surgery? [abstract no: P05]. British Transplantation Society (BTS).12th Annual Congress; 2009 Apr 21‐24; Liverpool, UK. 2009. VenugopalV , LaingCM , LudmanA , YellonDM , HausenloyD . Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials. American Journal of Kidney Diseases2010;56(6):1043‐9. [MEDLINE: 20974511] ">Venugopal 2009</a>; <a href="./references#CD010777-bbs2-0026" title="WalshSR , SadatU , BoyleJR , TangTY , LapsleyM , NordenAG , et al. Remote ischemic preconditioning for renal protection during elective open infrarenal abdominal aortic aneurysm repair: randomized controlled trial. Vascular &amp; Endovascular Surgery2010;44(5):334‐40. [MEDLINE: 20484066] ">Walsh 2010</a>; <a href="./references#CD010777-bbs2-0027" title="YoungPJ , DalleyP , GardenA , HorrocksC , LaFlammeA , MahonB , et al. A pilot study investigating the effects of remote ischemic preconditioning in high‐risk cardiac surgery using a randomised controlled double‐blind protocol. Basic Research in Cardiology2012;107(3):256. [MEDLINE: 22406977] ">Young 2012</a>; <a href="./references#CD010777-bbs2-0028" title="ZarbockA , SchmidtC , vanAkenH , WempeC , MartensS , ZahnPK , et al. Effect of remote ischemic preconditioning on kidney injury among high‐risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA2015;313(21):2133‐41. [MEDLINE: 26024502] ">Zarbock 2015</a>; <a href="./references#CD010777-bbs2-0029" title="ZimmermanRF , EzeanunaPU , KaneJC , ClelandCD , KempananjappaTJ , LucasFL , et al. Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney International2011;80(8):861‐7. [MEDLINE: 21677633] ">Zimmerman 2011</a>) reporting mortality in 2467 patients receiving remote ischaemic preconditioning and 2464 control patients. We included data on all‐cause mortality to 30 days and all‐cause in‐hospital mortality in our analysis. When both in‐hospital mortality and 30‐day mortality were reported (<a href="./references#CD010777-bbs2-0028" title="ZarbockA , SchmidtC , vanAkenH , WempeC , MartensS , ZahnPK , et al. Effect of remote ischemic preconditioning on kidney injury among high‐risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA2015;313(21):2133‐41. [MEDLINE: 26024502] ">Zarbock 2015</a>), in‐hospital mortality was used in the analysis. Mortality after a longer postoperative period and mortality due to a specific condition or disease were excluded. Remote ischaemic preconditioning made little of no difference to decreasing all‐cause mortality (<a href="./references#CD010777-fig-0041" title="">Analysis 8.1</a> (24 studies, 4931 participants): RR 0.86, 95% CI 0.54 to 1.37; I<sup>2</sup> = 0%, high quality evidence). </p> </section> <section id="CD010777-sec-0077"> <h5 class="title">Quality of life</h5> <p>Quality of life was not reported as an outcome measure by any of the included studies<b>.</b> </p> </section> <section id="CD010777-sec-0078"> <h5 class="title">Length of hospital stay</h5> <p>Eight studies (<a href="./references#CD010777-bbs2-0001" title="AliZA , CallaghanCJ , LimE , AliAA , NouraeiSA , AktharAM , et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation2007;116(11 Suppl):I98‐105. [MEDLINE: 17846333] ">Ali 2007</a>; <a href="./references#CD010777-bbs2-0002" title="CandilioL , MalikA , AritiC , BarnardM , DiSalvoC , LawrenceD , et al. Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial. Heart2015;101(3):185‐92. [MEDLINE: 25252696] ">Candilio 2015</a>; <a href="./references#CD010777-bbs2-0003" title="ChoiYS , ShimJK , KimJC , KangKS , SeoYH , AhnKR , et al. Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery2011;142(1):148‐54. [MEDLINE: 21272897] ">Choi 2011</a>; <a href="./references#CD010777-bbs2-0007" title="HongDM , JeonY , LeeCS , KimHJ , LeeJM , BahkJH , et al. Effects of remote ischemic preconditioning with postconditioning in patients undergoing off‐pump coronary artery bypass surgery ‐ randomized controlled trial. Circulation Journal2012;76(4):884‐90. [MEDLINE: 22301846] ">Hong 2012</a>; <a href="./references#CD010777-bbs2-0010" title="KimJC , ShimJK , LeeS , YooYC , YangSY , KwakYL . Effect of combined remote ischemic preconditioning and postconditioning on pulmonary function in valvular heart surgery. Chest2012;142(2):467‐75. [MEDLINE: 22281799] ">Kim 2012a</a>; <a href="./references#CD010777-bbs2-0023" title="ThielmannM , KottenbergE , BoenglerK , RaffelsieperC , NeuhaeuserM , PetersJ , et al. Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest. Basic Research in Cardiology2010;105(5):657‐64. [MEDLINE: 20495811] ThielmannM , KottenbergE , BoenglerK , RaffelsieperC , WendtD , NeuhauserM , et al. Remote ischemic preconditioning reduces myocardial and renal injury in elective coronary artery bypass surgery with crystalloid cardioplegic arrest: a randomized controlled trial [abstract no: D101]. Innovations: Technology &amp; Techniques in Cardiothoracic &amp; Vascular Surgery2010;5(3):239. [EMBASE: 70471618] ">Thielmann 2010</a>; <a href="./references#CD010777-bbs2-0024" title="KottenbergE , MusiolikJ , ThielmannM , JakobH , PetersJ , HeuschG . Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting. Journal of Thoracic &amp; Cardiovascular Surgery2014;147(1):376‐82. [MEDLINE: 23465551] KottenbergE , ThielmannM , BergmannL , HeineT , JakobH , HeuschG , et al. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol ‐ a clinical trial. Acta Anaesthesiologica Scandinavica2012;56(1):30‐8. [MEDLINE: 22103808] KottenbergE , ThielmannM , KleinbongardP , FreyUH , HeineT , JakobH , et al. Myocardial protection by remote ischaemic pre‐conditioning is abolished in sulphonylurea‐treated diabetics undergoing coronary revascularisation. Acta Anaesthesiologica Scandinavica2014;58(4):453‐62. [MEDLINE: 24548338] ThielmannM , KottenbergE , KleinbongardP , WendtD , GedikN , PasaS , et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single‐centre randomised, double‐blind, controlled trial.[Erratum appears in Lancet. 2013 Sep 14;382(9896):940]. Lancet2013;382(9892):597‐604. [MEDLINE: 23953384] ThielmannM , KottenbergE , MusiolikJ , WendtD , GedikN , SchluterM , et al. Prognostic benefit from remote ischemic preconditioning in 300 patients undergoing coronary artery bypass surgery: a randomized controlled trial [abstract no: 14034]. Circulation2012;126(21 Suppl 1). [EMBASE: 70958738] ">Thielmann 2013</a>; <a href="./references#CD010777-bbs2-0025" title="VenugopalV , HausenloyDJ , LudmanA , DiSalvoC , KolvekarS , YapJ , et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold‐blood cardioplegia: a randomised controlled trial. Heart2009;95(19):1567‐71. [MEDLINE: 19508973] VenugopalV , HausenloyDJ , LudmanA , LaingCM , YellonDM . Does remote ischemic preconditioning prevent acute kidney injury in patients undergoing elective cardiac surgery? [abstract no: P05]. British Transplantation Society (BTS).12th Annual Congress; 2009 Apr 21‐24; Liverpool, UK. 2009. VenugopalV , LaingCM , LudmanA , YellonDM , HausenloyD . Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials. American Journal of Kidney Diseases2010;56(6):1043‐9. [MEDLINE: 20974511] ">Venugopal 2009</a>) report data on the length of hospital stay, including a total of 457 remote ischaemic preconditioning‐treated patients and 463 patients undergoing a control intervention. Remote ischaemic preconditioning made little or no difference to the length of hospital stay (<a href="./references#CD010777-fig-0042" title="">Analysis 9.1</a> (8 studies, 920 participants): MD 0.17 days, 95% CI ‐0.46 to 0.80; I<sup>2</sup> = 49%, high quality evidence). </p> </section> </section> <section id="CD010777-sec-0079"> <h4 class="title">Subgroup analyses</h4> <p>We aimed to perform subgroup analyses for our primary outcome measures, for all subgroups containing two or more studies. Adverse effects occurred only in six patients in two studies (<a href="./references#CD010777-bbs2-0006" title="HausenloyDJ , CandilioL , EvansR , AritiC , JenkinsDP , KolvekarS , et al. Remote ischemic preconditioning and outcomes of cardiac surgery. New England Journal of Medicine2015;373(15):1408‐17. [MEDLINE: 26436207] HausenloyDJ , CandilioL , LaingC , KunstG , PepperJ , KolvekarS , et al. Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi‐centre randomized double‐blinded controlled clinical trial. Clinical Research in Cardiology2012;101(5):339‐48. [MEDLINE: 22186969] ">ERICCA Study 2012</a>; <a href="./references#CD010777-bbs2-0026" title="WalshSR , SadatU , BoyleJR , TangTY , LapsleyM , NordenAG , et al. Remote ischemic preconditioning for renal protection during elective open infrarenal abdominal aortic aneurysm repair: randomized controlled trial. Vascular &amp; Endovascular Surgery2010;44(5):334‐40. [MEDLINE: 20484066] ">Walsh 2010</a>), and as a consequence, RR could only be calculated for these two studies. Therefore, no subgroup analysis was performed for this outcome measure. The following subgroup analyses therefore only concern serum creatinine on postoperative day one, two and three. All subgroup analysis results are shown in <a href="#CD010777-tbl-0002">Table 1</a>. </p> <div class="table" id="CD010777-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Subgroup analyses</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b> Subgroups</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b> Creatinine day 1 post‐op (mg/dL)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b> Creatinine day 2 post‐op (mg/dL)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b> Creatinine day 3 post‐op (mg/dL)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>MD [95% CI]</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>I<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>MD [95% CI]</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>I<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>MD [95% CI]</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>I<sup>2</sup> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.02 [‐0.05 to 0.02]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.04 [‐0.09 to 0.02]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.05 [‐0.19 to 0.10]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="10" rowspan="1" valign=""> <p><b><i>Age</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.02 [‐0.09 to 0.05]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.01 [‐0.08 to 0.06]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.07 [‐0.24 to 0.09]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.02 [‐0.06 to 0.02]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.05 [‐0.16 to 0.06]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="10" rowspan="1" valign=""> <p><b><i>Total duration of ischaemia</i> </b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.02 [‐0.10 to 0.06]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.04 [‐0.14 to 0.06]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.09 [‐0.28 to 0.09]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41%</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.02 [‐0.07 to 0.03]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.03 [‐0.13 to 0.08]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.09 [‐0.44 to 0.27]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>82%</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.04 [‐0.16 to 0.25]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="10" rowspan="1" valign=""> <p><b><i>Number of RIPC cycles</i> </b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 cycles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.14 [‐0.27 to ‐0.02]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 cycles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.01 [‐0.06 to 0.08]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.03 [‐0.11 to 0.05]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.05 [‐0.15 to 0.06]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12%</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 cycles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.01 [‐0.05 to 0.03]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.02 [‐0.12 to 0.08]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.12 [‐0.00 to 0.24]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="10" rowspan="1" valign=""> <p><b><i>Method of RIPC induction</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blood pressure cuff upper arm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.03 [‐0.08 to 0.01]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.08 [‐0.13 to ‐0.02]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.09 [‐0.28 to 0.09]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blood pressure cuff lower limb</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.01 [‐0.04 to 0.06]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.01 [‐0.08 to 0.10]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.06 [‐0.03 to 0.15]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aortic or iliac artery clamping</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.14 [‐0.27 to ‐0.02]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="10" rowspan="1" valign=""> <p><b><i>Type of surgery</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Abdominal aortic aneurysm repair</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.27 [‐0.60 to 0.06]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Coronary artery bypass grafting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.02 [‐0.08 to 0.05]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.00 [‐0.08 to 0.08]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.01 [‐0.19 to 0.16]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other types of cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.01 [‐0.05 to 0.04]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.05 [‐0.13 to 0.03]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.01 [‐0.10 to 0.13]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>RIPC ‐ remote ischaemic preconditioning</p> </div> </div> <section id="CD010777-sec-0080"> <h5 class="title">Age</h5> <p>We stratified the included studies according to participants' age (child or adult). There was no effect of remote ischaemic preconditioning on serum creatinine on day one, two or three postoperatively in any of the subgroups, and no difference in treatment effect between subgroups. Compared to the overall analysis of serum creatinine on postoperative day two, heterogeneity was reduced in the subgroup of studies performed in adults, while heterogeneity in the subgroup of children increased to high. No change in heterogeneity was observed on for serum creatinine on day one and three. </p> </section> <section id="CD010777-sec-0081"> <h5 class="title">Sex</h5> <p>Subgroup analysis could not be performed, since none of the studies reported separate outcomes for men and women and no individual patient data were retrieved. </p> </section> <section id="CD010777-sec-0082"> <h5 class="title">Remote ischaemic preconditioning protocol</h5> <p>There were seven different remote ischaemic preconditioning protocols used in the studies, but only three different remote ischaemic preconditioning protocols were used in more than one study. We stratified the protocols according to the total duration of ischaemia and the number of remote ischaemic preconditioning cycles (<a href="#CD010777-tbl-0002">Table 1</a>). </p> <p>For total duration of ischaemia, the subgroups of 15, 20 and 30 minutes contained two or more studies and were included in the analysis. The subgroup of four minutes total ischaemia was not analysed since it contained two comparisons from the same study (<a href="./references#CD010777-bbs2-0004" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(5):976‐84. [MEDLINE: 18842422] ">Czibik‐stable 2008</a>; <a href="./references#CD010777-bbs2-0005" title="CzibikG , WuZ , BerneGP , TarkkaM , VaageJ , LaurikkaJ , et al. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia‐inducible factor 1 alpha in the heart. European Journal of Cardio‐Thoracic Surgery2008;34(1):976‐84. [MEDLINE: 18842422] ">Czibik‐unstable 2008</a>). There was no effect of treatment on serum creatinine on day one, two or three postoperatively in any of the subgroups, and no difference in treatment effect between subgroups. </p> <p>Compared to the overall analysis, heterogeneity was reduced in the 15 minutes subgroup, but increased in the other subgroups, on all three postoperative days. </p> <p>For the number of preconditioning cycles, the subgroups of two, three, and four cycles contained two or more studies and were included in the analysis. In the subgroup of two preconditioning cycles, serum creatinine was reduced on postoperative day one, while there was no effect of treatment on this day in the subgroups of three and four cycles. However, the confidence intervals overlapped between all subgroups. No effect of treatment and no differences between subgroups were observed for serum creatinine on postoperative days two and three. </p> <p>Heterogeneity in the subgroups was similar to the overall analysis on day one, was increased in the four cycles subgroup on day two, and was reduced in all subgroups on day three. </p> </section> <section id="CD010777-sec-0083"> <h5 class="title">Method of remote ischaemic preconditioning induction</h5> <p>The type and amount of tissue used to induce the remote ischaemic preconditioning stimulus may influence its efficacy in reducing kidney damage. Often, the preconditioning stimulus is applied to an extremity, by inflating a blood pressure cuff around an upper or lower limb. Alternatively, atraumatic vascular clamping of the aorta or iliac artery may be used. We therefore stratified the studies according to the method of remote ischaemic preconditioning induction, creating three subgroups: blood pressure cuff on the upper arm, blood pressure cuff on the lower limb or clamping of the aorta or iliac artery (<a href="#CD010777-tbl-0002">Table 1</a>). </p> <p>On postoperative day one, there was no effect of treatment in the subgroups using blood pressure cuff occlusion, but serum creatinine was reduced in the subgroup of studies using vascular clamping. On postoperative day two, serum creatinine was reduced in the subgroup using blood pressure cuff occlusion of the upper arm, but not in the lower limb subgroup. On postoperative day three, there was no effect of treatment in any of the groups. Importantly, the confidence intervals of all subgroups overlapped on each postoperative day. </p> <p>Heterogeneity in the subgroups was similar to the overall analysis for postoperative day one and two, and reduced in both subgroups on day three. </p> </section> <section id="CD010777-sec-0084"> <h5 class="title">Type of surgical procedure</h5> <p>The type of surgery is a major determinant of the risk and severity of perioperative kidney injury, which may influence remote ischaemic preconditioning efficacy. The type of surgery may also correlate to a type of patient with a specific susceptibility to kidney injury. Studies were stratified according to the type of surgery performed, including abdominal aortic aneurysm repair, coronary artery bypass grafting, and other types of cardiac surgery (<a href="#CD010777-tbl-0002">Table 1</a>). Only <a href="./references#CD010777-bbs2-0009" title="HuangJ , ChenY , DongB , KongW , ZhangJ , XueW , et al. Effect of remote ischaemic preconditioning on renal protection in patients undergoing laparoscopic partial nephrectomy: a 'blinded' randomised controlled trial. BJU International2013;112(1):74‐80. [MEDLINE: 23452148] ">Huang 2013</a> reported partial nephrectomy and was excluded from this subgroup analysis. </p> <p>There was no effect of treatment on serum creatinine on day one, two or three postoperatively in any of the subgroups, and no difference in treatment effect between subgroups. </p> <p>Compared to the overall analysis, heterogeneity in the subgroup of cardiac surgery was increased on day one and day two, but decreased on day three. Heterogeneity in the other subgroups and days was similar or decreased compared to the overall analysis. </p> </section> </section> <section id="CD010777-sec-0085"> <h4 class="title">Sensitivity analysis</h4> <p>Excluding studies of lower quality with regard to the primary outcome measures had no significant effect on the results of this meta‐analysis. Excluding studies of less than 30 patients in each group showed no significant difference in primary outcome measures. </p> </section> <section id="CD010777-sec-0086"> <h4 class="title">Publication bias</h4> <p>We aimed to construct funnel plots to assess publication bias for the primary outcome measures. For adverse events and creatinine on postoperative day three, there were ≤ 6 data points, which were considered insufficient to reliably assess funnel plot asymmetry. Our assessment of the funnel plot of serum creatinine data on postoperative day one and two (<a href="#CD010777-fig-0005">Figure 5</a>; <a href="#CD010777-fig-0006">Figure 6</a>) showed signs of publication bias, with small studies predominantly showing positive results. </p> </section> <section id="CD010777-sec-0087"> <h4 class="title">Summary of findings table</h4> <p>The summary of findings table can be found at: <a href="./full#CD010777-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010777-sec-0088" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010777-sec-0088"></div> <section id="CD010777-sec-0089"> <h3 class="title" id="CD010777-sec-0089">Summary of main results</h3> <p>Our search identified 28 studies investigating the effect of remote ischaemic preconditioning on kidney outcomes in patients undergoing surgery associated with kidney ischaemia reperfusion injury. Our primary endpoints showed no protective effect for remote ischaemic preconditioning application. Adverse effects were found in one study after vascular clamping to induce remote ischaemic preconditioning. The general method using cuff inflation on the upper arm or thigh showed no difference in serious adverse effects. Furthermore, the secondary outcomes ‐ need for dialysis, AKI indicated by RIFLE or AKIN criteria, serum NGAL, mortality and length of hospital stay ‐ were unchanged in patients undergoing remote ischaemic preconditioning when compared with controls. One study reported urinary NGAL was significantly reduced in the remote ischaemic preconditioning group (<a href="./references#CD010777-bbs2-0028" title="ZarbockA , SchmidtC , vanAkenH , WempeC , MartensS , ZahnPK , et al. Effect of remote ischemic preconditioning on kidney injury among high‐risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA2015;313(21):2133‐41. [MEDLINE: 26024502] ">Zarbock 2015</a>). </p> <p>We found that a significant effect was seen regarding the method of remote ischaemic preconditioning induction. The subgroup of Invasive clamping of arteries to induce remote ischaemic preconditioning is more effective compared to non‐invasive cuff inflation. However, this observation should be interpreted with care, since invasive remote ischaemic preconditioning induction included only three studies, one of which (<a href="./references#CD010777-bbs2-0001" title="AliZA , CallaghanCJ , LimE , AliAA , NouraeiSA , AktharAM , et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation2007;116(11 Suppl):I98‐105. [MEDLINE: 17846333] ">Ali 2007</a>) introduced high heterogeneity in the data‐set. Subgroup analysis indicated that age, type of surgery, site of preconditioning, number of cycles and duration of the remote ischaemic preconditioning protocol did not influence remote ischaemic preconditioning efficacy. </p> <p>Overall we conclude that after major surgery associated with kidney ischaemia reperfusion injury, remote ischaemic preconditioning does not significantly reduce kidney injury. Based on these data, routine use of remote ischaemic preconditioning in major surgery cannot be justified. </p> </section> <section id="CD010777-sec-0090"> <h3 class="title" id="CD010777-sec-0090">Overall completeness and applicability of evidence</h3> <p>The heterogeneity of the outcome measurements and surgical procedures makes them difficult to compare. Of note, local ischaemic preconditioning, which has been shown to be highly effective in animal models (<a href="./references#CD010777-bbs2-0086" title="WeverKE , MentingTP , RoversM , van derVlietJA , RongenGA , MasereeuwR , et al. Ischemic preconditioning in the animal kidney, a systematic review and meta‐analysis. PLoS ONE [Electronic Resource]2012;7(2):e32296. [MEDLINE: 22389693] ">Wever 2012</a>), has not been studied in patients and its feasibility therefore remains unclear. </p> <p>Because of expected differences in the underlying mechanism of kidney injury, studies including patients undergoing kidney transplantation or interventions using nephrotoxic contrast media were excluded from this review. Despite inclusion of 28 studies, the primary outcome measures were heterogeneous and this severely hampered our meta‐analysis. Therefore, we advocate a more standardised primary outcome measure in future studies. </p> <p>Many studies, as well as our meta‐analysis, focused on serum creatinine as the primary outcome. However, the use of this outcome measure as a gold standard for kidney injury is under debate (<a href="./references#CD010777-bbs2-0084" title="WaikarSS , BetenskyRA , EmersonSC , BonventreFJ . Imperfect gold standards for kidney injury biomarker evaluation. Journal of the American Society of Nephrology2012;23(1):13–21. [MEDLINE: 22021710] ">Waikar 2012</a>) and its relationship with the long‐term quality of life is not straightforward. Only a few studies assessed the effect of remote ischaemic preconditioning on long‐term outcome measures such as quality of life and long term mortality. </p> </section> <section id="CD010777-sec-0091"> <h3 class="title" id="CD010777-sec-0091">Quality of the evidence</h3> <p>Overall, the quality of the evidence provided by the included studies was moderate to high. Including data from studies of lower quality may lead to an overestimation of treatment effects, since low‐quality studies generally overstate efficacy. Excluding studies of lower quality did not affect the primary outcomes. Therefore, after performing the risk of bias assessment we included all available data in our analysis. </p> <p>One important aspect in the quality of the evidence and potential bias is the funding of the studies which might influence the outcome. Influential funding was reported by one study and seven studies did not report their funding sources, which is a source of potential bias. </p> </section> <section id="CD010777-sec-0092"> <h3 class="title" id="CD010777-sec-0092">Potential biases in the review process</h3> <p>We attempted to identify all relevant studies through comprehensive, systematic searching of the literature in multiple databases, as well as contacting authors to obtain additional publications and data. Still we could not exclude the presence of publication bias in our data‐set. </p> <p>Data extraction was completed independently by two authors without conflicts of interest regarding the outcome, thereby avoiding potential bias. We performed several subgroup analyses. However, since our approach is observational rather than experimental, their results should be regarded as hypothesis generating. This meta‐analysis was slightly hampered by missing data, resulting from studies reporting outcome data as medians and interquartile ranges. We were unable to obtain raw data for a number of these studies, and this may have biased our analysis. </p> <p>In summary, we consider this review to be influenced by missing data and an unclear risk of publication bias. </p> </section> <section id="CD010777-sec-0093"> <h3 class="title" id="CD010777-sec-0093">Agreements and disagreements with other studies or reviews</h3> <p>The results of this review are comparable with other meta‐analyses in the literature (<a href="./references#CD010777-bbs2-0061" title="D'AscenzoF , CavalleroE , MorettiC , OmedeP , SciutoF , RahmanIA , et al. Remote ischaemic preconditioning in coronary artery bypass surgery: a meta‐analysis. Heart2012;98(17):1267‐71. [MEDLINE: 22875822] ">D'Ascenzo 2012</a>; <a href="./references#CD010777-bbs2-0062" title="DesaiM , GurusamyKS , GhanbariH , HamiltonG , SeifalianAM . Remote ischaemic preconditioning versus no remote ischaemic preconditioning for vascular and endovascular surgical procedures. Cochrane Database of Systematic Reviews2011, Issue 12. [DOI: 10.1002/14651858.CD008472.pub2] ">Desai 2011</a>; <a href="./references#CD010777-bbs2-0087" title="YangY , LangXB , ZhangP , LvR , WangY , ChenJH . Remote ischemic preconditioning for prevention of acute kidney injury: a meta‐analysis of randomized controlled trials. American Journal of Kidney Diseases2014;64(4):574‐83. [MEDLINE: 24954246] ">Yang 2014</a>) despite differences in inclusion criteria (i.e. others included contrast studies and did not include studies in children). The negative result from this review contradicts the overall beneficial effect of remote ischaemic preconditioning in animal models of kidney ischaemia reperfusion injury. A meta‐analysis of animal studies by <a href="./references#CD010777-bbs2-0086" title="WeverKE , MentingTP , RoversM , van derVlietJA , RongenGA , MasereeuwR , et al. Ischemic preconditioning in the animal kidney, a systematic review and meta‐analysis. PLoS ONE [Electronic Resource]2012;7(2):e32296. [MEDLINE: 22389693] ">Wever 2012</a> showed that remote ischaemic preconditioning was successful in reducing kidney ischaemia reperfusion injury. Possible explanations for the discrepancy between human and animal studies are: </p> <p>The lower amount of kidney injury in human studies compared with experimental models of kidney ischaemia reperfusion injury. This review (<a href="./references#CD010777-fig-0012" title="">Analysis 1.6</a>; <a href="./references#CD010777-fig-0014" title="">Analysis 1.8</a>; <a href="./references#CD010777-fig-0016" title="">Analysis 1.10</a>) showed that postoperative serum creatinine levels among control groups were comparable with normal serum creatinine values. When there is limited kidney damage, very large numbers of patients are required to show a significant reduction by remote ischaemic preconditioning. The ischaemia reperfusion injury applied to the kidney in the animal models is much more severe compared to the amount of kidney injury in human studies. Most animal studies have a single kidney model where the pedicle is clamped for 45 minutes (<a href="./references#CD010777-bbs2-0086" title="WeverKE , MentingTP , RoversM , van derVlietJA , RongenGA , MasereeuwR , et al. Ischemic preconditioning in the animal kidney, a systematic review and meta‐analysis. PLoS ONE [Electronic Resource]2012;7(2):e32296. [MEDLINE: 22389693] ">Wever 2012</a>). For such an amount of kidney damage there is no comparable human patient group. Although kidney transplant recipients were not addressed in this review, kidneys from deceased donors are exposed to prolonged periods of (cold) ischaemia. Therefore, it may be interesting to pursue remote ischaemic preconditioning efficacy in those patients. </p> <p>Animal studies generally use healthy young animals (<a href="./references#CD010777-bbs2-0086" title="WeverKE , MentingTP , RoversM , van derVlietJA , RongenGA , MasereeuwR , et al. Ischemic preconditioning in the animal kidney, a systematic review and meta‐analysis. PLoS ONE [Electronic Resource]2012;7(2):e32296. [MEDLINE: 22389693] ">Wever 2012</a>); studies included in this review mostly recruited aged patients with significant comorbidity. Aging and comorbidity significantly reduce the effectiveness of remote ischaemic preconditioning in human models of ischaemia reperfusion injury (<a href="./references#CD010777-bbs2-0063" title="EngbersenR , RiksenNP , MolMJ , BravenboerB , BoermanOC , MeijerP , et al. Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot study. Cardiovascular Diabetology2012;11:124. [MEDLINE: 23051145] ">Engbersen 2012</a>; <a href="./references#CD010777-bbs2-0081" title="SeegerJP , BendaNM , RiksenNP , vanDijkAP , BellersenL , HopmanMT , et al. Heart failure is associated with exaggerated endothelial ischaemia‐reperfusion injury and attenuated effect of ischaemic preconditioning. European Journal Preventive Cardiology2014;23(1):33‐40. [MEDLINE: 25389072] ">Seeger 2014</a>; <a href="./references#CD010777-bbs2-0083" title="van denMunckhofI , RiksenN , SeegerJP , SchreuderTH , BormGF , EijsvogelsTM , et al. Aging attenuates the protective effect of ischemic preconditioning against endothelial ischemia‐reperfusion injury in humans. American Journal of Physiology ‐ Heart &amp; Circulatory Physiology2013;304(12):H1727‐32. [MEDLINE: 23604707] ">van den Munckhof 2013</a>). Experimental studies using animals with diabetes and hypertension confirm a decreased effectiveness of remote ischaemic preconditioning compared with healthy animals (<a href="./references#CD010777-bbs2-0074" title="PrzyklenkK . Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co‐morbidity conundrum. Drugs &amp; Aging2011;28(5):331‐43. [MEDLINE: 21542657] ">Przyklenk 2011</a>). Furthermore, studies in the present review may have included patients suffering from pathologies which induce temporary (mild) ischaemia of remote tissues, e.g. unstable angina or claudication. Such episodes could induce a protective remote preconditioning effect on kidney's ischaemia reperfusion injury, which may have abolished the protective effect of the experimental preconditioning stimulus. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010777-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Remote ischaemic preconditioning signalling pathways" data-id="CD010777-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Remote ischaemic preconditioning signalling pathways</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/full#CD010777-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="The flow diagram of references" data-id="CD010777-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>The flow diagram of references</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/full#CD010777-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010777-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/full#CD010777-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010777-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/full#CD010777-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Serum creatinine, outcome: 1.6 Creatinine day 1 [mg/dL]." data-id="CD010777-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Serum creatinine, outcome: 1.6 Creatinine day 1 [mg/dL].</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/full#CD010777-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Serum creatinine, outcome: 1.8 Creatinine day 2 [mg/dL]." data-id="CD010777-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Serum creatinine, outcome: 1.8 Creatinine day 2 [mg/dL].</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/full#CD010777-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Serum creatinine, Outcome 1 Creatinine: 1 hour." data-id="CD010777-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Serum creatinine, Outcome 1 Creatinine: 1 hour.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Serum creatinine, Outcome 2 Creatinine: 3 hours." data-id="CD010777-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Serum creatinine, Outcome 2 Creatinine: 3 hours.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Serum creatinine, Outcome 3 Creatinine 4 hours." data-id="CD010777-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Serum creatinine, Outcome 3 Creatinine 4 hours.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Serum creatinine, Outcome 4 Creatinine 6 hours." data-id="CD010777-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Serum creatinine, Outcome 4 Creatinine 6 hours.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Serum creatinine, Outcome 5 Creatinine 12 hours." data-id="CD010777-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Serum creatinine, Outcome 5 Creatinine 12 hours.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-001-06.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Serum creatinine, Outcome 6 Creatinine day 1." data-id="CD010777-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Serum creatinine, Outcome 6 Creatinine day 1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Serum creatinine, Outcome 7 Creatinine day 1: all subgroups." data-id="CD010777-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Serum creatinine, Outcome 7 Creatinine day 1: all subgroups.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-001-08.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Serum creatinine, Outcome 8 Creatinine day 2." data-id="CD010777-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Serum creatinine, Outcome 8 Creatinine day 2.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Serum creatinine, Outcome 9 Creatinine day 2: all subgroups." data-id="CD010777-fig-0015" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Serum creatinine, Outcome 9 Creatinine day 2: all subgroups.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Serum creatinine, Outcome 10 Creatinine day 3." data-id="CD010777-fig-0016" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Serum creatinine, Outcome 10 Creatinine day 3.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Serum creatinine, Outcome 11 Creatinine day 3: all subgroups." data-id="CD010777-fig-0017" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Serum creatinine, Outcome 11 Creatinine day 3: all subgroups.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Serum creatinine, Outcome 12 Creatinine day 4." data-id="CD010777-fig-0018" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Serum creatinine, Outcome 12 Creatinine day 4.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Serum creatinine, Outcome 13 Creatinine day 7." data-id="CD010777-fig-0019" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Serum creatinine, Outcome 13 Creatinine day 7.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Serum creatinine, Outcome 14 Creatinine 1 month." data-id="CD010777-fig-0020" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Serum creatinine, Outcome 14 Creatinine 1 month.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Serum creatinine, Outcome 15 Creatinine 6 months." data-id="CD010777-fig-0021" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Serum creatinine, Outcome 15 Creatinine 6 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Serum creatinine, Outcome 16 Peak creatinine." data-id="CD010777-fig-0022" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Serum creatinine, Outcome 16 Peak creatinine.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Adverse events related to remote ischaemic preconditioning, Outcome 1 Adverse events related to RIPC." data-id="CD010777-fig-0023" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Adverse events related to remote ischaemic preconditioning, Outcome 1 Adverse events related to RIPC. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Need for dialysis, Outcome 1 Need for dialysis." data-id="CD010777-fig-0024" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Need for dialysis, Outcome 1 Need for dialysis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Acute kidney injury defined by AKIN, Outcome 1 Acute kidney injury defined by AKIN." data-id="CD010777-fig-0025" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Acute kidney injury defined by AKIN, Outcome 1 Acute kidney injury defined by AKIN. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Acute kidney injury defined by AKIN, Outcome 2 AKIN: grade 1." data-id="CD010777-fig-0026" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Acute kidney injury defined by AKIN, Outcome 2 AKIN: grade 1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Acute kidney injury defined by AKIN, Outcome 3 AKIN: grade 2." data-id="CD010777-fig-0027" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Acute kidney injury defined by AKIN, Outcome 3 AKIN: grade 2.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Acute kidney injury defined by AKIN, Outcome 4 AKIN: grade 3." data-id="CD010777-fig-0028" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Acute kidney injury defined by AKIN, Outcome 4 AKIN: grade 3.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Acute kidney injury defined by RIFLE, Outcome 1 RIFLE." data-id="CD010777-fig-0029" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Acute kidney injury defined by RIFLE, Outcome 1 RIFLE.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Acute kidney injury defined by RIFLE, Outcome 2 RIFLE: R." data-id="CD010777-fig-0030" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Acute kidney injury defined by RIFLE, Outcome 2 RIFLE: R.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Acute kidney injury defined by RIFLE, Outcome 3 RIFLE: I." data-id="CD010777-fig-0031" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Acute kidney injury defined by RIFLE, Outcome 3 RIFLE: I.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Acute kidney injury defined by RIFLE, Outcome 4 RIFLE: F." data-id="CD010777-fig-0032" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Acute kidney injury defined by RIFLE, Outcome 4 RIFLE: F.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Acute kidney injury defined by RIFLE, Outcome 5 RIFLE: L." data-id="CD010777-fig-0033" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Acute kidney injury defined by RIFLE, Outcome 5 RIFLE: L.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Acute kidney injury defined by RIFLE, Outcome 6 RIFLE: E." data-id="CD010777-fig-0034" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 Acute kidney injury defined by RIFLE, Outcome 6 RIFLE: E.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Serum NGAL, Outcome 1 NGAL day 1." data-id="CD010777-fig-0035" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Serum NGAL, Outcome 1 NGAL day 1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Serum NGAL, Outcome 2 NGAL day 2." data-id="CD010777-fig-0036" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Serum NGAL, Outcome 2 NGAL day 2.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Serum NGAL, Outcome 3 NGAL day 3." data-id="CD010777-fig-0037" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Serum NGAL, Outcome 3 NGAL day 3.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Urine NGAL, Outcome 1 Urine NGAL 4 hours." data-id="CD010777-fig-0038" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Urine NGAL, Outcome 1 Urine NGAL 4 hours.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Urine NGAL, Outcome 2 Urine NGAL 12 hours." data-id="CD010777-fig-0039" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Urine NGAL, Outcome 2 Urine NGAL 12 hours.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Urine NGAL, Outcome 3 Urine NGAL day 1." data-id="CD010777-fig-0040" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Urine NGAL, Outcome 3 Urine NGAL day 1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Mortality, Outcome 1 Mortality." data-id="CD010777-fig-0041" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Mortality, Outcome 1 Mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010777-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/urn:x-wiley:14651858:media:CD010777:CD010777-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_t/tCD010777-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Length of hospital stay, Outcome 1 Length of hospital stay." data-id="CD010777-fig-0042" src="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Length of hospital stay, Outcome 1 Length of hospital stay.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/media/CDSR/CD010777/image_n/nCD010777-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010777-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings table</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Ischaemic preconditioning for the reduction of renal ischaemia reperfusion injury</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patients or population:</b> patients undergoing a surgical intervention that induces kidney injury<br/> <b>Setting:</b> perioperative hospital setting<br/> <b>Intervention:</b> ischaemic preconditioning<br/> <b>Control:</b> no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Absolute effect<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of patients<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with RIPC</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serum creatinine: day 1</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean serum creatinine on day 1 was 0 mg/dL</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD was <b>0.02 mg/dL lower</b> (0.05 mg/dL lower to 0.02 mg/dL higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1022 (14)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Funnel plot assessment suggests publication bias. Analysis without small studies showed no significant differences. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serum creatinine: day 2</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean serum creatinine on day 2 was 0 mg/dL</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD was <b>0.04 mg/dL lower</b> (0.09 mg/dL lower to 0.02 mg/dL higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>770 (9)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Funnel plot assessment suggests publication bias, however due to a limited amount of studies these results should be interpreted with care. Analysis without small studies showed no significant difference </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serum creatinine: day 3</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean serum creatinine day 3 was 0 mg/dL</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD was <b>0.05 mg/dL lower</b> (0.19 mg/dL lower to 0.1 mg/dL higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>417 (6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insufficient data to assess publication bias.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Adverse events related to RIPC</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 3.47<br/> (0.55 to 21.76) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>3993 (15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Adverse effects due to remote ischaemic preconditioning only occurred in traumatic clamping of arteries. There were no reports of adverse events when applying remote ischaemic preconditioning by cuff </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2 per 1,000<br/> (0 to 11) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Need for dialysis</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.85<br/> (0.37 to 1.94) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2417 (13)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊖<br/> <b>Moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>The low incidence of dialysis results in a moderate Grade of evidence</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>38 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>32 per 1,000<br/> (14 to 74) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Acute kidney injury defined by AKIN</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.76<br/> (0.57 to 1.00) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2364 (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>This outcome regards the overall AKIN score, when subdivided in grade 1, 2 and 3 there is no evidence of effect </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>369 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>281 per 1,000<br/> (211 to 369) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Mortality</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.86<br/> (0.54 to 1.37) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>4931 (24)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>17 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>15 per 1,000<br/> (9 to 23) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>The risk in the intervention group</b> (and the 95% confidence interval) is based on the risk in the control group and the <b>relative effect</b> of the intervention<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High quality</b>: Further research is very unlikely to change our confidence in the estimate of effect. </p> <p><b>Moderate quality</b>: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. </p> <p><b>Low quality</b>: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> <p><b>Very low quality</b>: We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>RIPC ‐ remote ischaemic preconditioning</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings table</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/full#CD010777-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010777-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Subgroup analyses</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b> Subgroups</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b> Creatinine day 1 post‐op (mg/dL)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b> Creatinine day 2 post‐op (mg/dL)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b> Creatinine day 3 post‐op (mg/dL)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>MD [95% CI]</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>I<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>MD [95% CI]</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>I<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>MD [95% CI]</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>I<sup>2</sup> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.02 [‐0.05 to 0.02]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.04 [‐0.09 to 0.02]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.05 [‐0.19 to 0.10]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="10" rowspan="1" valign=""> <p><b><i>Age</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.02 [‐0.09 to 0.05]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.01 [‐0.08 to 0.06]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.07 [‐0.24 to 0.09]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.02 [‐0.06 to 0.02]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.05 [‐0.16 to 0.06]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="10" rowspan="1" valign=""> <p><b><i>Total duration of ischaemia</i> </b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.02 [‐0.10 to 0.06]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.04 [‐0.14 to 0.06]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.09 [‐0.28 to 0.09]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41%</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.02 [‐0.07 to 0.03]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.03 [‐0.13 to 0.08]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.09 [‐0.44 to 0.27]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>82%</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.04 [‐0.16 to 0.25]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="10" rowspan="1" valign=""> <p><b><i>Number of RIPC cycles</i> </b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 cycles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.14 [‐0.27 to ‐0.02]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 cycles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.01 [‐0.06 to 0.08]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.03 [‐0.11 to 0.05]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.05 [‐0.15 to 0.06]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12%</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 cycles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.01 [‐0.05 to 0.03]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.02 [‐0.12 to 0.08]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.12 [‐0.00 to 0.24]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="10" rowspan="1" valign=""> <p><b><i>Method of RIPC induction</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blood pressure cuff upper arm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.03 [‐0.08 to 0.01]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.08 [‐0.13 to ‐0.02]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.09 [‐0.28 to 0.09]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blood pressure cuff lower limb</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.01 [‐0.04 to 0.06]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.01 [‐0.08 to 0.10]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.06 [‐0.03 to 0.15]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aortic or iliac artery clamping</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.14 [‐0.27 to ‐0.02]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="10" rowspan="1" valign=""> <p><b><i>Type of surgery</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Abdominal aortic aneurysm repair</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.27 [‐0.60 to 0.06]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Coronary artery bypass grafting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.02 [‐0.08 to 0.05]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.00 [‐0.08 to 0.08]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.01 [‐0.19 to 0.16]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other types of cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.01 [‐0.05 to 0.04]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.05 [‐0.13 to 0.03]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.01 [‐0.10 to 0.13]</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p>RIPC ‐ remote ischaemic preconditioning</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Subgroup analyses</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/full#CD010777-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010777-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Serum creatinine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Creatinine: 1 hour <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 CABG</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Creatinine: 3 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.04, 0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.04, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 AAA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.12 [‐0.40, 0.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Creatinine 4 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Creatinine 6 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 CABG</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Creatinine 12 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>115</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.07, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.07, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 CABG</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.18, 0.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Creatinine day 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1022</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.05, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>541</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.09, 0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>481</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.06, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Creatinine day 1: all subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>541</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.09, 0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>481</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.06, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 15 min total ischaemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>191</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.10, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4 20 min total ischaemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>658</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.07, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.5 30 min total ischaemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.16, 0.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.6 2 RIPC cycles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>165</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.27, ‐0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.7 3 RIPC cycles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.06, 0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.8 4 RIPC cycles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>536</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.05, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.9 Upper arm cuff</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>490</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.08, 0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.10 Lower limb cuff</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>367</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.04, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.11 Vascular clamping</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>165</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.27, ‐0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.12 AAA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.27 [‐0.60, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.13 CABG</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>289</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.08, 0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.14 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>611</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.05, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Creatinine day 2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>770</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.09, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>361</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.08, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>409</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.16, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Creatinine day 2: all subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>361</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.08, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>409</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.16, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 15 min total ischaemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.14, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.4 20 min total ischaemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>504</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.13, 0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.5 30 min total ischaemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.15, 0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.6 2 RIPC cycles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.61 [‐1.41, 0.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.7 3 RIPC cycles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>266</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.11, 0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.8 4 RIPC cycles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>464</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.12, 0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.9 Upper arm cuff</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>489</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.13, ‐0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.10 Lower limb cuff</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>241</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.08, 0.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.11 Vascular clamping</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.61 [‐1.41, 0.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.12 AAA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.61 [‐1.41, 0.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.13 CABG</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>245</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.08, 0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.14 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>485</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.13, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Creatinine day 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>417</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.19, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>344</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.24, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.16, 0.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Creatinine day 3: all subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>344</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.24, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.16, 0.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.3 15 min total ischaemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.28, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.4 20 min total ischaemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>210</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.44, 0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.5 30 min total ischaemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.14, 0.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.6 2 RIPC cycles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.66 [‐1.10, ‐0.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.7 3 RIPC cycles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>207</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.15, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.8 4 RIPC cycles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [‐0.00, 0.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.9 Upper arm cuff</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.28, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.10 Lower limb cuff</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.03, 0.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.11 Vascular clamping</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.66 [‐1.10, ‐0.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.12 AAA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.66 [‐1.10, ‐0.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.13 CABG</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>186</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.19, 0.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.14 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>149</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.10, 0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Creatinine day 4 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Creatinine day 7 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 AAA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Creatinine 1 month <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 Partial nephrectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Creatinine 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 Partial nephrectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Peak creatinine <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>365</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.20, ‐0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.37, 0.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 CABG</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>311</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.11 [‐0.23, 0.01]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Serum creatinine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010777-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Adverse events related to remote ischaemic preconditioning</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Adverse events related to RIPC <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3993</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.47 [0.55, 21.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Adverse events related to remote ischaemic preconditioning</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010777-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Need for dialysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Need for dialysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2417</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.37, 1.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1800</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.32, 2.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 CABG</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>473</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.07, 11.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 AAA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Need for dialysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010777-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Acute kidney injury defined by AKIN</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Acute kidney injury defined by AKIN <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.57, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>469</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.64, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 CABG</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1895</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.32, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 AKIN: grade 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.47, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>240</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.61, 1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 CABG</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1895</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.29, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 AKIN: grade 2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.41, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>240</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.25, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 CABG</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1895</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.29, 1.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 AKIN: grade 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.37, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>240</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.18, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 CAGB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1895</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.45, 1.43]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Acute kidney injury defined by AKIN</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010777-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Acute kidney injury defined by RIFLE</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 RIFLE <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1586</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.75, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 RIFLE: R <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1586</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.58, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 RIFLE: I <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1586</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.78, 1.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 RIFLE: F <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1586</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.59, 2.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 RIFLE: L <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 RIFLE: E <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Acute kidney injury defined by RIFLE</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010777-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Serum NGAL</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 NGAL day 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [‐2.65, 3.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Cardiac surgery: adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>15.30 [‐40.85, 71.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Cardiac surgery: children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [‐2.71, 3.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 NGAL day 2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Cardiac surgery: children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 NGAL day 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Cardiac surgery: children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Serum NGAL</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010777-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Urine NGAL</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Urine NGAL 4 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Urine NGAL 12 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Urine NGAL day 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Urine NGAL</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010777-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Mortality</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4931</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.54, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Mortality</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010777-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Length of hospital stay</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>920</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [‐0.46, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [‐2.19, 3.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 CABG</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.48, 0.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 AAA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.0 [‐5.69, 1.69]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Length of hospital stay</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010777.pub2/references#CD010777-tbl-0011">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010777.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010777-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010777-note-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="ms#CD010777-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD010777-note-0001">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD010777-note-0009">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010777\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010777\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010777\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010777\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010777\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010777\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010777\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010777\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010777\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010777\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010777\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010777\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010777\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010777\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010777\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010777\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010777\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010777\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=77cjsSG8&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010777.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010777.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010777.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010777.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010777.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718514154"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010777.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718514157"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010777.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dd2319984f401',t:'MTc0MDcxODUxNC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 